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Abstract 
Background 
The largest proportion of HIV-infected people resides in Southern Africa. In South 
Africa, the government has taken the lead in the provision of free HIV treatment with 
a high coverage rate. Provision of free antiretroviral treatment has led to a decline in 
mortality rates and an increase in life expectancy. However, a significant number of 
people with HIV continue to die despite the availability of free treatment. A large 
proportion of studies have concentrated on using quantitative methods of analysis. 
Very few have used mixed methods that combine quantitative time-to-event frailty 
models and qualitative methods in assessing risk factors for mortality in HIV-infected 
individuals. However, use of such mixed methods approach could provide insights 
that may lead to an improvement in patient care and management.  
Aim 
To determine mortality risk factors in HIV-infected people through incorporating 
unobserved variables using a mixed methods approach in which quantitative findings 
are explained by the qualitative. 
Methods 
To critically review statistical methods used for assessing risk factors for mortality in 
HIV-infected people between the years 2002 and 2011. We conducted a literature 
review on the design of studies, how data were analysed and whether suitable 
statistical methods were utilised in assessing mortality risk factors in HIV-infected 
people in the period 2002-2011. Only publications written in English and listed in 
Pubmed/Medline were considered. In this review, papers using time-to-event 
techniques were regarded as appropriate. Data were split into two equal periods 
allowing for the comparison of the statistical methods over time. 
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To compare the different time-to-event methods, we ran 1,000 simulations of 
parametric clustered data using parameters derived from an HIV study that was 
conducted in South Africa by the Perinatal HIV Research Unit (PHRU). Data for 5, 10 
and 20 clusters of size 50 and 100 were simulated.  Survival and censoring times 
were derived from a Weibull distribution. The minimum of survival and censoring 
times was taken as the study time. Using the simulated data, we compared the 
following time-to-event methods: Cox proportional hazards regression, shared 
Gamma frailty with Weibull and exponential baseline hazards (frequentist models), 
and the Bayesian integrated nested Laplace approximation (INLA) with Weibull 
baseline hazard. Parameter estimates, standard errors and their fit statistics were 
averaged over 1,000 simulations. Similarly, means and standard deviations from 
INLA were averaged (over the 1,000 simulations). Frequentist models were 
compared using the -2 loglikelihood fit statistics while all the four models were 
compared using the mean square error (MSE). Additionally, we simulated semi-
parametric clustered frailty models (using gamma and log-normal frailties) including 
INLA, h-likelihood, penalized likelihood and penalised partial likelihood estimations. 
Parameter estimates and their standard errors were presented graphically and 
compared using the MSE.  
To assess mortality risk factors in HIV-infected people in South Africa in different 
settings, factors associated with mortality in HIV-infected people were assessed by 
INLA survival frailty model using cohort data of HIV-infected people from South 
Africa. Two thirds were from Soweto (urban) and the rest from Mpumalanga (rural). 
Findings were evaluated by site.  
Mixed methods were used to evaluate risk factors for mortality by combining the best 
fitting model applied to retrospective data and qualitative analysis on prospective 
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data. In order to explain the unobserved frailty modelling results, we conducted a 
qualitative study that enrolled 20 participants who had confirmed knowing a person 
that had died as a result of HIV. Participants were recruited from the Zazi VCT in 
PHRU and were interviewed using a semi-structured interview guide. The aim of the 
qualitative study was to attempt to explain the unobserved factors influencing 
mortality in HIV-infected individuals using perceived reasons for death given by the 
participants. These were later used to complement the potential reasons for death as 
identified in the frailty modelling (quantitative) results.    
Results 
In the critical review, 189 studies met the inclusion criteria that included prospective 
(69%) and retrospective (30%) studies. Of the 189 studies, 91 were published in the 
period 2002-2006 and 98 in 2007-2011. Cox regression analysis with frailty was 
used in only 7 studies (~4%); of which 6 were published between the years 2007-
2011.  
The simulation study showed that the shared frailty models performed better than 
Cox-PH. Within the shared frailty models, the Gamma frailty model with a Weibull 
baseline performed better than the Gamma frailty model with an exponential 
baseline. The MSE showed that in general, the Bayesian INLA had better results. In 
the semiparametric simulations, results were similar but INLA had a slightly better fit 
with consistently lower MSE values relative to both gamma and log-normal frailty 
models. The random effects estimate for INLA, whose method is slightly different, 
had lower MSE values consistently relative to the other methods. 
In the HIV cohort study, 6,690 participants were enrolled with majority being female 
(78%) and most participants residing in an urban area (67%). Rural participants were 
older (36 years; IQR: 31-44) and with a higher mortality rate (11/100 person years). 
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Among those residing in rural areas, HAART treatment for between six and twelve 
months (HR: 0.2, 95% CI: 0.1-0.4) and more than 12 months (HR: 0.1, 95% CI: 0.1-
0.2) was protective relative to not being on treatment. Being on HAART treatment for 
greater than twelve months was protective in the urban participants (HR: 0.35, 
95%CI: 0.27-0.46). Significant heterogeneity, assessed by frailty variance, was high 
in rural participants and lower in the urban. 
Since the frailty modelling results suggested that the unobserved variables had a 
significant effect on mortality in HIV-infected individuals, a qualitative study was 
conducted to explore the potential causes of death. In the qualitative study, 
participants perceived that mortality in HIV-infected individuals may have been 
influenced by engagement in risky sexual behaviour such as multiple sexual 
partnerships, negative attitude by healthcare workers towards HIV-infected people, 
believing in the healing power of religion, traditional medicine, food security and 
social support structure.  
Conclusions 
The study found that Cox proportional hazards regression with frailty is not 
commonly used in research on mortality in HIV-infected individuals as it is used in 
other fields of health research. Additionally, use of the more complex semiparametric 
frailty models was even lower in this population. From simulations, we found that 
frailty survival models provided a better fit in modelling mortality due to their ability to 
account for unobserved variables especially the Bayesian INLA. As the unobserved 
variables are complex to explain using only quantitative modelling techniques, 
qualitative analysis of perceived causes of death was explored. Unobserved 
variables affecting mortality were explored through qualitative analysis of perceived 
reasons provided by bereaved participants. This mixed methods approach optimised 
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data by using a quantitative approach followed by a qualitative one that 
complemented each other. Use of optimal methods in assessing morbidity and 
mortality in HIV-infected patients may improve patient care and management in 
South Africa and other countries. 
Key words: HIV, Mortality, Rural, Urban, unmeasured variables, HAART, Frailty 
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Preface 
HIV remains a burden in sub-Saharan Africa where most of the infected people live.  
While the risk of mortality is lower due to the availability of free antiretroviral therapy 
in most sub-Saharan countries, a significant number of the infected people continue 
to die. Furthermore, those dying are largely in the productive stages of their lives. 
Hence further research is required to provide further insights on the factors 
associated with mortality in this cohort especially in patients on long term treatment. 
Working in the field of HIV and TB research, I have had an opportunity of analysing 
several datasets for different purposes including conference abstracts, regulatory 
authorities and manuscripts. In the process, I was confronted by interesting 
situations where statistical modelling alone was insufficient in explaining study 
findings. While statistical analysis is helpful in assessing a hypothesis, there may 
arise situations where “the why” part of the findings cannot be sufficiently explained 
by modelling.  
We sought to analyse mortality risk factors in HIV-infected individuals using Cox 
regression analysis modelling with frailty. Frailty is simply a term that assesses 
heterogeneity within a cluster or at the individual level in a sample. In our study, 
clusters were defined as either clinics where patients sought care or individuals with 
longitudinal data collected during follow-up. Hence in this study, frailty was assessed 
at the cluster level for the simulations and repeated measures data for individuals 
enrolled in the Adult Wellness cohort study. Both are indications of the shared frailty 
model assuming similar frailty within a cluster (or set of observations in repeated 
measures in an individual). Within an individual, the set of repeated measures form a 
cluster. Under the guidance of my supervisors, we sought to critically review 
literature on frailty modelling specifically applied to HIV-infected cohorts during the 
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period 2002-2011. In the literature, a low number of publications had utilised frailty 
modelling in assessing HIV risk factors. Furthermore we found no single publication 
assessing HIV risk factors using a mixed methods approach that incorporates frailty 
modelling and qualitative research. Following these findings and discussions with my 
supervisors, a clearer picture of a potential research question for PhD emerged. This 
was further strengthened by establishing key objectives that generated at least three 
publications.  
The benefits of using methods that complement each other (mixed methods) are 
illustrated when assessing risk factors for mortality in HIV-infected people. 
 
“Mixed methods research is important in health systems because it allows 
researchers to view problems from multiple perspectives, contextualize 
information, develop a more complete understanding of a problem, triangulate 
results, quantify hard-to-measure constructs, provide illustrations of context 
for trends, examine processes/experiences along with outcomes and capture 
a macro picture of a system” (Creswell and Clark, 2011) 
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1.0 Introduction  
1.1 Problem statement 
In an ideal study, researchers would just collect as many relevant variables as 
possible that may help in addressing a particular research question. However, due to 
funding and logistical constraints, this is often impossible. Depending on the 
research question at hand, this may pose challenges during the analysis - requiring 
the use of a combination of methods in addressing the primary objectives.  
Research studies generally involve the collection of data from people with similar 
characteristics such as those residing in the same household or neighbourhood or 
attending the same school or health clinics.1-5 In other instances, research studies 
may involve collection of data longitudinally on the same people over time. In these 
cases, data collected within the same setting or from the same individuals during 
follow-up are correlated and are assumed to form a cluster. Other examples of 
clustering include healthcare workers employed in the same facility as well as 
participants enrolled in the same centre in a multi-centre clinical trial. Evaluating the 
health outcomes of people clustered in the same setting may involve analysing a 
time-to-event outcome like death or birth in a family or the first incident of a specific 
disease or hospitalisation. Such outcomes may be clustered within a household, a 
community, a school or a hospital due to similarity between members leading to 
correlation in cluster units.1, 2, 4-8 Additionally, there may be other important variables 
that were not observed or collected during the study as well as variations between 
members of a cluster. The variations may involve some members being sicker than 
others hence introducing heterogeneity within the cluster. 
Currently, the analysis of time-to-event data with mortality as outcome in HIV-
infected individuals’ involves using classical statistical approaches like Cox 
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proportional hazards regression.9-12 However, the assumption underlying this 
methodology such as existence of a uniform risk13 in mortality, ignores the effect of 
unobserved variables as well as participant heterogeneity within clusters or across 
participants in the same cluster. Ignoring these effects may lead to biased estimates 
and conclusions. Hence modelling mortality in data such as this requires application 
of suitable techniques that will account for the effect of unobserved heterogeneity. 
Frailty models may be individual (unshared) or shared. In the individual frailty models 
sometimes referred to as univariate frailty, diversity or heterogeneity of data is 
evaluated within individuals; in the shared frailty model, sometimes referred to as 
multivariate frailty, groups of individuals such as patients in a clinic are assumed to 
share the same frailty. 
 More complex survival analysis techniques that form extensions of the classical Cox 
regression analysis exist that may be suitable for fitting time-to-event models that 
account for unobserved variables as well as within cluster heterogeneity. This 
includes Cox proportional hazards regression modelling with frailty1, 4, 5, 7 that adjusts 
for unobserved heterogeneity.  The approach has the capability of quantifying the 
effect of unobserved heterogeneity while at the same time indicating whether the risk 
of an event increases or decreases significantly in the presence of unobserved 
variables. Survival frailty models are often applied using different statistical 
distributions for the frailty term. Several possibilities for the frailty distribution exist 
and include making assumptions about the type of distribution (parametric) or 
working under a distribution free (semiparametric) framework. The performance of 
the frailty methods is tested through simulated data that compares them. Statistical 
distributions are used to generate data that mimic’s the real world which can then be 
used for analysis. Simulations are powerful and important since they are less biased 
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and lead to plausible parameter estimates during the analysis. Through simulations, 
this study sought to identify the most suitable technique for fitting the Cox regression 
analysis with frailty and accounting for unobserved heterogeneity in a cohort of HIV-
infected adults. 
When unobserved heterogeneity is found to exist, the variable is often unknown 
because it was never collected during the study. However during the analysis where 
frailty is assessed, a cluster variable such as a clinic or individual with longitudinal 
data is specified. In this study, clusters representing clinics were assessed for frailty 
in the simulations whereas in the HIV Adult Wellness cohort data, individuals with 
longitudinal data were used as the clustering unit.  Subsequently, it is explained by 
using speculative but plausible variables. In cohort studies involving HIV-infected 
individuals, speculative reasons may not truly reflect the true situation on the ground. 
This therefore justifies the need for a qualitative follow-up study to provide further 
insights that complement the quantitative analysis findings using the mixed methods 
approach. The qualitative findings are used to explain the unobserved heterogeneity 
(represented by the frailty result) from the quantitative analysis. There are few 
studies that use a mixed methods approach for investigating risk factors for mortality 
in HIV-infected people. Hence, this study proposes to explore the benefits of 
integrating both quantitative and qualitative analysis in identifying mortality risk 
factors. It is envisaged that findings from the mixed methods approach could provide 
further details that could be utilised to improve patient care and management. 
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1.2 Study justification 
South Africa is the most successful country in providing free anti-retroviral treatment 
to HIV-infected people in the public sector. It is also among the countries with the 
highest burden of HIV and tuberculosis as well a good coverage of treatment for both 
diseases.14 The free ART programs have been scaled up by the government in order 
to initiate therapy to as many eligible people as possible following the treatment 
guidelines. Once ART treatment is initiated, an HIV-infected person remains on 
treatment for life thus requiring appropriate patient care and management. In the 
long term however, there is need to understand these risks better for preventative 
purposes and identification of modifiable factors. As such, several studies in 
literature report on risk factors for mortality in HIV-infected people using short-term 
studies.9, 10 Longer-term studies where conditions might change over time are likely 
to identify modifiable variables of interest that may be important in the care of 
patients. Such can be identified through use of robust methods that include both 
quantitative and qualitative techniques, otherwise called mixed methods, if utilised 
complementarily. In quantitative analysis involving time-to-event data, survival frailty 
modelling is a statistical modelling approach that enables one to account for 
unobserved variables. Furthermore, it also quantifies the magnitude of the 
unobserved measure.  This improves precision of estimates for the predictors of 
mortality through alleviation of bias.6, 15, 16  
While quantitative methods are popular in assessing risk factors for mortality, they 
lack a strengthened justification of their findings by not using a mixed methods 
approach. The use of mixed methods analysis provides the benefit of combining 
findings from quantitative and qualitative approaches. These findings are 
triangulated to present an integrated set of findings that are more informative than 
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those deduced from one approach. Mixed methods approaches are slowly gaining 
ground in the research community due to their power in providing complementary 
results. 
1.3 Aims and objectives of the study 
1.3.1 Overall aim 
To determine mortality risk factors in HIV-infected people through incorporating 
unobserved variables using a mixed methods approach in which quantitative findings 
are explained by the qualitative. 
1.3.2 Specific Objectives 
1. To critically review statistical methods used for assessing risk factors for 
mortality in HIV-infected people between the years 2002 and 2011. 
2. To use parametric and semiparametric frailty model simulations and real HIV 
data to compare mortality risk factors using a variety of methods and identify 
the type of model that provides a better fit.  
3. To assess mortality risk factors in HIV-infected people in South Africa in 
different settings using the model identified in objective 2. 
4. To use mixed methods (combining the best fitting model applied on 
retrospective data and qualitative analysis on prospective data) to evaluate 
mortality risk factors.  
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1.4 Background 
The burden of HIV/AIDS mortality remains a major challenge worldwide despite the 
introduction of free anti-retroviral treatment (ART). According to the UNAIDS 2010 
AIDS Global report, the number of HIV/AIDS related deaths has reduced from 
approximately 2.1 million in 2004 to 1.8 million in 2009.17 This is largely attributed to 
the availability of free ART, care and support and decreasing incidence rates as a 
result of successful prevention of mother to child transmission (PMTCT).17 Other 
intervention measures like behaviour change, condom promotion and distribution 
and medical male circumcision have also played a role in reducing HIV infection 
rates. 
Globally, two out of three HIV-infected people reside in Sub-Saharan Africa, the 
region with the highest burden of the disease. The prevalence of the disease varies 
from under 1% to above 20%. But some of the countries with low prevalence have 
large populations translating to large numbers of people who are HIV-infected. Just 
above 11 million HIV-infected people were residing in Southern Africa in the year 
2009, a figure that is higher than that reported a decade earlier.17 Though HIV 
incidence rates have dropped in Sub-Saharan Africa, the proportion of new cases 
remains high.18 It is estimated that approximately 1.2 million people died in 2010 
whereas the number of new infections was significant.17, 18 About half of the global 
mortality figures associated with HIV in the year 2010 were traced to Southern 
Africa.18  
At 5.6 million estimated HIV-infected people, South Africa is among the countries 
with the highest proportion of HIV positive people globally even though they have 
successfully implemented PMTCT programs with a coverage of above 90%.17, 18  
Though ART has reduced mortality rates in general, a significant number of deaths 
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are attributed to HIV.18-20 Investments by the government and donors have resulted 
in significant changes in the management of HIV in the country leading to an 
increase in prevention programs and widespread availability of ART that have 
lowered mortality associated with HIV. 
With the scaling up of ART programs in many Sub-Saharan African countries, further 
insight on the long-term implications of treatment and its effect on mortality is 
required in order to provide optimal care. A plethora of literature exists on risk factors 
for mortality in HIV-infected people.10, 21-23 Such literature has however seldom 
utilized robust statistical methods that provide a better assessment of mortality risk 
factors and the effect of hidden (latent) variables. 
Statistical analyses (quantitative technique) of such data often use classical 
approaches such as logistic and Cox regression (survival analysis) models. Logistic 
regression models require large sample sizes to ensure sufficient power to detect 
mortality differences especially in checking model fit.24-26 Cox regression makes the 
assumption of uniform risk in mortality across all patients (homogeneity).13, 27 This 
assumption is generally limited because it is known that frail patients have a higher 
chance of death.  
This study seeks to investigate risk factors for all-cause mortality in HIV positive 
participants using a mixed methods approach. The quantitative analysis proposed 
will be an extension of the classical survival analysis. The study will compare several 
survival analysis methods including frailty models using simulations and real data. 
We postulate that if properly modelled, frailty models provide a better fit compared 
with classical Cox proportional hazards regression. Thereafter, a qualitative analysis 
will be conducted involving participants with a deceased HIV-infected relative or 
friend. Findings from the qualitative and quantitative analysis will be used 
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complementarily to better understand the risk factors for mortality in HIV-infected 
people. Qualitative results will specifically be used to provide further insight to the 
frailty modelling results. 
1.5 Conceptual framework 
In order to show the process that was followed, Bhaskar’s critical realism conceptual 
framework was applied.28 This framework advocates for the use of a combination of 
methods in the analysis of research data with the understanding that they 
complement each other.29-31 The study was designed to use quantitative analysis in 
assessing the literature review of publications on risk factors for mortality in HIV-
infected people in a specified period followed by analysis on simulations and real 
data. The literature review involved identifying the commonly used statistical 
techniques in publications reporting on mortality risk factors. Thereafter simulations 
were used to identify the best fitting model that was later applied to the analysis of 
the Adult Wellness data. This was later followed by a qualitative analysis whose 
findings were used to explain those from the quantitative. As a whole, combinations 
of methodologies were used including in-depth analysis of qualitative data in 
explaining the findings as advocated by the critical realism framework. 
We assessed the pathways presented in Figure 1 for the objectives specified above 
and the results are presented as attached publications at the end of this thesis. The 
literature review publication (see attached original paper 1) identified the 
methodological gap while simulations were helpful in identifying the best fitting and 
most robust method (original paper 2). The evaluation of mortality risk factors by 
setting (rural versus urban) identified the presence and quantified the effect of the 
unobserved (latent) variables (original paper 3). Findings from the qualitative 
analysis were instrumental in complementing those from the quantitative analysis by 
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providing further insight on the nature of important unobserved variables that may be 
affecting mortality which were not captured in the Adult Wellness study (paper 4 in 
progress). 
 
 
 
 
Figure 1: Critical Realism Conceptual Framework 
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2.0 Literature review 
2.1 A critical review of existing methods 
In biomedical research, the use of appropriate statistical methods in the analysis of 
study data is increasingly receiving more attention. This is demonstrated by the 
inclusion of statisticians in the review of manuscripts. A plethora of publications exist 
on the design of studies and suitability of the statistical analysis techniques 
applied.32-36 Incorrect methodology may lead to wrong results and conclusions that 
may lead to poor decisions in the management and care of patients.  
Reviews on commonly used statistical methodologies suggest use of simple 
inferential analysis methods that are easy to implement in standard software. A 
common methodology for assessing risk factors for mortality is the logistic regression 
model,22, 37, 38 where predictors of a binary response are determined.26 While the 
implementation of logistic regression is fairly straightforward, it ignores the effect of 
time especially in long-term studies with heterogeneity between patients.  
Cox proportional hazards (Cox-PH) regression is widely used in evaluating time-to-
death because it has the benefit of incorporating the effect of time and assumes that 
the risk of death is uniform across participants.13 Research assessing risk factors for 
mortality favour this method.9-12, 39 However, participants with a longer term of follow-
up experience varying levels of disease and mortality risk (heterogeneity). 
Unfortunately, the Cox-PH model ignores heterogeneity and the relatedness 
between measurements taken from the same individual. 
While many publications exist on risk factors for mortality in HIV-infected individuals, 
reviews assessing design of studies, nature of statistical analysis techniques used 
and their suitability is sparse. As such, there is need to understand the robustness of 
the methods used for the benefit of the public health community.  Therefore, we 
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evaluated original publications meeting our study criteria in HIV-infected cohorts in 
the period 2002-2011 to assess the suitability of the methods used.   
2.2 Comparison of survival analysis methods 
While Cox-PH is the most implemented survival analysis technique, several 
extensions have been developed. In a review of oncology studies, the majority 
provided inadequate summary of methods.40 The most commonly used methods 
were the logrank test and the Cox-PH. In a review of the survival analysis methods 
for assessing competing risks (defined as mutually exclusive events), variants of the 
Cox-PH model were implemented. The effect of incorrect assumptions on parameter 
estimates and confidence intervals have previously been evaluated.41 When 
evaluating competing risks events in survival analysis of inferiority studies, the use of 
multiple time-to-event methods provides an opportunity to assess robustness.42 
Methods such as competing risks, marginal, frailty and Cox-PH models are 
recommended. Non-parametric covariate adjusted survival models perform better in 
non-inferiority studies compared to Cox-PH models.43 
When the assumption of uniform risk of mortality (homogeneity) is violated, the Cox-
PH model provides a poor fit. In this case, modelling focuses on addressing 
heterogeneity using the Cox-PH with frailty. Frailty models are superior when 
heterogeneity is inherent in data and perform better than the classical Cox-PH.4, 5, 7, 
42, 44, 45 Though more complex to fit, the Bayesian frailty models perform better.1, 7, 45, 
46  
Frailty modelling assumes some form of distribution for the frailties. Several 
distributions for the frailties have been proposed in the literature with the most 
common being the gamma and log-normal. The gamma distribution is commonly 
used due to its mathematical tractability while the log-normal fits in well with the 
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generalised linear mixed models. Frailty models may be implemented in parametric 
or semi-parametric forms.47 In the parametric form, a distribution is assumed for the 
survival time while in the non-parametric form, no distribution is assumed allowing for 
flexibility in the modelling process. While methods for modelling the parametric form 
are well developed, the semi-parametric form requires use of more complicated 
approaches. 47, 48  
Semi-parametric frailty models have been used to compare various frailty 
distributions with the most common frailty distributions being the gamma and log-
normal. Using a comparison of four models involving correlated data, it was shown 
that the semi-parametric frailty models perform better than the naïve Cox model. 49 
The use of the Dirichlet process prior in the Bayesian modelling of frailties has been 
shown to perform better in the semi-parametric frailty modelling compared with the 
parametric. 50 Using simulations, several software packages capable of fitting shared 
semi-parametric frailty models were compared and found to fit well but with varying 
levels of complexity. 2 Other examples on the performance of various 
semiparametric methods have been presented in literature using both gamma and 
lognormal frailties. 51-53 
Though frailty models are not commonly used in epidemiological research evaluating 
risk factors for mortality in HIV-infected people,54 they provide better, more reliable 
and robust estimates. We simulated survival data and analysed it using five methods 
available in standard software: Cox-PH, time varying Cox-PH, shared Gamma frailty 
with Weibull and exponential baseline hazards and the integrated nested Laplace 
approximation (INLA)17, 46, 55, 56 with a Weibull baseline. INLA is a recent Bayesian 
inference technique that provides accurate approximations and is computationally 
fast.45, 46, 55 Simulations were implemented to enable the identification of the best 
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fitting model through evaluating the fit statistics, parameter estimates and standard 
errors. The mean and standard deviations were similarly assessed for INLA. To our 
knowledge, studies comparing frequentist and the Bayesian INLA time-to-event 
methods are limited. Furthermore, our findings are an addition to the existing 
literature comparing frequentist and Bayesian time-to-event frailty models. In 
addition, articles presenting an overview of maximisation methods in semiparametric 
frailty models that include the integrated nested Laplace approximation are limited. 
This study provides such an overview using the gamma and lognormal frailties 
through simulations.  
2.3 Risk factors for mortality  
Mortality rates in HIV-infected people in Africa are declining because of free ART in 
public healthcare facilities. However, despite the availability of free treatment, 
patients continue to start treatment when they have advanced HIV disease, with a 
significant number succumbing to death soon after initiating treatment. As a result, it 
is imperative to re-assess risk factors for mortality with the aim of identifying where 
the challenge lies. 
Commonly reported risk factors vary across the literature and include clinical and 
socio-economic factors. Clinical factors include: declining CD4 count and increasing 
viral loads;10, 15, 23, 57 World Health Organisation (WHO) stages;23, 39 Centres for 
Disease Control (CDC) clinical staging;10 low haemoglobin levels;21, 23 and 
opportunistic infections6, 11, 58 such as pneumonia and undiagnosed and untreated 
tuberculosis (TB). Demographic variables such as age and gender have been 
associated with mortality.6 Education level, smoking of tobacco products59 and use of 
alcohol has similarly been associated with an elevated mortality risk in persons with 
HIV.58  
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The care of HIV-infected patients is improved by an in-depth understanding of the 
context in which mortality is likely to occur and how it can be mitigated. Different 
factors in both rural and urban settings in developing countries affect access to care 
impacting on the timing of treatment initiation or care seeking. Furthermore, the long 
term implications of anti-retroviral treatment need to be well understood. To 
understand these dynamics, epidemiological studies are required in African countries 
that bear the greatest burden of the disease and other resource limited countries 
where coverage of free antiretroviral care programmes has been rolled out. 
Analysing epidemiological research data using optimal statistical methods that 
incorporate unobserved variables may be helpful in providing further insights in the 
management and care of HIV patients. Additionally, these methods should seek to 
identify modifiable factors that may be used to develop tailored interventions.  
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3.0 Methodology 
3.1 Study setting and population 
In the quantitative analysis, data from the Adult Wellness study, a cohort of HIV-
infected adults, was analysed.58 Participants were enrolled at the Soweto based 
Perinatal HIV Research Unit (PHRU) and Tintswalo hospital in Mpumalanga, South 
Africa. The Adult Wellness study, whose data was used for the quantitative analysis 
in this study, was conducted from the year 2003 and ended in the year 2010. 
Thereafter, a qualitative study was conducted at PHRU between May and August 
2014 targeting participants who had reported a bereavement involving a person who 
was HIV-infected.   
PHRU is a leading clinical research centre located in a more urbanised area while 
Tintswalo is a primary healthcare facility located in a rural area.  Both sites managed 
patients using the same treatment guidelines as provided by the South African 
government. 
The township of Soweto is in the Southwestern part of Johannesburg and is 
estimated to have a population above a million people.60 It is estimated that a large 
proportion of the working population in the city of Johannesburg reside in Soweto. 
Poverty levels and high unemployment rates are the biggest challenges in the 
area.60  
The overall HIV prevalence of the province where Soweto is located is 12.4% and 
females are disproportionately affected by HIV.61 Access to free anti-retroviral 
treatment has reduced mortality rates associated with HIV but challenges such as 
delays in seeking care and starting medication timeously as well as development of 
opportunistic infections such as TB remains.62-64  
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Tintswalo is a rural based hospital that is located in Mpumalanga province of South 
Africa. It serves the people of Bushbuckridge district whose population size is about 
500, 000 people. High poverty levels affecting approximately three-quarters of the 
population have been documented in Bushbuckridge district. 65  
3.2 Ethical consideration 
The Human Research Ethics Committee (Medical) of the University of the 
Witwatersrand provided approval to conduct the study (clearance number M130818) 
as well as for the Adult Wellness study (clearance number M021129). All the 
participants willingly provided written informed consent to participate in the study. 
In the qualitative study, consenting was provided for study participation and audio-
recording. The consent forms and interview guides were written in English but the 
consenting process and the in-depth interviews were carried out in either English or 
Zulu as appropriate. Participants were re-imbursement (about $15 that approximated 
to 150 Rands at the time) for their time. To reduce selection bias, reimbursement 
was only made known during consenting. Counsellors were available at the PHRU 
ZAZI VCT clinic to provide counselling to any distressed participants.  
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3.3 Data and methods for objective 1 
Objective one involved a critical review of existing literature drawn from papers 
written on mortality risk factors in people with HIV. The areas of focus were in the 
design of the study, the methodology used for analysis and their suitability.  
3.3.1 Search strategy and selection criteria 
The online reference library Pubmed/Medline was searched for the terms ‘‘Predictors 
of HIV Mortality’’, ‘‘Determinants of HIV Mortality’’ and ‘‘Factors associated with HIV 
mortality’’.54 Publications had to be written in the English language to be eligible.  
Only publications written in the period 2002-2011 were retrieved as this period 
coincided with the window the Adult Wellness study was conducted. To evaluate 
whether an improvement in the use of statistical methods occurred over time, 
outcomes were analysed in the periods 2002-2006 and 2007-2011. Our criteria 
focussed primarily on original articles while excluding others such as editorials. 
Data were collected following a modified version of the method of Colditz and 
Emerson66, 67 and put on to a spreadsheet. The statistical methods extracted from 
the eligible publications were classified variously as outlined elsewhere.54   
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3.3.2 Data analysis 
The data were categorised into two periods 2002-2006 and 2007-2011 and 
comparisons made between them. Since all the data collected was categorical, 
frequencies were determined followed by chi-square analysis or Fishers exact test 
as appropriate. All the statistical analysis was assumed to be two-sided and 
performed using SAS Enterprise Guide 5.1 (SAS Institute, Cary, NC) at 5% level of 
significance. 
3.4 Data and methods for objective 2 
In the second objective, the parametric and non-parametric frailty models were used 
to analyse simulated data. Parametric methods are presented first followed by the 
non-parametric.  
In the parametric frailty modelling, four survival analysis techniques were used: Cox 
proportional hazards regression (Cox-PH), shared Gamma frailty (with Weibull and 
exponential baseline hazards) all frequentist and the Bayesian integrated nested 
Laplace approximation (INLA) with a Weibull baseline hazard.  
These methods were also applied to real data from a HIV-infected cohort in South 
Africa.  
3.4.1 Parametric frailty model simulations 
The four methods were compared through a simulation. Data were simulated from 
the shared frailty model ℎ𝑖𝑗(𝑡) = ℎ0(𝑡)𝑤𝑖 exp (𝑋𝑖𝑗𝛽) where, ℎ0(𝑡), 𝑤𝑖, 𝑋𝑖𝑗 and 𝛽  where 
ℎ0(𝑡) is the baseline hazard, 𝑤𝑖 is the frailty term, 𝑋𝑖𝑗 are the observed covariates for 
subject 𝑗 in cluster 𝑖 and 𝛽 are the parameter estimates. The Weibull distribution, 
defined as ℎ(𝑡) = 𝜆𝑡𝛼 with a uniform exponential baseline hazard was utilised for 
modelling the hazard for event and censor times. We first generated the frailties, 
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defined as 𝑤𝑖~𝑁(0, 𝜗) where  𝜗 is unknown variance, that were determined across 
clusters and number of participants per cluster. 68 The observed time was considered 
as the minimum of  (𝑇, 𝐶) where 𝑇 and 𝐶  are the event and censoring times 
respectively. T and C were derived from a Weibull distributed linear predictor to 
generate event and censoring times. The covariates 𝑋𝑖𝑗 (gender, employment status 
and CD4 categories) were generated from the uniform distribution 𝑈~(𝑎, 𝑏) after 
setting some parameters derived from the Adult Wellness study using the Cox 
proportional hazards regression. Categorisation (e.g male and female) of the 
variables in the simulated data was done using proportions determined in an actual 
HIV dataset on completion of follow-up. Participant information was assessed at their 
last visit. We assessed the probability coverage, the interval containing the true 
value most of the time, of the simulated data at 95% confidence level.  
We ran 1,000 simulations of a hypothetical data with 5, 10 and 20 clusters each of 
cluster size 50 and 100 participants. The final estimates/mean and standard 
errors/standard deviation were averaged over the simulated data.  
3.4.2 Statistical models 
Notation 
Let  𝑗 = 1, … , 𝑛 participants be enrolled in a study with 𝑖 = 1, … , 𝑛𝑗   clusters and a 
time-to-event endpoint. We assume that participants are followed until time 𝑇𝑖𝑗 when 
an event occurs or consent is withdrawn or are lost to follow-up or study completion. 
Let the observation time for participant 𝑗 in cluster 𝑖  be defined as 𝑇𝑖𝑗 = min (𝑇, 𝐶) 
where 𝜎 = 1 is the censoring variable defined as: 
𝜎 = {
1 ∶ 𝑖𝑓  𝑇𝑖𝑗 ≤  𝜎𝑖𝑗              𝑇ℎ𝑒 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒 𝑖𝑠 𝑛𝑜𝑡 𝑐𝑒𝑛𝑠𝑜𝑟𝑒𝑑
0 ∶ 𝑖𝑓 𝑇𝑖𝑗 >  𝜎𝑖𝑗              𝑇ℎ𝑒 𝑜𝑏𝑠𝑒𝑟𝑣𝑎𝑡𝑖𝑜𝑛 𝑡𝑖𝑚𝑒 𝑖𝑠 𝑐𝑒𝑛𝑠𝑜𝑟𝑒𝑑         
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Let 𝑋𝑖𝑗  be the explanatory variables such as gender, employment status and CD4 
count. Hence we may now define the hazard for person 𝑗 in cluster 𝑖 as ℎ𝑖𝑗(𝑡). For 
the purpose of illustration and without any loss of generality, analysis is confined to 
the covariates 𝑋𝑖𝑗 outlined above. 
We compare four selected time-to-event methods available in standard software:  
Cox-PH, shared Gamma frailty with Weibull and exponential baseline hazards and 
the integrated nested Laplace approximation (INLA) with a Weibull baseline hazard. 
The study site is considered a clustering variable in which frailty modelling is used to 
assess unobserved heterogeneity.  
3.4.2.1 Cox proportional hazards (PH) regression 
 
The Cox-PH is a semi-parametric regression model defined as ℎ𝑗(𝑡) = ℎ0(𝑡)𝑒
𝑋𝑗𝛽 
where ℎ0(𝑡) is an unspecified baseline hazard,  𝑿 is the vector of covariates and 𝛽 
are the parameter estimates.13, 69 The parameter estimates 𝛽𝑗′𝑠 are determined 
through the likelihood function 𝐿(𝜃|𝑦) =  ∏ 𝑝(𝑦𝑗|𝜃)
𝑛
𝑗=1 = ∏ [𝑓(𝑡𝑗)]
𝑐𝑗[𝑆(𝑡𝑗)]
1−𝑐𝑗𝑛
𝑗=1  on 
adjusting for censoring.69 𝑓(𝑡𝑗) is the probability density function while 𝑆(𝑡𝑗) is the 
survival function at a specified time and 𝐶𝑗 is the censoring indicator for subject  𝑗. 
The hazard ℎ𝑗(𝑡)  in this case allows for a population-averaged interpretation of the 
effect over all the clusters. 
3.4.2.2 Weibull Parametric Cox regression with Shared Gamma frailty 
To account for the effect of unobserved variables, the hazard function is modified to: 
ℎ𝑖𝑗(𝑡; 𝑥) = ℎ0(𝑡)𝑒
𝑋𝑖𝑗𝛽+𝑍𝛾 = ℎ0(𝑡)𝑤𝑖𝑒
𝑋𝑖𝑗𝛽 where 𝑤𝑖 is the Gamma frailty term (with a 
known mean and unspecified variance) and  ℎ0(𝑡) is the Weibull-distributed baseline 
hazard ℎ(𝑡) = 𝜆𝑣𝑡𝑣−1. 𝑤𝑖 accounts for unobserved heterogeneity in the risk of death 
through estimating the variance. 5, 7 Large values of the variance 𝜎2 reflect a greater 
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degree of heterogeneity. The Gamma frailty model is the most popular due to its 
simplicity in computation and analytical form in survival and hazard functions. 1, 4, 5, 7, 
44  
3.4.2.3 Exponential Parametric Cox regression with Gamma frailty 
In the frailty model ℎ𝑖𝑗(𝑡; 𝑥) = ℎ0(𝑡)𝑤𝑖𝑒
𝑋𝑖𝑗𝛽, the exponentially-distributed baseline 
hazard ℎ0(𝑡) = 𝜆 has a constant hazard. 
3.4.2.4 Bayesian Frailty modelling using Integrated Nested Laplace 
Approximation (INLA) 
Following the development of INLA using Bayesian inference, 45, 46, 55, 56 the hazard 
rate for the i-th subject is defined as ℎ𝑖(𝑡; 𝑥) = ℎ0(𝑡)exp (𝜂𝑖) where 𝑛𝑖 is a structured 
additive predictor from Latent Gaussian models. Using a baseline hazard function 
derived from the Weibull distribution, ℎ𝑖(𝑡; 𝑥) = 𝜆𝑣𝑡
𝑣−1 exp (𝜂𝑖) and  𝜂𝑖 = 𝛽0 + 𝛽𝑖 +
log 𝑤𝑖 where  𝛽0, 𝛽𝑖~𝑁(0,0.001) and 𝑣~ᴦ(1,0.001) are prior densities. 𝑤𝑖 are frailty 
effects ~𝑁(0, 𝜏−1). The likelihood is assumed exponential and defined as ∏(𝑦𝑖|𝜂𝑖 , 𝜃) 
where 𝜃 is the set of hyper-parameters. Parameter values are determined from 
estimates of the posterior marginals ?̂?(𝑥|𝑦) and ?̂?(𝜃|𝑦) that are resolved numerically 
in INLA. 45 
3.4.3 Parametric Frailty Model Data Analysis 
For the Cox-PH and frailty models, data were assessed at the end of follow-up. In 
the frailty models, site was considered as the clustering variable. The Gamma frailty 
was modelled with a Weibull and exponential baseline hazard while INLA, the 
Bayesian frailty, was modelled with a Weibull baseline hazard.  
For comparison across the frequentist models, -2 loglikelihood fit statistics were 
used. Parameters and standard errors (frequentist models) as well as means and 
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standard deviations (from INLA) were compared to assess their similarity. INLA 
generates the Deviance Information Criterion (DIC) defined as 𝐷𝐼𝐶 = ?̅? + 𝑝𝐷  where 
?̅? = −2 ∗ 𝑙𝑜𝑔𝑙𝑖𝑘𝑒𝑙𝑖ℎ𝑜𝑜𝑑 70, 71 and 𝑝𝐷 is the number of effective parameters. The 
mean squared error (MSE) defined as 𝑀𝑆𝐸(𝜃) = 𝐸 [(𝜃 − 𝜃)
2
] was used to compare 
parameter estimates across all the simulated models excluding the model with five 
clusters.  
Cox-PH was fitted using SAS Enterprise Guide 5.1 (SAS Institute, Cary, NC) while 
Gamma frailty models with Weibull and exponential baseline hazards were 
determined in STATA 14. 72 INLA was assessed by the R statistical software. 73 
3.4.4 Non-Parametric frailty model simulations 
Simulations for the semiparametric frailty modeling were conducted using the 
frailtysurv R package approach. 74 Underlying assumptions were the mean and 
variance of the gamma distribution was 𝐸(𝑋) = 1 and 𝑉𝑎𝑟(𝑋) = 𝜃 whereas the 
lognormal was 𝐸(𝜃 2⁄ ) = 1 and 𝑉𝑎𝑟(𝑋) = 𝐸(2𝜃) − 𝐸(𝜃). For each of the frailty 
models, 10 clusters of size 50 and 100 were generated 1,000 times. For each 𝑗𝑡ℎ 
observation that belongs to the 𝑖𝑡ℎ cluster, the conditional survival function was 
derived by 𝑆𝑖𝑗(𝑡|𝑍𝑖𝑗 , 𝑤𝑖) = 𝑒𝑥𝑝(−𝐻0(𝑡)𝑤𝑖𝑒𝑥𝑝 (𝛽𝑋𝑖𝑗)) where the unspecified cumulative 
hazard function is represented by 𝐻0(𝑡) whereas 𝑤𝑖 and 𝛽𝑋𝑖𝑗 are as previously 
defined 74. To simulate the failure time 𝑇𝑖𝑗 in the region (0, ∞), 𝐻0(𝑡) is inverted and 
the failure times are determined by 𝑇𝑖𝑗 = 𝐻0
−1(−𝑙𝑛(𝑈𝑖𝑗)exp (−𝛽𝑋𝑖𝑗)/𝑤𝑖) where 𝑈𝑖𝑗 is 
uniformly distributed. The generated frailties are dependent on the selected frailty 
distributions, in our case the gamma and lognormal. Using a normal distribution for 
right censoring, an indicator for failure time was defined as 𝜎𝑖𝑗 = 𝐼(𝑇𝑖𝑗 ≤ 𝐶𝑖𝑗) where 
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𝐶𝑖𝑗 is the censoring variable for the 𝑗
𝑡ℎ subject in the 𝑖𝑡ℎ cluster. In our simulation, the 
censoring rate was fixed at 20%. 
3.4.4.1 Penalized partial likelihood  
In this approach, smoothing splines that help in parameter estimation through 
transformations are used in conjunction with the penalized partial likelihood75, 76 to 
determine parameter estimates. The penalized partial likelihood is defined by  
𝑙𝑃𝑃𝐿
𝑠 (𝛽) = 𝑙𝑜𝑔 [∏ ∏ [exp(𝑔(. )) / ∑ exp (𝑔(. . ))𝑅(𝑡𝑖𝑗) ]
𝜎𝑖𝑗𝑛𝑖
𝑗=1
𝑛
𝑖=1 ] − 𝜆 ∫{𝑔
′′(𝑧)}2𝑑𝑧  where 
the parameter estimate 𝛽 defines functions 𝑔(. ), 𝑔(. . ) and 𝑔′′(𝑧) and 𝜆 ∫{𝑔′′(𝑧)}2𝑑𝑧 
is the penalty term subtracted from each iteration during the parametrization 
process.75, 76  
3.4.4.2 H-Likelihood  
The h-likelihood functions fit both the gamma and lognormal frailty distributions. The 
approach utilises the Laplace approximation procedures leading to efficient 
parametrisation of frailty estimates. The approach is defined as ℎ = ℎ(𝛽, ℎ0, 𝛼) = 𝑙0 +
𝑙1 where 𝑙0 and 𝑙1 is conditional log densities and sum of log densities respectively. 
77 
An in-depth analysis of the h-likelihood theory and its potential applications are 
presented elsewhere. 77-79 
3.4.4.3 Piecewise log-constant baseline hazard   
In this Bayesian approach, the time of observation is partitioned and the baseline 
hazard in each partition remains constant. The covariate effect is assumed uniform 
as well. Here, parameter estimation is carried out using data augmentation through 
latent Gaussian models and through a first-order random walk (RW1). 80, 81 The 
likelihood of the 𝑗𝑡ℎ observation in the 𝑖𝑡ℎ cluster is given by 𝜋(𝑦𝑖𝑗|𝜂𝑖𝑗, 𝜃) where 𝜂𝑖𝑗 is 
a linear predictor and 𝜃 is a vector of hyper-parameters. 81 
46 
 
 3.4.4.4 Penalized full Likelihood 
This method uses a full likelihood in conjunction with splines in parameter estimation. 
Splines are useful where precise estimations in semiparametric frailty modelling are 
unachievable 82. A penalty is imposed on the likelihood by this method through 
introduction of large values on functions classified as rough. It is defined as 
𝑝𝑙(ℎ0(. ), 𝛽, 𝜃) = 𝑙(ℎ0(. ), 𝛽, 𝜃) − ∑ 𝐾𝑑 ∫ ℎ0𝑑
′′ 2(𝑡) 𝑑𝑡
∞
0
𝐾
𝑑=1  and 𝑙(ℎ0(. ), 𝛽, 𝜃) is the full 
likelihood and 𝐾𝑑 ≥ 0 are smoothing parameters per stratum 
82, 83. 
3.4.5 Semiparametric Frailty Model Data Analysis 
Simulated data were analysed by fitting semiparametric gamma and lognormal frailty 
models where parameter estimates, their standard errors and frailty variances were 
generated. For comparison, box plots were generated for parameter estimates and 
standard errors for the models. The mean squared error (MSE) was used to 
compare parameter estimates across all simulated models.  
The semiparametric frailty models were fitted using the following R packages: 
Integrated Nested Laplace Approximation (INLA) for Piecewise log-constant baseline 
hazard, frailtyHL for H-likelihood, coxPH for penalized partial likelihood and  
frailtyPack for penalized full likelihood. The SAS SGPLOT procedure in SAS 
Enterprise Guide 7.1 (SAS Institute, Cary, NC) was used to generate plots. 
Findings from the parametric analysis are not provided in detail as they are not 
considered original. Additionally, previous reviewers’ comments indicated that non-
parametric frailty modelling would be more original and worthy presenting. Hence 
manuscript 2 focusses on simulation results from non-parametric frailty modelling 
whose presentations are fewer in the literature of frailty modelling.  
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3.5 Data and methods for objective 3 
The third objective involved modelling risk factors for mortality using the best fitting 
model identified in objective 2. Data were clustered at the individual level in the frailty 
models and risk factors for mortality were assessed by site. 
3.5.1 Eligibility and Data collection 
The Adult Wellness study was a nurse based program at both sites offering care to 
HIV-infected individuals. Funding was provided by PEPFAR through USAID South 
Africa and the program run from the year 2003-2010. Participants were referred into 
the program from surrounding clinics. Those eligible to start treatment under the 
South African guidelines were referred.  
Being HIV positive, an adult ≥ 18 years and on care at PHRU or Tinstwalo hospitals 
as well as consent was required for enrolment. The study procedures are described 
in detail elsewhere.84, 85  
Following enrolment, participants were followed up approximately every 6 months. 
Those missing visits were followed up through telephone calls and home visits. Data 
were collected on socio-demographic and clinical factors at enrolment. During follow-
up, clinical measurements such as CD4 counts and changing socio-demographic 
measures such as employment were collected. Tuberculosis was confirmed if one of 
the following conditions was met: on multidrug therapy for TB, a positive outcome in 
the acid fast bacilli test, a positive mycobacterium culture test, hospital admission or 
death due to TB. 
3.5.2 Measures 
The primary outcome of the study was all-cause mortality that was confirmed by a 
home visit or contact with a relative.  Other measures collected included socio-
demographic variables such as age, gender and household income and clinical 
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measures such as body mass index (BMI) and the WHO stage. BMI was categorised 
following the CDC classification: underweight (< 18.5), normal (18.5-24.9) and 
overweight or obese (≥ 25). CD4 count was classified into the groups: 0-200, 201-
350, 351-500 and > 500 cells/mm3. The variables CD4 Count and BMI were treated 
as time-varying covariates. Further details on the methods and measures are 
presented in original paper 3 that appears as an attachment at the end of this thesis. 
3.5.3 Statistical analysis 
All the analysis was stratified by site: rural and urban. Descriptive statistics such as 
medians and interquartile ranges were determined for continuous measures such as 
age, CD4 count, BMI, crowding index and household income. These measures were 
compared between sites using the Kruskal-Wallis non-parametric test. Continuous 
measures such as age and BMI were categorised into age-groups and BMI groups 
respectively. Frequencies were determined for all categorical variables. Chi-square 
analysis and Fishers Exact test, whichever was appropriate, were used for the 
comparisons between sites. 
Poisson regression modelling was used to compare mortality rates per 100 person-
years between sites. Mortality rates were determined overall, pre-HAART and post-
HAART. Graphical plots were generated for the comparison of rates by site. Kaplan-
Meier graphs were plotted to show the hazard rate for mortality by site. Hazard rates 
were determined by Cox proportional hazards regression modelling. 
There was missing information of approximately 18% and 11% in CD4 counts and 
BMI respectively. Missing data techniques were used to impute for incomplete data 
using the Multiple Imputation (MI) procedure in which five complete datasets were 
generated and analysed. 86-88 The average of the estimates was used as the final 
result.  
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The integrated nested Laplace approximation (INLA) with the shared gamma frailty 
model 45, 46 was used to assess mortality risk factors. Univariate analysis was 
performed first followed by multivariate analysis. Hazard rates and their 95% 
confidence intervals were determined through exponentiating model results. The 
multivariate analysis was conducted using variables that were thought important 
followed by application of the backward selection procedure. Variables thought to be 
important included age, CD4 count, BMI, crowding index, household income, length 
on HAART and an indicator for employment, smoking and whether they have ever 
had TB. Sensitivity analyses were conducted to assess different scenarios. This 
included assessing time to death overall and per site by CD4 count, BMI, gender, 
whether on HAART or not, length of time on HAART. Mortality rates pre and post 
HAART were also determined. Further details on the statistical methods are 
available in original paper 3 at the end of this thesis.  
Frailty variance in both sites was determined through INLA. A frailty variance value > 
1 suggests an increased hazard rate in the event of interest while that < 1 suggests a 
decreased hazard rate.  
Statistical analyses were conducted in R (www.r-project.org) and SAS Enterprise 
Guide 5.1 (SAS Institute, Cary, NC). 
3.6 Data and methods for objective 4 
The fourth objective involves using a mixed methods approach in which findings from 
the qualitative analysis complement those from the quantitative as suggested by the 
critical realism framework. The methods for the qualitative research are presented in 
section 3.6.1. 
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3.6.1 Sampling 
Participants were recruited through the PHRU ZAZI voluntary counselling and testing 
(VCT) centre.  ZAZI is a successful HIV testing service that is offered for free to 
clients in Soweto and surrounding areas. In the present study, participants were 
purposively recruited from the ZAZI VCT. Of the 26 participants invited to participate, 
20 were enrolled.  During the VCT counselling process, clients were routinely asked 
about the loss of a person in their life and probed further to determine if it was due to 
HIV. Those responding in the affirmative were probed further by counsellors to 
determine who it was, when it happened and how they dealt with the loss. 
Thereafter, they were invited to enrol into the study. Interviews were scheduled 
within a period of seven days for those willing to participate. A day prior to the 
scheduled interview date, a telephone call was made to confirm the appointment. 
3.6.2 Eligibility 
To be eligible, participants had to be 18 years or older, have known a close person 
who had died due to HIV and were willing to participate in a face-to face in-depth 
interview.  
3.6.3 In-depth interviews 
Data were collected between May and August 2014 using in-depth interviews to 
understand the characteristics of the participant and the deceased persons. A 
demographic questionnaire assessed age, gender, primary home language and 
educational level and was administered prior to the in-depth interview.  
Interviews were conducted in English and/or isiZulu by a trained interviewer who had 
experience in conducting qualitative interviews. The in-depth interviews explored 
participants perceptions about: the deceased persons’ relationships with significant 
others or in general, health seeking behaviours, attitude of healthcare workers 
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towards HIV-infected patients seeking care, initiation and adherence to antiretroviral 
therapy (ART), home-based care support, nutrition and/or food security and financial 
stability. Interviews occurred in private rooms at the ZAZI VCT centre and lasted no 
more than an hour.  
All interviews were audio-recorded and transcribed verbatim one day after the 
interview. Transcriptions were performed by an external team with experience in 
transcribing audio recordings that was approved by the study team. Where audio-
recordings had a mixture of the local language and English, translations into English 
occurred during the transcription process. Every second transcript was selected by 
the interviewer for comparison with the audio recording to check for consistency. 
Where discrepancies were identified, audio-recordings were transcribed again. A 
total of 10 transcripts were selected for comparison with the audio-recordings for 
quality checks (that were done by a bilingual research assistant). 
All the study procedures were recorded in a study work book that was used to 
monitor study progress. It contained information such as how many people had been 
interviewed, how many more were likely to be interviewed, scheduled interview 
appointments and administrative information such as participant re-imbursements for 
transport. 
3.6.4 Data analyses 
Data were analysed through a framework analysis approach where similar and 
interrelated codes were grouped together to form sub-themes and themes in a data 
matrix.89, 90 Core codes were independently developed by two research assistants 
and agreed upon in collaboration with an experienced qualitative researcher. The 
first four transcripts were reviewed by two research assistants line by line and the 
findings used to develop a code book. A meeting was organised between the 
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research assistants and a qualitative analysis expert to verify the consistency of the 
codes. Divergent codes were discussed and a resolution reached on the most 
appropriate coding term. Subsequent transcripts were assessed based on the code-
book. Updated codes were only included if subsequent codes could not fit within the 
initial ones.  
The data matrix was instrumental in assessing the coding progress allowing for the 
development of sub-themes and themes.89, 90 The process of developing sub-themes 
and themes was regularly refined during the analytic process as new codes 
emerged. Any discrepancies in coding were resolved through consensus. 
Development of codes, sub-themes and themes followed a combined approach of 
deductive and inductive data reduction procedures.  
3.6.6 Trustworthiness of the data 
Trustworthiness of the data was assessed using various methodologies.91-94 An audit 
trail was kept to monitor the study progress such as evaluating the first two 
interviews and amending the interview guides as appropriate. Codes were 
independently prepared by the research assistants and harmonised in a meeting 
together with an experienced qualitative researcher. Thereafter, a codebook was 
developed for all subsequent interviews. Code development stopped when no further 
changes occurred. Audio-recordings were compared with the transcripts to verify 
consistency, ensure translations matched the recordings and make any appropriate 
amendments. The individual construction of the participants, which involves seeking 
clarification of their responses, was improved through probing by the research 
assistant. Final results were shared with the study team for verification of the themes 
and interpretation. Differences in the coding, themes and interpretations were 
resolved as a team. 
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4.0 Results 
4.1 Review of methods for statistical analysis 
 
Detailed findings on the design of studies, methodology used to analyse them and 
their suitability in the identified publications on mortality related risk factors in HIV 
positive people are presented elsewhere.54 
4.1.1 Disposition flow chart 
 
Figure 2: The flow of screened and selected publications 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
Records identified through 
database searching  
(n = 1656) 
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(n = 1389) 
Records excluded  
(n = 971) 
Full-text articles 
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Full-text articles 
excluded, with reasons 
(n = 229) 
 
 Letters to editor 
(n=4) 
 Editorials (n=19) 
 Reviews/Systemat
ic (n=19) 
 Meta-analysis 
(n=14) 
 Case Reports 
(n=162) 
 Others (n=11) 
Studies included in 
quantitative synthesis  
(n = 189) 
2002-2006  
(n = 91) 
2007-2011  
(n = 98) 
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From 1656 initial publications, only 189 qualified for inclusion in this study. These 
were further split into two periods of assessment: the years 2002-2006 (n=91) and 
2007-2011 (n=98). Articles were excluded if they were editorials, reviews (systematic 
and meta-analytic) and patient case reports. Figure 2 illustrates the process of 
selecting publications meeting the study criteria. 
4.1.2 Design of studies 
 
Table 1: Design of studies and study sample sizes 
 2002-2006 2007-2011  
Research Design No.  (%) No.  (%) p-value 
 
Prospective 
 
67 
 
74 
 
62 
 
63 
 
0.66 
      
Retrospective 23 25 33 34 0.14 
      
Case control 1 1 3 3 - 
Prospective 1 - 0 - - 
Retrospective 0 - 3 - - 
      
Total 91  98   
      
Sample sizes      
      
up to 200 22 24 15 15 0.5 
201 to 500 21 23 25 26  
501 to 1,000 16 18 20 20  
>1,000 32 35 38 39  
      
 
There were more prospective studies than retrospective studies and the proportions 
did not differ significantly between the two periods. A summary of the design of 
studies together with the number of enrolled participants is presented in Table 1. 
4.1.3 Overview of statistical analysis approaches 
 
A summary of the statistical methods commonly reported in the publications 
identified during the review are presented in Table 2. Of the 186 eligible publications, 
only 7 (4%) reported using frailty modelling. Though not significantly different 
between the periods, Cox proportional hazards regression was more commonly 
reported probably due to the study design.  
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Table 2: Summary of statistical methods 
 2002-2006 2007-2011  
Statistical methods No. of 
publications 
(N=91) 
(%) No. of 
publications 
(N=98) 
(%) p-value 
      
Descriptive statistics 88 97 94 96 0.78 
      
Inferential methods      
      
t-test 13 14 19 19 0.35 
      
Contingency table analysis      
 Basic (chi-square/Fisher 
exact) 
25 27 37 38 0.13 
      
Correlation 9 10 1 1 - 
      
Epidemiologic statistics 39 43 45 46 0.67 
      
Analysis of variance 3 3 1 1 - 
      
Regression      
#Multiple regression 13 14 31 32 0.005 
      
Survival analysis      
    Kaplan-Meier 69 76 53 54 0.002 
    Cox-Regression 68 75 63 64 0.12 
    Time dependent Cox       
regression 
21 23 11 11 0.03 
    Cox-Regression with frailty 1 1 6 6 - 
      
Non-parametric methods 86 95 91 93 0.64 
      
No. of different inferential methods      
2 or 3 methods 10 11 11 11 0.96 
4 or 5 methods 44 48 43 44 0.54 
More than 5 methods 37 41 44 45 0.56 
      
¶Basic analysis 36 40 45 46 0.38 
*Advanced analysis 90 99 97 99 0.96 
      
#Includes logit and Poisson modelling 
¶Includes parametric and non-parametric inferential analysis methods such as student t-test 
*Includes logit, Poisson and time-to-event methods as well as epidemiological statistics 
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4.1.4 Suitability of utilised statistical techniques 
 
There were 53 (78%) and 48 (77%) prospective studies from 2002-2006 and 2007-
2011 respectively that reported using Cox proportional hazards regression (Table 3). 
Prospective studies reporting time dependent Cox proportional hazards regression 
were 16 (24%) in 2002-2006 and 10 (16%) in 2007-2011. Overall, frailty modelling 
(n=6) was more commonly reported in the period 2007-2011. 
Table 3: Suitability of utilised techniques in assessing mortality risk factors 
 2002-2006 2007-2011 
 Prospective 
(N=68) 
Retrospective 
(N=23) 
Prospective 
(N=62) 
Retrospective 
(N=36) 
Statistical methods No. (%) No. (%) No. (%) No. (%) 
     
Appropriate statistical 
analysis 
    
Cox regression 53 (78) 15 (65) 48 (77) 15 (42) 
Time dependent Cox 
regression  
16 (24) 5 (22) 10 (16) 1 (3) 
Cox regression analysis with 
frailty 
1 (1) 0 (0) 3 (5) 3 (8) 
Poisson regression 3 (4) 0 (0) 4 (6) 0 (0) 
     
Sub-Optimal statistical 
analysis 
    
Logistic regression 4 (6) 4 (17) 7 (11) 17 (47) 
Unclear 1 (1) 2 (9) 2 (3) 3 (8) 
     
NB: Some of the publications utilized ≥ 1 statistical method 
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4.2 Comparing time-to-event methods 
 
4.2.1 Parametric frailty modelling  
 
4.2.1.1 Simulation 
 
The simulation results are presented in Tables 4, 5 and 6. To be consistent, all the 
four models are fitted using the same simulated dataset. In general, the simulation 
results across parameter estimates and standard errors as well as the INLA means 
and standard deviations are similar.  
Within the frequentist models, the Gamma frailty models with Weibull (319.9 and 
645.2 in table 4; 651.7 and 1300 in table 5; 1314 and 2609 in table 6) and 
exponential (314.9 and 651.4 in table 4; 652.8 and 1301 in table 5; 1315 and 2613 in 
table 6) baseline hazards had lower -2 loglikelihood values compared with the Cox-
PH models (328.5 and 796.4 in table 4; 660.7 and 1600.5 in table 5; 1330.3 and 
3215.4 in table 6).   
The INLA model had a lower frailty variance (0.1 and 0.2 in table 4; 0.2 in table 5; 0.3 
in table 6) relative to the Gamma frailty models with Weibull (0.3 in table 4 and 6; 0.4 
in table 6) and exponential (0.3 in table 4 and 6; 0.4 in table 6) baseline hazards. 
The probability coverage values were high for all the simulated datasets. In the data 
with five clusters, the coverage values ranged between 94.5% and 95.3% while it 
was 94.6% to 94.9% in the data with ten clusters. In the data with twenty clusters, 
the probability coverage ranged between 94.7% and 95%. The distribution of 
probability coverage for specific variables within different clusters is presented in 
table 7. 
In the model with ten clusters (n=50 per cluster), the INLA MSE was lower for the 
parameter estimates for male gender and CD4 count between 201 and 350. In the 
model with twenty clusters, the INLA MSE was better in general (table 8).  
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Table 4: Five clusters of size 50 and 100 
Variable Cox Regression 
Gamma Frailty 
(Weibull) 
Gamma Frailty 
(Exponential) 
INLA 
 Beta (SE) Beta (SE) Beta (SE) Beta (SE) 
5 Clusters (n=50 per cluster)     
     
Gender     
Male 0.8836 (0.3131) 0.8858 (0.3060) 0.9382 (0.3107) 0.8670 (0.3031) 
Female Ref Ref Ref Ref 
     
Employment Status     
Employed Ref Ref Ref Ref 
Unemployed 0.9861 (0.5071) 1.0177 (0.4694) 0.9437 (0.4891) 1.0680 (0.6050) 
     
CD4 Categories     
0-200 Ref Ref Ref Ref 
201-350 -.3848 (0.3754) -.3816 (0.3680) -.3111 (0.3741) -.3955 (0.3657) 
> 350 -.8011 (0.4016) -.8138 (0.3908) -.7811 (0.4009) -.8223 (0.4030) 
     
-2 Log L 328.5 319.9 314.9 N/A 
     
DIC N/A N/A N/A 178.8 
     
Frailty Variance N/A 0.3 0.3 0.1 
     
5 Clusters (n=100 per cluster)     
     
Gender     
Male 0.8782 (0.2143) 0.8800 (0.2116) 0.8691 (0.2105) 0.8756 (0.2117) 
Female Ref Ref Ref Ref 
     
Employment Status     
Employed Ref Ref Ref Ref 
Unemployed 0.9558 (0.3436) 0.9642 (0.3394) 0.9740 (0.3362) 0.9704 (0.3519) 
     
CD4 Categories     
0-200 Ref Ref Ref Ref 
201-350 -.3961 (0.2586) -.4008 (0.2564) -.3851 (0.2540) -.4006 (0.2561) 
> 350 -.7851 (0.2730) -.7938 (0.2710) -.7783 (0.2688) -.7947 (0.2708) 
     
-2 Log L 796.4 645.2 651.4 N/A 
     
DIC N/A N/A N/A 267.9 
     
Frailty Variance N/A 0.3 0.3 0.2 
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Table 5: Ten clusters of size 50 and 100  
Variable Cox Regression 
Gamma Frailty 
(Weibull) 
Gamma Frailty 
(Exponential) 
INLA 
 Beta (SE) Beta (SE) Beta (SE) Beta (SE) 
     
10 Clusters (n=50 per cluster)     
     
Gender     
Male 0.8825 (0.2154) 0.8820 (0.2101) 0.8803 (0.2102) 0.8755 (0.2099) 
Female Ref Ref Ref Ref 
     
Employment Status     
Employed Ref Ref Ref Ref 
Unemployed 0.9423 (0.3420) 0.9584 (0.3364) 0.9557 (0.3365) 0.9592 (0.3369) 
     
CD4 Categories     
0-200 Ref Ref Ref Ref 
201-350 -.3801 (0.2576) -.3890 (0.2527) -.3877 (0.2527) -.3889 (0.2521) 
> 350 -.7845 (0.2731) -.7984 (0.2685) -.7974 (0.2686) -.7986 (0.2681) 
     
-2 Log L 660.7 651.7 652.8 N/A 
     
DIC N/A N/A N/A 289.2 
     
Frailty Variance N/A 0.3 0.3 0.2 
     
10 Clusters (n=100 per cluster)     
     
Gender     
Male 0.8855 (0.1487) 0.8866 (0.1466) 0.8875 (0.1466) 0.8856 (0.1469) 
Female Ref Ref Ref Ref 
     
Employment Status     
Employed Ref Ref Ref Ref 
Unemployed 0.9215 (0.2337) 0.9283 (0.2320) 0.9286 (0.2320) 0.9286 (0.2320) 
     
CD4 Categories     
0-200 Ref Ref Ref Ref 
201-350 -.3943 (0.1786) -.3983 (0.1769) -.3985 (0.1769) -.3983 (0.1768) 
> 350 -.7706 (0.1883) -.7773 (0.1866) -.7774 (0.1866) -.7776 (0.1866) 
     
-2 Log L 1600.5 -1300 -1301 N/A 
     
DIC N/A N/A N/A 525.4 
     
Frailty Variance N/A 0.3 0.3 0.3 
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Table 6: Twenty clusters of size 50 and 100 
Variable Cox Regression 
Gamma Frailty 
(Weibull) 
Gamma Frailty 
(Exponential) 
INLA 
 Beta (SE) Beta (SE) Beta (SE) Beta (SE) 
     
20 Clusters (n=50 per cluster)     
     
Gender     
Male 0.8868 (0.1502) 0.8864 (0.1466) 0.8863 (0.1466) 0.8854 (0.1469) 
Female Ref Ref Ref Ref 
     
Employment Status     
Employed Ref Ref Ref Ref 
Unemployed 0.9078 (0.2338) 0.9230 (0.2307) 0.9233 (0.2307) 0.9231 (0.2307) 
     
CD4 Categories     
0-200 Ref Ref Ref Ref 
201-350 -.3848 (0.1795) -.3938 (0.1762) -.3939 (0.1762) -.3940 (0.1762) 
> 350 -.7676 (0.1891) -.7815 (0.1860) -.7810 (0.1860) -.7819 (0.1860) 
     
-2 Log L 1330.3 1314 1315 N/A 
     
DIC N/A N/A N/A 570.6 
     
Frailty Variance N/A 0.4 0.4 0.3 
     
20 Clusters (n=100 per cluster)     
     
Gender     
Male 0.8919 (0.1041) 0.8923 (0.1027) 0.8928 (0.1026) 0.8926 (0.1028) 
Female Ref Ref Ref Ref 
     
Employment Status     
Employed Ref Ref Ref Ref 
Unemployed 0.8992 (0.1618) 0.9057 (0.1607) 0.9073 (0.1607) 0.9069 (0.1607) 
     
CD4 Categories     
0-200 Ref Ref Ref Ref 
201-350 -.3933 (0.1250) -.3946 (0.1239) -.3980 (0.1238) -.3977 (0.1238) 
> 350 -.7623 (0.1313) -.7706 (0.1303) -.7704 (0.1302) -.7699 (0.1302) 
     
-2 Log L 3215.4 2609 2613 N/A 
     
DIC N/A N/A N/A 1041.3 
     
Frailty Variance N/A 0.4 0.4 0.3 
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Table 7: Probability coverage 
Variable 
 
5 clusters  
(n=50) 
 
 
 
5 Clusters  
(n=100) 
 
10 Clusters  
(n=50) 
 
10 Clusters  
(n=100) 
 
20 Clusters  
(n=50) 
 
  20 Clusters 
(n=100) 
       
Gender 94.8% 94.5% 94.7% 94.6% 94.7% 94.7% 
       
Employment Status 94.7% 94.5% 94.9% 94.6% 95.0% 94.9% 
       
CD4 Categories 95.3% 95.0% 94.9% 94.8% 94.9% 95.0% 
       
 
Table 8: Mean squared error of parameter estimates 
 
10 Clusters, 
(n=50) 
10 Clusters, 
(n=100) 
20 Clusters, 
(n=50) 
20 Clusters, 
(n=100) 
Male  
    
Cox 0.04908 0.02211 0.02264 0.01065 
INLA 0.04673 0.02142 0.02131 0.01030 
Gamma Frailty (Weibull Baseline) 0.04679 0.02142 0.02138 0.01057 
Gamma Frailty (Exponential Baseline) 0.04700 0.02141 0.02211 0.01103 
     
Unemployment  
    
Cox 0.12115 0.05500 0.05725 0.02617 
INLA 0.11756 0.05376 0.05603 0.02579 
Gamma Frailty (Weibull Baseline) 0.11718 0.05372 0.05612 0.02575 
Gamma Frailty (Exponential Baseline) 0.11493 0.05369 0.05619 0.02577 
     
CD4 Count 201-350 mm
3
 
    
Cox 0.06763 0.03068 0.03266 0.01612 
INLA 0.06505 0.03058 0.03148 0.01588 
Gamma Frailty (Weibull Baseline) 0.06537 0.03056 0.03152 0.01644 
Gamma Frailty (Exponential Baseline) 0.06518 0.03060 0.03155 0.01592 
     
CD4 Count > 350 mm
3
 
    
Cox 0.08295 0.03640 0.03847 0.01693 
INLA 0.08242 0.03568 0.03740 0.01666 
Gamma Frailty (Weibull Baseline) 0.08172 0.03571 0.03747 0.01703 
Gamma Frailty (Exponential Baseline) 0.08253 0.03567 0.03807 0.01668 
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Table 9: Comparison of models using HIV data 
Variable Cox-PH Gamma Frailty with 
Weibull Hazard  
Gamma Frailty with 
Exponential Hazard  
INLA 
 Estimate (SE) Estimate (SE) Estimate (SE) Mean (SD) 
     
βGender     
Male 0.3006 (0.0906) 0.2844 (0.0908) 0.4485 (0.0913) 0.2849 (0.0908) 
Female Ref Ref Ref Ref 
     
βEmployment     
Employed Ref Ref Ref Ref 
Unemployed 0.3598 (0.1122) 0.4011 (0.1130) 0.5954 (0.1119) 0.4025 (0.1130) 
     
βCD4 Categories     
[0-200) Ref Ref Ref Ref 
[200-350) -0.8973 (0.1125) -1.0016 (0.1136) -1.2491 (0.1156) -1.0031 (0.1137) 
[350-500) -1.3544 (0.1610) -1.4539 (0.1621) -1.5537 (0.1642) -1.4559 (0.1622) 
≥500 -1.6926 (0.1947) -1.7767 (0.1956) -1.9338 (0.1962) -1.7789 (0.1956) 
     
     
βWHO Stage     
Stage 1 or 2 Ref Ref Ref Ref 
Stage 3 or 4 0.6225 (0.0899) 0.6156 (0.0920) 0.3806 (0.0976) 0.6176 (0.0920) 
     
Fit statistics     
     
DIC - - - 4615.66 
     
-2 Log Likelihood 9387.44 5715.32 7593.3 - 
     
     
Effective number of 
parameters 
- - - 8.97 
     
Frailty variance - 0.5038 2.22 0.40=1/2.53 
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4.2.2.2 Application to HIV data 
 
The Adult Wellness study enrolled 6,690 HIV-infected participants of whom three-
quarters were females (n=5035).   A total of 566 (8.5%) participants died during 
follow-up with the proportion of male deaths (11.4%, 189/1655) being higher than 
that of females (7.5%, 377/5035).  
Findings comparing the four models as applied to data from an HIV-infected cohort 
from South Africa are presented in table 9.  The estimates from the shared Gamma 
frailty5 with exponential baseline hazard differed from those obtained using the other 
models. For example the estimate (se) for gender was 0.4485 (0.0913) while it was 
0.3006 (0.0906), 0.2844 (0.0908) and 0.2849 (0.0908) for Cox-PH, Gamma frailty 
(Weibull baseline hazard) and INLA respectively. The Cox-PH model had the highest 
fit statistic value (-2 loglikelhood=9387.44) relative to other models. Within the 
Gamma frailty models, the model with a Weibull baseline hazard (-2 
loglikelhood=5715.32) had a lower fit statistic relative to that with an exponential 
baseline hazard (-2 loglikelhood=7593.3). Within the frailty models, the estimates 
(standard errors) and means (standard deviations) of the Gamma frailty (with Weibull 
baseline hazard) and INLA respectively were similar.  
The standard errors and standard deviation values were similar to 1 decimal place 
across all models. Parameter estimates were generally similar except for the 
Gamma frailty with exponential baseline hazard. A summary of the findings are 
presented in Appendix 2. 
4.2.3 Semiparametric frailty modelling  
 
In the comparison of the semiparametric gamma frailty models of 10 clusters of size 
50 and 100, four maximisation procedures (penalized full and partial likelihood, INLA 
and H-likelihood) were compared (Figure 3a and 3b). Findings were close in the 
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measure of parameter estimates but INLA performed better. Findings were also 
similar under the lognormal frailty. Variability in general seemed higher in the smaller 
cluster of size 50 relative to the larger cluster of size 100. 
Figure 4 presents the graphical plots showing the distribution of the standard errors 
as well as standard deviations from INLA. The MSE results (table 10) derived from 
the estimates of the parameters were also similar but INLA had consistently smaller 
values. MSE values determined from the larger cluster of size 100 had less 
variability compared to that derived from the cluster of size 50. 
Gamma frailty variances from the four likelihood procedures were similar (table 11). 
INLA associated frailty variances that are associated with the piecewise log-constant 
baseline hazard were lower for both Gamma and lognormal frailties. On the contrary, 
those associated with the H-likelihood and penalized full likelihood were higher for 
both Gamma and lognormal frailties. 
Efficiency of the parameter estimates is presented in table 12. 
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Figure 3a: Gamma frailty parameter estimates 
(n=50) 
 
Figure 3b: Gamma frailty parameter estimates 
(n=100) 
 
Figure 3c: Log-Normal frailty parameter estimates 
(n=50) 
 
Figure 3d: Log-Normal frailty parameter 
estimates (n=100) 
NB: n=50 and n=100 are the cluster sizes 
Figure 3: Distribution of parameter estimates of the gamma and lognormal 
frailties 
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Figure 4a: Gamma standard error/INLA SD (n=50) 
 
Figure 4b: Gamma standard error/INLA SD 
(n=100) 
 
Figure 4c: Lognormal standard error/INLA SD 
(n=50) 
 
Figure 4d: Lognormal standard error/INLA SD 
(n=100) 
NB: n=50 and n=100 are the cluster sizes 
Figure 4: Distribution of standard errors/standard deviation 
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Table 10: Distribution of parameter estimate MSE 
Parameter Estimates INLA frailtyHL frailtyPack coxph 
     Semiparametric Gamma Frailty 
    
     Cluster size (n=50) 
    Z1 0.0033 0.0036 0.0035 0.0035 
Z2 0.0041 0.0046 0.0044 0.0044 
Z3 0.0051 0.0054 0.0056 0.0058 
     Cluster size (n=100) 
    Z1 0.0015 0.0017 0.0017 0.0017 
Z2 0.0020 0.0022 0.0022 0.0022 
Z3 0.0025 0.0026 0.0027 0.0027 
     Semiparametric Log-Normal Frailty 
    
     Cluster size (n=50) 
    Z1 0.0030 0.0033 0.0032 0.0032 
Z2 0.0043 0.0047 0.0049 0.0046 
Z3 0.0053 0.0058 0.0058 0.0058 
     Cluster size (n=100) 
    Z1 0.0015 0.0016 0.0018 0.0016 
Z2 0.0020 0.0022 0.0025 0.0022 
Z3 0.0024 0.0026 0.0031 0.0026 
     NB: INLA- Piecewise log-constant baseline hazard; frailtyHL-H-Likelihood; frailtyPack-Penalized full 
likelihood; CoxPH-Penalized partial likelihood; n=50 and n=100 are the cluster sizes 
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Table 11: Median (IQR) distribution of the variances of the frailty distributions 
Variable INLA FrailtyHL FrailtyPack CoxPh 
    
 
Gamma frailty 
   
 
    
 
Gamma (Cluster size n=50) frailty 
variance 1.1 (1.0-1.1) 1.9 (1.4-2.4) 1.8 (1.3-2.3) 1.8 (1.3-2.3) 
    
 
Gamma (Cluster size n=100) 
frailty variance 1.1 (1.0-1.1) 1.9 (1.4-2.5) 1.8 (1.3-2.3) 1.8 (1.3-2.3) 
    
 
    
 
Log-Normal frailty 
   
 
    
 
Log-Normal (Cluster size n=50) 
frailty variance 1.1 (1.1-1.2) 1.9 (1.3-2.5) 1.8 (1.2-2.5) 1.2 (0.9-1.6) 
    
 
Log-Normal (Cluster size n=100) 
frailty variance 1.1 (1.1-1.2) 1.8 (1.3-2.5) 1.7 (1.2-2.3) 1.2 (1.0-1.6) 
    
 
NB: INLA- Piecewise log-constant baseline hazard; frailtyHL-H-Likelihood; frailtyPack-Penalized full 
likelihood; CoxPH-Penalized partial likelihood;  
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Table 12: Efficiency of parameter estimates 
Method/package Var (𝒛?̂?)/Var (𝒛?̂?) Var (𝒛𝟐?̂?)/Var (𝒛?̂?) Var (𝒛?̂?)/Var(𝒛?̂?) 
    Semiparametric Gamma 
Frailty/Cluster size (n=50) 
   INLA (n=50) 1.2499 1.5489 1.2392 
frailtyHL (n=50) 1.2715 1.4880 1.1703 
frailtyPack (n=50) 1.2698 1.6149 1.2717 
frailtySurv (n=50) 1.2893 1.5493 1.2016 
Coxph (n=50) 1.2573 1.6336 1.2993 
    Semiparametric Gamma 
Frailty/Cluster size (n=100) 
   INLA (n=100) 1.2892 1.6207 1.2571 
frailtyHL (n=100) 1.3026 1.6009 1.2289 
frailtyPack (n=100) 1.3121 1.6184 1.2334 
frailtySurv (n=100) 1.3282 1.6442 1.2380 
Coxph (n=100) 1.3075 1.6156 1.2357 
    Semiparametric Log-Normal 
Frailty/Cluster size (n=50)  
   INLA (n=50) 1.4303 1.7521 1.2250 
frailtyHL (n=50) 1.4297 1.7731 1.2402 
frailtyPack (n=50) 1.4955 1.7750 1.1869 
Coxph (n=50) 1.4271 1.7763 1.2447 
    Semiparametric Log-Normal 
Frailty/Cluster size (n=100) 
   INLA (n=100) 1.3762 1.6076 1.1681 
frailtyHL (n=100) 1.3835 1.6242 1.1740 
frailtyPack (n=100) 1.4163 1.7159 1.2115 
Coxph (n=100) 1.3916 1.6197 1.1639 
NB: Var =variance; z1, z2 and z3 are parameter estimates; n=50 and n=100 are the cluster sizes 
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4.3 Mortality risk factors by setting in South Africa 
 
4.3.1 Enrolment characteristics stratified by rural and urban setting 
 
There were 6,690 enrolled participants (with 67% from PHRU). Relative to males, 
females were more at both sites (n=1,555 (70%) in rural; n=3,480 (78%) in urban). 
Rural participants were older (median age 36 vs 33 years) and had lower CD4 count 
(178 vs 303 cells/mm3) whereas urban participants were associated with a higher 
BMI (24.9 vs. 21). Table 13 provides a further illustration of the characteristics during 
study entry.    
4.3.2 Most recent socio-economic and clinical characteristics 
 
Of those enrolled in the urban site, 63% (n=2,826) were not on HAART; only 30% 
(n=666) were not on HAART in the rural site. While the proportion of unemployed 
people was high at both sites, there were more males that were employed relative to 
females. Those enrolled in the rural site were more likely to have had TB relative to 
those in the urban (995/2221, 45% vs. 1134/4469, 25%; p<0.0001). Table 14 
provides clinical and behavioural characteristics stratified by setting. 
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Table 13: Participant characteristics at enrolment by site 
 
Rural (Tintswalo) Urban (PHRU) 
Variable 
 Overall 
Male Gender  
 
Female Gender 
 
Overall  
 
Male Gender 
 
Female Gender 
 
       
No. enrolled 2,221 666 1,555 4,469 989 3,480 
       
Age (Median/IQR)) 36.4 (31.0-44.1) 39.2 (33.3-48.1) 35.2 (30.0-42.5) 32.7 (28.2-38.1) 35.7 (31.5-41.5) 31.7 (27.4-37.0) 
       
Age-Group in years 
       [18-25] (%) 216 (9.7)  30 (4.5) 186 (12.0) 672 (15.0)  65 (6.6) 607 (17.4) 
 [26-30] (%)  342 (15.4)   72 (10.8)  270 (17.4) 1117 (25.0)  158 (16.0)  959 (27.6) 
 [31-34] (%)  420 (18.9)  111 (16.7)  309 (19.9)  984 (22.0)  222 (22.4)  762 (21.9) 
 [35-39] (%)  424 (19.1)  136 (20.4)  288 (18.5)  864 (19.3)  250 (25.3)  614 (17.6) 
 >39 (%)  819 (36.9)  317 (47.6)  502 (32.3)  832 (18.6)  294 (29.7)  538 (15.5) 
       
CD4 Count 
(Median/IQR) 178.0 (81.0-333.6) 162.0 (69.0-289.9) 184.0 (86.0-350.6) 303.0 (156.0-470.7) 281.0 (142.0-443.7) 309.0 (163.0-478.2) 
CD4 Categories        
 [0-200] (%) 1235 (55.6)  398 (59.8)  837 (53.8) 1474 (33.0)  367 (37.1) 1107 (31.8) 
 [201-350] (%)  472 (21.3)  144 (21.6)  328 (21.1) 1102 (24.7)  241 (24.4)  861 (24.7) 
 [351-500] (%)  284 (12.8)   75 (11.3)  209 (13.4)  915 (20.5)  190 (19.2)  725 (20.8) 
 ≥501 (%)  230 (10.4)   49 (7.4)  181 (11.6)  978 (21.9)  191 (19.3)  787 (22.6) 
72 
 
       
BMI (Median/IQR) 21.0 (17.9-25.0) 19.9 (17.2-23.4) 21.4 (18.4-25.8) 24.9 (20.7-29.2) 22.5 (18.2-26.4) 25.6 (21.4-30.0) 
       
BMI 
       Underweight (%) 638 (29.0) 241 (36.9) 397 (25.7) 594 (13.4) 240 (24.8) 354 (10.2) 
 Normal (%)  987 (44.9)  299 (45.7)  688 (44.6) 1612 (36.4)  393 (40.6) 1219 (35.2) 
 Obese/Overweight 
(%)  572 (26.0)  114 (17.4)  458 (29.7) 2226 (50.2)  336 (34.7) 1890 (54.6) 
       
Crowding index 
(Median/IQR) 1.5 (1.0-2.3) 1.3 (0.8-2.0) 1.6 (1.0-2.5) 1.5 (1.0-2.3) 1.0 (1.0-2.0) 1.5 (1.0-2.5) 
       
Household Income 
(IQR) in Rands 
  600.0 (189.8-
1010.0) 
  780.0 (50.0-
1500.0) 
  500.0 (190.0-
974.7) 
 1080.0 (500.0-
2130.0) 
 1200.0 (600.0-
2400.0) 
 1020.0 (500.0-
2020.0) 
       
Household Income  
       ≤ R1,000 (%) 1516 (72.8) 423 (67.4) 1093 (75.2) 2161 (48.5) 453 (45.9) 1708 (49.2) 
 R1,001-R5,000 (%)  528 (25.4)  193 (30.7)  335 (23.1) 2092 (46.9)  487 (49.3) 1605 (46.3) 
 > R5,000 (%)   37 (1.8)   12 (1.9)   25 (1.7)  203 (4.6)   47 (4.8)  156 (4.5) 
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Table 14: Distribution of clinical and socio-behavioural factors 
 
Rural Urban 
Variable 
 
Male Gender (%) 
 
Female Gender (%) 
 
Male Gender (%) 
 
Female Gender (%) 
 
     
No. enrolled 666 1,555 989 3,480 
     
Time on Treatment  
     Not on Treatment 
(%)  174 (26)  492 (32)  555 (56)  2271 (65) 
 < 6 Months (%)  153 (23)  315 (20)    108 (11)    248 (7) 
6-12 Months (%)  133 (20)  301 (19)    35 (4)    143 (4) 
>12 Months (%)  206 (31)  447 (29)  291 (30)    818 (24) 
     
Employment (ever) 
     Yes (%) 143 (21) 153 (10) 400 (40) 909 (26) 
 No (%)  523 (79) 1402 (90)  589 (60) 2571 (74) 
     
Smoking (ever) 
     Yes (%) 295 (44)  63 (4) 706 (71) 578 (17) 
 No (%)  371 (56) 1492 (96)  283 (29) 2902 (83) 
     
TB Infection (ever) 
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 Yes (%)  350 (53)  645 (41)  313 (32)  821 (24) 
 No (%)  316 (47) 910 (59)  676 (68) 2659 (76) 
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4.3.3 Describing mortality by site 
 
Approximately 11% and 7% of the rural and urban participants demised respectively 
during the course of the study. The rate of mortality was significantly elevated among 
rural participants in comparison to those recruited in the urban site. Their hazard of 
mortality was twice as high as that of the urban group. The overall rate of all-cause 
mortality as well as mortality on treatment is presented graphically in Figure 5 using 
the Kaplan-Meier plot. 
 
5a: Time to the event of death by setting 
 
5b: Rate of mortality by HAART status 
stratified by site 
 
Figure 5: Survival analysis of death and its associated rate/100 person-years 
with or without treatment stratified by setting 
 
Kaplan-Meier survival analysis curves for time-to-death overall as well as mortality 
rates per 100 person years with or without HAART stratified by setting are presented 
in Figures 5a and 5b. Similarly, Kaplan-Meier curves of time-to-death stratified by 
gender per site are presented in Figures 6a and 6b. 
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Figure 6a: Time to death by gender (rural) 
 
 
Figure 6b: Time to death by gender (urban) 
 
Figure 6: Survival by gender in each setting 
 
 
 
Figure 7a: Time to death by CD4 Count 
(rural) 
 
Figure 7b: Time to death by CD4 Count (urban) 
 
Figure 7: Time to death by CD4 count within sites 
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In Figure 7, the Kaplan-Meier plot for time to death by CD4 count per site is 
presented. At both sites, those with CD4 count under 200 had a higher hazard for 
mortality relative to those with 201-350, 351-500 and > 500 cells/mm3.  
 
 
Figure 8a: Time to death by BMI (rural) 
 
Figure 8b: Time to death by BMI (urban) 
 
Figure 8: Time to death by BMI within sites 
A higher risk of death at both sites (HR of 2 at both sites) was hazardous for 
underweight BMI whereas overweight/obese was protective in the urban group 
(Figure 8).  
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Figure 9a: Time to death by WHO Stage (rural) 
 
 
Figure 9b: Time to death by WHO Stage 
(urban) 
 
Figure 9: Time to death by WHO Stage within sites 
WHO stage 3 or 4 was hazardous elevating the risk of death relative to WHO stage 1 
or 2 (Figure 9). 
 
Figure 10a: Time to death by HAART eligibility 
(rural) 
 
Figure 10b: Time to death by HAART eligibility 
(urban) 
 
Figure 10: Time to death by eligibility (CD4 < 200 cells/µl) to start HAART by 
site 
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4.3.4 Mortality risk factors by setting 
Being on treatment for 6-12 months (HR: 0.2, 95%CI: 0.1-0.4), > 12 months (HR: 
0.1, 95%CI: 0.1-0.2)  and a CD4 count > 200 cells/mm3 (CD4 201-350 HR: 0.3, 
95%CI:0.1-0.5 ;CD4 Count 351-500 HR: 0.4, 95%CI: 0.2-0.9; CD4 Count >500 HR: 
0.2, 95%CI: 0.1-0.5) reduced the hazard of death in rural participants. Those with 
underweight BMI had an elevated risk of death (table 15). 
Treatment for >12 months (HR: 0.4, 95%CI: 0.3-0.5), a BMI value classified as 
overweight/obese (HR: 0.7, 95%CI: 0.6-0.9)  and a CD4 count > 200 cells/mm3 
(CD4 201-350 HR: 0.2, 95%CI:0.2-0.3 ;CD4 Count 351-500 HR: 0.1, 95%CI: 0.1-0.2; 
CD4 Count >500 HR: 0.1, 95%CI: 0.03-0.1) was associated with a lower hazard of 
death in the urban group. It was higher in those on treatment < 6 and 6-12 months, 
had underweight BMI, were unemployed, had ever smoked and got TB infection 
(table 15). 
Both frailty variances were statistically significant suggesting the need to account for 
the effect of unobserved variables (heterogeneity) in the modelling process.  
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Table 15: Mortality risk factors by setting 
 Rural Urban 
Variable Univariate Multivariate Univariate Multivariate 
 HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI) 
Gender     
Female  0.7 (0.5-1.1) 0.8 (0.5-1.3) 0.5 (0.4-0.7) 1.1 (0.8-1.4) 
Male Ref Ref Ref Ref 
     
Length of time on treatment     
<6 months  1.1 (0.6-2.2) 1.2 (0.6-2.2) 17.3 (11.7-24.8) 4.5 (3.0-6.6) 
6-12 months  0.2 (0.1-0.4) 0.2 (0.1-0.4) 7.2 (4.9-10.4) 2.4 (1.6-3.5) 
>12 months  0.1 (0.1-0.2) 0.1 (0.1-0.2) 1.0 (0.8-1.3) 0.4 (0.3-0.5) 
No HAART Ref Ref Ref Ref 
     
BMI Groups     
Underweight  2.2 (1.4-3.3) 1.7 (1.1-2.9) 4.3 (3.3-5.6) 2.5 (1.9-3.1) 
Overweight/Obese  0.6 (0.3-0.98) 0.6 (0.3-1.2) 0.6 (0.4-0.7) 0.7 (0.6-0.90) 
Normal Ref Ref Ref Ref 
     
CD4 Count (cells/mm
3
)     
201-350  0.3 (0.1-0.6) 0.3 (0.1-0.5) 0.2 (0.1-0.2) 0.2 (0.2-0.3) 
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351-500  0.5 (0.2-1.1) 0.4 (0.2-0.9) 0.1 (0.1-0.1) 0.1 (0.1-0.2) 
>500  0.3 (0.1-0.7) 0.2 (0.1-0.5) 0.04 (0.02-0.1) 0.1 (0.03-0.1) 
0-200 Ref Ref Ref Ref 
     
Employment (ever)     
No  0.95 (0.5-1.8) 1.1 (0.6-2.2) 2.0 (1.6-2.7) 1.9 (1.4-2.5) 
Yes Ref Ref Ref Ref 
     
Smoking (ever)     
Yes  0.99 (0.6-1.6) - 2.1 (1.7-2.6) 1.4 (1.04-1.8) 
No Ref  Ref Ref 
     
TB infection (ever)     
Yes  1.7 (1.1-2.5) 1.6 (0.98-2.5) 2.8 (2.3-3.5) 2.8 (2.2-3.5) 
No Ref Ref Ref Ref 
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4.4 Perceptions of risk factors for mortality-qualitative study 
4.4.1 Demographics 
 
Of the 20 participants attending the PHRU clinic for VCT counselling services that were 
enrolled, 17 were females. Their ages ranged from 18 to 63 years, highest school grade 
completed was between 2nd and 12th Grades and 9 reported Isizulu as their main language. 
They reported living in households with between 1 and 9 people and the total rooms in their 
houses ranged from 1 to 17. There were 10 and 7 participants from female headed households 
where the head of household was aged 18-60 and > 60 years respectively. Participants 
reported knowing the deceased persons for between 5 and 40 years. Eight participants were 
employed, 8 were unemployed and 4 were students in tertiary institutions. Deceased persons 
were either an aunt (n=5), cousin (n=7), son (n=2) or other relative (n=6).  
Participants reported that the deceased persons were aged between 18 and 54 years, 8 
reported IsiZulu as their main language and their highest school grade was between 2 and 12. 
Of the 20 deceased persons, 15 were females. Among the deceased persons, 12 were 
employed, 6 were unemployed and 2 were students in tertiary institutions. 
4.4.2 Emerging themes on perceptions of mortality risk factors 
 
Following the interviews, several themes emerged that were perceived as having an association 
with mortality among the deceased persons. Participants perceived that engagement in risky 
sexual behaviour including multiple sexual partnerships may have a role in worsening the 
situation for an HIV-infected person. A negative attitude by healthcare workers towards HIV-
infected people was perceived to be associated with avoidance in seeking care. Those who 
believed in the healing power of religion and ignored antiretroviral treatment in favour of 
traditional medicine were perceived to have had their health deteriorate. Food security such as 
availability of regular meals as well as a good social support structure such as receiving help in 
domestic chores was perceived as important in keeping the HIV-infected persons healthy. 
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4.4.2.1 Perceived engagement in risky sexual behaviour 
 
Participants reported about the deceased’s risky behaviour such as multiple partnerships, 
unprotected sex and alcohol use. Some of the deceased were perceived to be involved in 
multiple relationships whilst being married.  For instance, a participant stated the following of 
her father:  
 
“I stayed with him for that 6 years and he was alright but you could see that even when 
he was here in Joburg, he still had a gift of liking women…he used to take me with him 
when he went to see his women (girlfriends). He was aware that he is with me. He had 4 
(wives).” (Female Participant 1 in relation to her deceased father) 
 
Another provided the following summary of her friend’s husband: 
 
 “She told me about (her husband) from what he does and so on. She said (her husband) 
would come back home in the morning and he knew very well that we (husband and 
deceased) are sick but he still did the things he did. That was reason why I moved out of 
the house cause he made me sick. He should have done the right thing. I joked about it 
and told her that she shouldn’t have had just one boyfriend in life till they got married. 
She (deceased) said that is one thing that hurt her and made her sad. On the other hand, 
her partner (husband of the deceased) went on and slept with multiple partners” (Female 
participant 6 in relation to her deceased friend’s husband) 
 
Participants commonly reported that once the deceased persons had improved while on 
treatment, they defaulted on their treatment. Thereafter they went back to their previous habit of 
drinking alcohol and engaging in multiple partnerships. A participant stated the following of her 
aunt: 
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“Yes she (deceased person) recovered then she stopped taking the treatment and went 
back to drinking again, continued with her boyfriends and that’s where she fell ill and got 
worse.” (Female participant 12 in relation to her deceased aunt) 
 
Participants reported that engagement in unprotected sex occurred and it was unclear if 
disclosure of their HIV status happened. A female participant quoted the following of her aunt: 
 
“Now she (deceased person) is in a relationship with a pastor who has a wife and they 
don’t use a condom and who knows if (my aunt) told him that she is sick” (Female 
participant 6 in relation to her deceased aunt) 
 
It was perceived that the deceased persons engaged in multiple partnerships and unprotected 
sex while knowing their HIV status. Furthermore, it was unclear if they disclosed their HIV status 
to their partners. Defaulting on treatment was a more likely cause of death in those engaging in 
risky sexual behaviour. 
4.4.2.2 Negative attitude by healthcare workers 
 
A negative attitude by the healthcare workers was perceived to be a barrier in seeking care in 
public health facilities. The quote below summarises the advice given by a clinician to the 
deceased aunt of a participant: 
 
“He (the doctor) told her to terminate (her pregnancy) but she didn’t want to and she 
never went back to the doctor and that is why she never went to the clinic to get 
medication to protect the baby from getting infected.” (Female participant 6 in relation to 
her aunt) 
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Another participant reported on the perceived negative attitude shown to her deceased relative 
by the nurses in the local clinic. The perceived negative attitude to a sister-in-law is summarised 
below:  
 
“She (deceased person) said that nurses were not treating her well. I asked her why she 
didn’t tell us because we could ask our aunt to take her to the (local) clinic and you (the 
deceased) would take the treatment there. She said that she was afraid. I asked her, how 
long would she be afraid when she had kids who were already complaining that their 
mother is always sleeping and they didn’t understand what was going on.” (Female 
participant 16 in relation to her sister-inlaw) 
 
Sometimes when participants reported on the perceived negative attitude by clinicians, they 
failed to be specific. A female participant provided the following summary of her deceased 
aunt’s experience: 
  
“The only thing she (deceased person) told me was that the doctors are rude. That is the 
only thing I knew. People usually used to say that. But she (deceased person) would 
never explain to you why she’s saying they are rude. I would ask why you (deceased 
person) say they are rude and she would say they are rude. And the nurses when you 
call them, they take their time (to respond)” (Female participant 9 in relation to her 
deceased aunt” 
 
It was perceived that the negative attitude by healthcare workers discouraged the deceased 
persons from seeking care in the public health care facilities and that may have led to 
deteriorating health. 
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4.4.2.3 Healing power of religion and traditional medicine 
 
The use of religious prayers as well as traditional medicine for purposes of healing was 
espoused during the interviews. Others perceived witchcraft as the cause of their HIV infection. 
They believed someone bewitched them into their status. 
The perceived use of religious prayers as a measure of healing by an aunt is summarised in the 
following quote by a female participant: 
 
“She (deceased) believed in the church. She never went to sangomas (traditional 
healer). She went (to the church) because she loved it. She believed in it. She knew 
even if she was HIV (infected), God is there. She believed that miracles do happen” 
(Female Participant 6 in relation to her deceased aunt) 
 
Others attended churches where the clergy provided holy water or tea. Holy water refers to 
water that has been blessed by the clergy and apparently contains healing powers. Similarly 
holy tea is blessed tea. This is summarised in the following quotes by relatives of deceased 
persons:  
 
 “She (deceased person) believed in church. They asked the pastor and the congregation 
to come to our house. Then they prayed for her (deceased person). And they prayed for 
the (holy) water and told her how she must drink it and she must wash with it.” (Female 
Participant 10 in relation to her deceased cousin) 
 
 “He had a belief that since he is a member of (name of church) that he will get healed 
(by drinking tea).  It was tea that they got from the church. How can you get healed by 
drinking tea? I even asked him (deceased person). Has he ever seen anyone get healed 
by drinking tea” (Male Participant 11 in relation to his deceased brother) 
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The use of traditional medicine in managing HIV emerged during the interview. It was perceived 
that traditional medicine, provided by sangomas (traditional healers), was favoured by either the 
deceased person or their families. This is encapsulated by relatives of deceased persons in the 
following quotes: 
 
“You know they even tried to consult a Sangoma to help her to get better. You know the 
traditional healers said we need to slaughter a chicken and make a ceremony for her. Oh 
and the Sangoma said she must drink the chicken’s blood.” (Female Participant 9 in 
relation to her deceased aunt) 
 
“They (family) did take him to a traditional healer and he was given traditional tonic and 
medication and things like that. I am not sure, but they took him to a traditional healer 
because of the chest pains suspecting that he was bewitched in his beer. You know how 
people are? So they suspected witchcraft because he was complaining of pain at the 
side of his chest.” (Female Participant 20 in relation to his deceased uncle) 
 
Other participants reported that some family members perceived witchcraft as the cause of the 
illnesses suffered by the deceased. One participant summarised the following of her aunt: 
 
“No I don’t think she (deceased person) told them because they did not visit her while 
she was sick. My aunt suspected witchcraft and because I knew the situation, I told her 
not to point fingers because I was here when mother was very sick. I saw her. Some 
people are like that. They blame witches for everything. When things go wrong, when 
their children fail at school, they say it is witchcraft.” (Female Participant 8 in relation to 
her deceased mother) 
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The significance attached to religious prayers, traditional medicine and witchcraft emerged 
during the interview. These were perceived as avenues that offered alternative forms of care for 
HIV infected individuals.   
4.4.2.4 Food security 
 
During the interviews, it emerged that food security was perceived as a matter of concern for 
HIV infected individuals that had stopped working due to HIV associated opportunistic 
infections. Participants noted that availability of food was important in maintaining good health 
especially for those who are HIV-infected. Participants described the nature of symptoms of the 
deceased persons, their experiences in relation to quitting employment and its effect on food 
security. Additionally, the support of the family, relatives and friends signified the importance of 
the social support structure. A female participant described her mother’s symptoms that led her 
to quit employment as follows: 
 
 “When she started coughing seriously, she had to quit (working). It was her decision. 
Her body became weak and she was not coping. She was very sick and feeling pain. 
She could not go to work.” (Female Participant 8 in relation to her deceased mother) 
 
Unfortunately not working led to loss of income followed by reduced availability of food 
especially for those who were self-employed and running their own businesses. A participant 
stated the following of her deceased aunt:  
 
“She used to sell food in a shop (in Soweto). So when she got sick, she couldn’t go sell. 
So there was no one running her business. She was used to doing things on her own. 
That actually stressed her because on the other hand she didn’t have money. So my 
uncle that lives in Pimville (a township in Soweto) and another aunt that lives with us 
helped her. They told her if she needs anything, they will help. They told her not to worry 
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but to focus on her health. That is when she relaxed a bit.” (Female Participant 7 in 
relation to her deceased aunt) 
 
Some of the deceased persons were unemployed and relied on others such as parents, friends 
or partners for food. A female participant summarises the experience of her deceased cousin as 
follows: 
 
“Her mother would bring her food but then she said there were times when she had 
nothing to eat. So she would have to go eat with her friends or her boyfriends, something 
like that.” (Female Participant 2 in relation to her deceased cousin) 
 
Not only did the deceased persons stop working and impacting on household food security but 
also those who cared for them. As one participant noted, of the mother of one of the deceased 
persons: 
 
“Yes, then she (mother of deceased) stopped (working) when her daughter got sick. Yes, 
she (mother of deceased) stopped working so that she can take care of…(her daughter) 
and her child (grandchild)” (Female Participant 5 in relation to her deceased cousin) 
 
Poor health of the deceased persons influenced their decision to stop working. Symptoms such 
as coughing, feeling weak and pain were commonly reported. Additionally, participants reported 
on the association between income and food security. Those who stopped working due to 
illness lost their income and livelihood. Participants noted that the support provided by the 
family, relatives and friends enabled the deceased persons an opportunity to live without 
worrying about food. 
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4.4.2.5 Social support structure 
 
The perceived importance of the social support structure such as the family, relatives and 
friends emerged during the interviews. Discussions revealed that deceased persons were able 
to receive care at home including support in attending to domestic chores or attending clinics. 
While other deceased persons received family support, others did not. A female participant 
noted the following of her aunt who never got support from the boyfriend: 
 
“The only thing that I heard was about her (aunty’s) boyfriend. She (aunty) complained 
that since she started being sick, he (boyfriend) didn’t come and see her. He wasn’t there 
for her”. (Female Participant 7 in relation to her deceased aunt) 
 
 There were those who became weak, frail and bedridden and required support with domestic 
cores such as washing their dirty linen. As one female participant noted of her aunt, the frail 
required help. 
 
“They did everything for her. Her father would wake up early in the morning to make 
porridge for her and her mother would give her a bath. She would change her linen for 
her. She was very clean. Every Sunday, they would get someone to drive her to church 
because she liked church. They would drive her everywhere she would want to go “ 
(Female Participant 6 in relation to her deceased aunt) 
 
Participants reported that support to move around and take treatment on time was possible due 
to the availability of a social support structure. A participant summarised her thoughts in relation 
to her aunt as follows: 
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 “She made food for her. She made sure that she takes her pills on time. If she needed 
her to help her stand, she would do that for her. The pills that she was taking were 
grandpas (analgesics) that she bought herself at the spaza shop (informal store). She 
would boil water for her and also rub her feet if they needed to get rubbed until she went 
to the hospital” (Female Participant 7 in relation to her deceased aunt) 
 
The perceived importance of a social support structure to provide support to frail HIV-infected 
persons was emphasised during the interviews. The social support structure enabled the 
deceased HIV-infected persons to lead a comfortable life. Timeous initiation of treatment was 
possible where social support was available. 
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5.0 Discussion 
This study was conducted to show the benefit of utilising a mixed methods approach 
incorporating both quantitative and qualitative analysis methods to complementarily. The 
methods were applied on the Adult Wellness Study involving HIV-infected individuals that was 
conducted at two sites in South Africa over seven years (2003-2010). The statistical techniques 
applied in the analysis of data assessing the risk of death, and their suitability were critically 
reviewed.54 The assessment was conducted using a modified statistical classification method 
that has been used previously in other fields in health research.66 Additionally, a selected 
number of time-to-event methods were compared using simulations with the aim of providing 
guidance on the most suitable technique to utilise in order to account for the effect of 
unobserved variables (heterogeneity), a factor that is often ignored. Risk factors for mortality in 
the Adult Wellness study were assessed by study site using INLA, a Bayesian survival frailty 
model.58 The two sites were classified into rural (Tintswalo hospital in Mpumalanga) and urban 
(PHRU in Chris Hani Baragwanath hospital, Soweto). Thereafter, a qualitative study was 
conducted in the urban site (PHRU in Soweto) and analysed. The findings were subsequently 
used to complement those from the quantitative risk factors analysis. 
This section discusses the results in the context of existing information. Findings are discussed 
under the following key areas: critical review of literature, comparison of time-to-event models, 
incorporation of latent variables and perceived risk factors. 
5.1 Critical review of literature 
 
This study critically reviewed articles on mortality risk factors in HIV-infected individuals in the 
periods: 2002-2006 and 2007-2011 to determine methods used and whether they improved 
over time. Basic inferential statistical techniques were likely to be reported in these two periods. 
Our findings concurred with others who also assessed commonly used statistical methods for 
such outcomes and study design.35, 95 The use of frailty modelling that incorporates the effect of 
unobserved variables was more common in the later period of 2007-2011.96 Though analysis 
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using sub-optimal methods has previously been reported,97-101 there were few in our review; 
limited use of the advanced survival frailty modelling was observed. It may be that there is a 
compelling need for capacity building in the use of complex survival analysis techniques in 
health related studies. Additional findings from this study are presented in Appendix 1. 
5.2 Selecting an appropriate time-to-event model 
 
A selected number of parametric and semiparametric frailty models were compared to examine 
how well they incorporate unobserved (latent) measures when assessing the risk factors for 
mortality. Cox regression methods with shared frailty performed better than the classical Cox 
regression in the parametric simulation parameters. In general, the Bayesian INLA had a better 
fit under the MSE criteria. While parameter estimates were similar in the semiparametric 
models, the INLA models consistently led to a better fit using the MSE criteria. Our findings 
agree with previous work showing a better fit with lower MSE values in the semiparametric 
models. 2 Additionally, INLA, a Bayesian technique, performed better than other methods as 
previously shown.8, 44, 102, 103 Appendix 2 presents further clarity of the methods used and 
findings. 
5.3 Accounting for unobserved heterogeneity variables 
 
Our findings suggest that where possible, it may be worthwhile to fit a model that adjusts for 
clusters such as clinics that act as surrogates for unobserved variables. Participants in the rural 
site had more heterogeneity compared to those from the urban site suggesting a higher risk for 
mortality. Opportunistic infections, socio-economic and socio-cultural factors are some of the 
potential unobserved variables that could be associated with mortality. Other publications that 
have determined factors associated with mortality found that unobserved variables had a 
significant effect on the outcome.6, 15, 16 Ignoring unobserved variables may lead to biased 
conclusions that are likely to negatively affect the management and care of HIV-infected 
patients. This may lead to disease progression and death. Hence using several complementary 
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methods in a mixed methods framework may provide insights that will improve patient care. An 
in-depth presentation of findings from this study is reported in Appendix 3. 
5.4 Perceived risk factors  
 
Since unobserved variables were significantly associated with mortality in HIV-infected people, 
qualitative analysis was explored with the aim of identifying the potential unobserved variables 
and using them to complement the quantitative findings. Participants were required to have 
been bereaved due to HIV. Several themes emerged including risky behaviour, negative 
attitude by healthcare workers, religious prayers and traditional medicine, food security and 
social support structure. 
Participants perceived an elevated mortality risk potentially associated with risky behaviour 
including multiple sexual partnerships and unprotected sex. The role of multiple sexual 
partnerships as well as unprotected sex in relation to HIV and new HIV cases has widely been 
researched.104-109 Additionally, evidence shows that HIV infection is likely to occur in stable 
relationships.105, 108 Unfortunately partners only become aware of their HIV status when their 
health condition deteriorated. Often this leads to late diagnosis and initiation of therapy when 
the immune system is severely immunosuppressed leading to early mortality.110, 111 While 
antiretroviral therapy is free in public health facilities, mortality rates associated with HIV still 
remain high. Following the qualitative analysis findings on the perceived relationship between 
multiple partnerships and mortality, we postulate that defaulting on treatment was a more likely 
cause of death as indicated by one of the key informants.  
Negative attitude by healthcare workers was perceived to have discouraged the deceased 
persons from seeking care in the public healthcare facilities. This finding is consistent with 
existing literature about discrimination of HIV-infected people by healthcare workers.112-115 While 
there has been more awareness about management of HIV and HIV-infected patients among 
healthcare workers,116 there is still a small proportion that continues to display negative attitude 
towards HIV-infected individuals. Discriminatory practice against HIV-infected individuals 
95 
 
dissuades them from seeking care in public healthcare facilities. Discrimination of HIV-infected 
individuals may lead to poor health due to low levels of treatment adherence and utilisation of 
healthcare services.113, 116, 117  
In our findings, participants perceived that some of their deceased relations had more faith in 
healing through religious prayers. They believed that going to church, asking for forgiveness 
and praying might lead to a miracle that would reverse their HIV condition. This was reinforced 
by religious leaders willing to offer prayers and support towards healing. Furthermore, some 
clergy even presented a form of blessed water suggesting that consuming it would lead to 
healing from HIV. The use of religion as a coping mechanism for HIV has previously been 
documented.118, 119 While religion frames the way of life for many people including HIV-infected 
individuals, the choice of ignoring care and initiation of therapy for those eligible to start 
treatment for the sake of religious prayers may be detrimental to their health. It may worsen the 
health of immunosuppressed individuals leading to negative consequences such as death.110, 
111 It may be that healthcare providers need to consider an integrated approach that provides 
care to HIV-infected individuals while at the same time accommodating their religious way of life 
such as allowing them to continue seeking healing through prayers. The interplay between 
religion and the belief that it leads to healing of HIV requires further research. 
We found preference for traditional medicine over antiretroviral therapy by some of the 
deceased persons. The perceived benefits associated with the use of traditional medicine in 
treating HIV remains unclear. However, it may be that its use is associated with the need to 
identify with one’s indigenous identity, family expectations, privacy and confidentiality.120, 121  
Furthermore use of traditional medicine in combination with antiretroviral therapy may lead to 
drug interactions122 and poor health outcomes such as death. Healthcare providers should 
consider use of both traditional and contemporary medicine under their supervision in order to 
mitigate any adverse events and manage them accordingly.120 This should be feasible within 
systems where regulations governing use of traditional medicine are in place such as in South 
Africa.  
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The combined effect of a HIV-related death and food insecurity has previously been studied 
where it has been shown that social and development implications cannot be ignored.123, 124 
Participants perceived a threat to food security in the livelihood of deceased persons due to loss 
of income when they ceased employment. This was often due to HIV-associated illnesses. 
Mortality is disproportionately high in the HIV-infected people who are often economically 
active.123, 125, 126 As a result, the livelihood of their dependents is put at risk. Our findings are 
consistent with previous work linking food insecurity and mortality.124, 127-129   
Our findings showed the importance of providing social support to HIV-infected individuals. 
Participants perceived that provision of social support such as helping in domestic chores, food 
security and support to move around may have reduced the burden of disease and potentially 
reduced the risk of mortality. While literature on social support such as home-based care for 
HIV-infected people is widely available,130-134 there is limited information if any to show how 
provision of social support is linked to HIV-associated mortality.135 The need for further research 
in low socio-economic settings on the interaction between social support and HIV-associated 
morbidity and mortality is required.  
5.5 Linkage between study findings and conceptual framework 
 
This study has confirmed the benefits of using a mixed methods approach to complement 
findings using the critical realism framework as presented in Figure 1 of section 1.5.  A critical 
review of the literature was performed to determine existing gaps followed by a comparison of 
time-to-event methods to determine a model that would be appropriate in accounting for 
unobserved variables. Thereafter, the model was applied to real data from a South African HIV 
study conducted at two sites. Findings from the quantitative analysis were complemented by the 
qualitative study to provide further insights. The critical realism conceptual framework enabled 
triangulation of results increasing the scope of our findings. Observed and important 
unobserved covariates from both methods were identified as influencing mortality in HIV-
infected people. Additionally, the framework increased our confidence in the hypothesis and 
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findings by providing a wider view.  Following both approaches, risk factors for mortality are 
summarised as demographic, socio-economic, clinical, socio-cultural, behavioural, social 
support and attitude of healthcare workers. More research is required to understand how socio-
cultural, behavioural and social support affects morbidity and mortality in HIV infected 
individuals.  
5.6 Study limitations 
 
5.6.1 Eligibility criteria 
 
Publications included in the critical review paper on statistical methods were only those 
published in Pubmed/Medline. Additionally only publications written in the English language 
were considered. Therefore any other publications written in a foreign language and indexed in 
a database other than Pubmed/Medline were excluded.  Additionally, our hypothesis testing 
may have been influenced by the non-random sample since this was dependent on the 
available prospective and retrospective studies found during our search criteria; the comparison 
of proportions may also have been influenced by the categories of years chosen. 
5.6.2 Missing data 
 
In the Adult Wellness data, some variables such as CD4 count had a low percentage of missing 
data. For such variables, multiple imputation technique was used assuming data were missing 
at random and this may have introduced bias. 
5.6.3 Social desirability bias 
 
In the HIV study conducted in South Africa, some variables were self-reported suggesting the 
possibility of social desirability bias, where the respondent provides responses that are 
favourably viewed. 
5.6.4 Misclassification of data 
 
Some variables such as “ever employed” were assessed cumulatively suggesting that 
misclassification may have occurred because they were not instantaneous. It is also likely that 
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some outcome measures captured as loss to follow-up may have later resulted into deaths that 
were not subsequently captured in our database.  
5.6.5 Perceptions of participants 
 
The qualitative study used participants from the urban site (PHRU), and their responses may 
not reflect those from the rural site. Additionally, participants were enrolled after the Adult 
Wellness HIV study had ended. It is likely that findings may have differed if the study had been 
implemented at both sites at the same time. Furthermore, the study period was different, with 
the qualitative study being conducted a few years after the end of the quantitative one, in which 
perceptions may have changed or participants experienced recall bias. Additionally, all of them 
were VCT clients (and thus likely to follow a line of thought introduced to them by the VCT 
counsellors). 
5.6.7 HAART Adherence data 
 
Use of HAART and its adherence is an important factor for positive outcomes. In the Adult 
Wellness study, adherence to HAART treatment was collected but not reliably. Hence it was not 
possible to assess the impact of HAART on patient clinical outcomes.  
5.7 Strengths of the study 
 
The use of simulated data provided a statistically powerful platform to compare the selected 
time-to-event methods and thereafter apply them to real data.  Actual cohort data from a real 
study may be influenced by uncontrolled factors, introducing bias in the results. As such, they 
may not be the best data to use for comparing methods other than for confirmatory work. 
An advantage of the HIV data from South Africa was that it was a large sample with long-term 
follow-up that allowed for the fitting of various survival frailty models, accounting for unobserved 
variables.   
Analysis using mixed methods afforded a complementary approach allowing a wider scope of 
coverage in identifying important covariates. While the frailty model determined the significance 
of unobserved variables, the qualitative analysis was helpful in identifying them.  
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6.0 Conclusions, implications and future research 
6.1 Conclusions and implications 
 
The benefits associated with using a mixed methods approach were explored in this study in 
which the need for capacity building in the use of complex time-to-event methods was 
observed. These involve using statistical techniques that allow for modelling of time-to-event 
outcomes while at the same time accounting for unobserved measures. 
This study presented results on the comparison of selected parametric and semiparametric 
time-to-event methods in which parameter estimates, standard errors and their frailty variances 
were assessed. In general, frailty models performed better with the Bayesian INLA performing 
best. While frailty models can be complex to implement, they reduce bias by incorporating the 
effect of unobserved covariates hence improving interpretation of study conclusions.4, 5, 7, 44 
Statistical practitioners need to ensure robustness in the analysis of data. 
A comprehensive analysis of data is likely to provide stakeholders (such as policy makers or 
HIV care managers) a clear understanding of the existing gaps and types of interventions to 
implement. Interventions could be adapted to settings allowing for adaptability and scaling up 
both locally and regionally  
6.2 Areas of further research 
 
Following our findings, the following areas for further research are proposed: 
1. In the analysis of qualitative data, participants perceived the importance of a good social 
support structure in mitigating the risk of mortality in HIV infected individuals. Our findings 
though showed limited information on the association of social support and mortality in 
HIV-infected individuals in sub-Saharan Africa. Therefore further research and data are 
required to understand better the association between social support and mortality in 
HIV-infected individuals. 
2. Findings from this study have shown further insight may be achieved through using a 
mixed methods analysis in assessing mortality risk factors in which modelling accounts 
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for unobserved variables that may be explained by qualitative studies. Most explanations 
in existing literature that have applied frailty modelling provide speculative reasons for 
the frailty variance. Hence more studies on risk factors for mortality in HIV-infected 
people using mixed methods are required. 
3. Using data from the Adult Wellness study, risk factors for mortality were assessed per 
site and the findings compared. Participants enrolled at each site were from different 
townships (localities) in the neighbourhoods surrounding the study sites. Using the 
participant’s recorded street address at enrolment, it would be possible to determine their 
geo-spatial location. This would allow for the assessment of risk factors for mortality while 
accounting for unobserved variables and spatial effects. Geo-spatial analysis could be 
helpful in identifying hot spots and where clusters of risk factors for mortality exist. 
4. Based on findings from the qualitative study, future quantitative studies looking at 
mortality in HIV infected people should include questions or tools  relating to social 
support that have been validated in sub-Saharan Africa. 
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Abstract
Background: Research in the predictors of all-cause mortality in HIV-infected people has widely been reported in literature.
Making an informed decision requires understanding the methods used.
Objectives: We present a review on study designs, statistical methods and their appropriateness in original articles
reporting on predictors of all-cause mortality in HIV-infected people between January 2002 and December 2011. Statistical
methods were compared between 2002–2006 and 2007–2011. Time-to-event analysis techniques were considered
appropriate.
Data Sources: Pubmed/Medline.
Study Eligibility Criteria: Original English-language articles were abstracted. Letters to the editor, editorials, reviews,
systematic reviews, meta-analysis, case reports and any other ineligible articles were excluded.
Results: A total of 189 studies were identified (n = 91 in 2002–2006 and n= 98 in 2007–2011) out of which 130 (69%) were
prospective and 56 (30%) were retrospective. One hundred and eighty-two (96%) studies described their sample using
descriptive statistics while 32 (17%) made comparisons using t-tests. Kaplan-Meier methods for time-to-event analysis were
commonly used in the earlier period (n = 69, 76% vs. n = 53, 54%, p = 0.002). Predictors of mortality in the two periods were
commonly determined using Cox regression analysis (n = 67, 75% vs. n = 63, 64%, p = 0.12). Only 7 (4%) used advanced
survival analysis methods of Cox regression analysis with frailty in which 6 (3%) were used in the later period. Thirty-two
(17%) used logistic regression while 8 (4%) used other methods. There were significantly more articles from the first period
using appropriate methods compared to the second (n = 80, 88% vs. n = 69, 70%, p-value = 0.003).
Conclusion: Descriptive statistics and survival analysis techniques remain the most common methods of analysis in
publications on predictors of all-cause mortality in HIV-infected cohorts while prospective research designs are favoured.
Sophisticated techniques of time-dependent Cox regression and Cox regression with frailty are scarce. This motivates for
more training in the use of advanced time-to-event methods.
Citation: Otwombe KN, Petzold M, Martinson N, Chirwa T (2014) A Review of the Study Designs and Statistical Methods Used in the Determination of Predictors
of All-Cause Mortality in HIV-Infected Cohorts: 2002–2011. PLoS ONE 9(2): e87356. doi:10.1371/journal.pone.0087356
Editor: Barbara Ensoli, Istituto Superiore di Sanita`, Italy
Received November 25, 2013; Accepted December 19, 2013; Published February 3, 2014
Copyright:  2014 Otwombe et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: KO was supported by an academic scholarship from the Canadian-Africa Prevention Trials Network, the Consortium for Advanced Research Training in
Africa (Carnegie Corporation of New York Grant no. B8606.R01, Swedish International Development Corporation Agency Grant no. 54100029, Ford Foundation
Grant no. 1120-1838 and Wellcome Trust Grant no. 087547/Z/08/Z) and the Forgaty International Center (grant no. TW007370/3). The funders had no role in
study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: otwombek@phru.co.za
Introduction
Appropriate utilization of biostatistical methods is becoming
increasingly important in biomedical research. Many journals, if
not all, have a dedicated statistical committee that scrutinizes the
methods used in analyzing data. In the last decade, several papers
addressing study design issues and statistical analysis approaches in
different clinical fields have been published underpinning the
importance of robustness in methodology [1–8]. There is
consensus that inappropriate study designs and statistical meth-
odology lead to incorrect results, poor interpretation of study
findings and wrong conclusions.
An array of study designs and appropriate statistical techniques
with varying levels of complexity exists. Selecting the appropriate
study design and relevant statistical analysis technique is largely
dependent on the complexity of the study and its objectives.
Research on statistical content of medical research shows wider
usage of techniques [9,10] beyond descriptive statistics as a result
of advanced software that can handle complex analyses. Much as
advanced analyses are being conducted, simple techniques of
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descriptive and inferential statistical analysis like student t-tests and
chi-square tests remain popular in the literature [4,6,11].
Despite major successes in the development of interventions for
prevention of mother to child treatment (PMTCT) and anti-
retrovirals (ARVs), HIV still remains a major public health
concern. To date, limited information is available if any, reporting
on the study design and statistical techniques used in determining
the predictors of all-cause mortality in HIV positive cohorts in the
last decade. With a large number of clinicians and public health
experts relying on published research for new developments in
HIV research, it is important they understand appropriateness of
study designs and statistical techniques used in determining
predictors of all-cause mortality. This study reviews relevant
original articles in HIV-infected cohorts with the aim of identifying
study designs, statistical methods used and further assess their
appropriateness. We also sought to determine whether there was
an increase in the use of time-to-event analysis techniques over
time and highlight the need for methodological training.
Methods
Search strategy and selection criteria
In this bibliometric analysis, we searched all original English-
language articles indexed in Pubmed/Medline using the terms
‘‘Predictors of HIV Mortality’’, ‘‘Determinants of HIV Mortality’’
and ‘‘Factors associated with HIV mortality’’. The search covered
the period between January 2002 and December 2011, a period of
ten years. These were further split into two five year periods;
January 2002–December 2006 and January 2007 to December
2011 in order to assess whether there was a variation in the
methods used over time. Original articles on HIV-infected cohorts
within the specified period were eligible for inclusion. Letters to
the editor, editorials, reviews, systematic reviews, meta-analysis
and case reports were excluded. Other studies comparing both
HIV positive and negative participants were also excluded. We
identified a total of 91 and 98 papers between the periods 2002–
2006 and 2007–2011 respectively.
Each article was reviewed to determine the study design, nature
of statistical methods used and their appropriateness. Time-to-
event analysis methods were considered optimal or appropriate in
this study. A spreadsheet containing a checklist of items of interest
was prepared as a data collection tool. Findings were systemat-
ically recorded based on statistical methods previously reported
[12]. We used a modified version of the classification proposed by
Colditz and Emerson (Table 1) [13,14]. Where a statistical
technique was used more than once in an article, we recorded it as
having occurred only once. A count of the number of statistical
techniques employed in each article was determined for purposes
of comparing the two periods.
The statistical methods used in the research articles were
classified as either parametric or non-parametric. A further
classification was made describing the statistical methods used as
either basic or advanced. Methods classified as basic included
Student t-test, Chi-Square and Fishers Exacts test, Mann-Whitney,
Kruskall-Wallis, Wilcoxon, simple one-way ANOVA and corre-
lation statistics. Modelling approaches such as logistic Regression,
Conditional Logistic Regression, Poisson Regression, Cox regres-
sion, time-varying Cox-regression and Cox regression with frailty
and epidemiologic statistics were classified as advanced (Table 1).
The logistic regression is used to analyse the relationship
between a binary dependent variable and independent predictor
through estimation of the probability of an event occurring. It
Table 1. Classification of statistical methods as reported in journals.
Category Brief description
t-tests One-sample, matched pair and two-sample t-tests
Contingency tables Chi-square tests, Fisher’s exact test, McNemar’s test
Pearson correlation Classical product moment-correlation
Simple linear regression Least squares regression with one predictor and one response variable
Power Loosely defined, includes use of the size of detectable (or useful) difference in determining sample size
Epidemiological statistics Relative risk, odds ratio, log odds, measures of association, sensitivity, specificity
Adjustment and standardization Pertains to incidence rates and prevalence rates
Multiway tables Mantel-Haenszel procedure, log-linear models
Non-parametric tests Sign test, Wilcoxon signed-rank test, Mann-Whitney test
Non-parametric correlation Spearman’s rho, Kendall’s tau, test for trend
Analysis of variance Analysis of variance, analysis of co-variance and F-tests
Multiple comparisons Procedures for handling multiple inferences on same data sets, includes Bonferroni techniques, Scheffe’s
contrasts, Duncan multiple range procedures, Newmann-Keuls procedure
Transformation Use of data transformation (e.g logarithms) often in regression
Multiple regression Includes polynomial regression and stepwise
Life table Actuarial life table, Kaplan-Meier estimate of survival
Regression for survival Includes Cox regression and logistic regression
Other survival analysis Breslow’s Kruskal-Wallis, log-rank, Cox model for comparing survival
Cost benefit analysis The process of combining estimates of cost and health outcomes to compare policy alternatives
Sensitivity analysis Examines sensitivity of outcome to modest changes in parameters of model, or in other assumptions
Other Anything not fitting above headings, includes cluster analysis, discriminant analysis and some mathematical
modeling
doi:10.1371/journal.pone.0087356.t001
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makes no assumption about normality, linearity and homogeneity
of variance. But used with time-to-event outcomes, it fails to
account for follow-up time. For this reason, articles reporting use
of logistic regression on such outcomes were classified as sub-
optimal [15]. Cox regression analysis is a survival analysis
technique in time-to-event data that incorporates follow-up time
and fixed covariates [16]. Censoring is done when events occur.
The method assumes risk of an event is homogeneous. Extensions
of the Cox regression exist which include time dependent Cox
regression and Cox regression analysis with frailty [17,18]. Time
dependent Cox regression analysis accounts for the inherent
correlation that may exist when covariates change over time. Cox
regression analysis with frailty, if used in some of the reviewed
articles, tries to account for unobserved heterogeneity.
The data collected in this study were compared between two
periods. Frequency analysis was used to determine the number of
studies reporting use of specified statistical techniques. The
number of optimal or sub-optimal methods used in the determi-
nation of predictors of mortality was determined using frequencies.
The comparison between numbers of methods reported between
the two periods was compared using the chi-square test where
appropriate. All the Statistical analysis was performed using SAS
9.3 software and p-values #0.05 were considered a significant
difference.
Results
The total number of studies reporting on predictors of HIV
mortality that met our criteria in the era January 2002 and
December 2011 was 189 (n = 91 in 2002–2006 and n= 98 in
2007–2011). Figure 1 is a flow chart displaying the selection
criteria that was followed in arriving at the final number of articles.
All the identified articles used at least one (basic or advanced)
statistical test. Journal of Acquired Immune Infection (JAIDS)
(n = 34, 18%) and AIDS (n= 24, 13%) published more articles on
HIV mortality. JAIDS and AIDS published 19/34 (56%) and 14/
24 (58%) of these articles in the era 2002–2006. Majority of the
articles used a prospective study design and the number was
Figure 1. Flow chart showing the selection process of articles and the number in each period.
doi:10.1371/journal.pone.0087356.g001
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similar in both periods (n = 67, 74% vs. n= 62, 63%; p= 0.66).
Sample sizes varied from under 200 to greater than 1,000
participants. Table 2 presents the study design and sample size
distribution of the included articles between the two periods.
There were no significant differences in the study designs and
sample sizes used between the two periods.
The number of studies reporting descriptive statistics for the two
periods was similar. Table 3 presents the distribution of commonly
reported statistical methods. The number of articles reporting use
of t-tests, contingency table analysis, correlation and epidemiolog-
ical statistics was similar. Few studies in both periods reported
using one-way analysis of variance technique (ANOVA). The
number of modeling approaches such as logistic, conditional
logistic, generalized estimating equations and Poisson regression
was significantly higher in the later period compared to the earlier
(n = 31, 32% vs. n = 13, 14% p=0.005).
A total of 122 (65%) articles reported using the Kaplan-Meier
methods and it was commonly used in the first period compared to
the second (p = 0.002). Use of the Cox proportional hazards
regression modeling was reported by 131 (69%) articles and the
number was similar between the two eras (p = 0.12). The number
reporting use of time dependent Cox regression was higher in the
first period (n= 21, 23% vs. n= 11, 11%; p= 0.03). Overall Cox
regression with frailty was scarcely used (n= 7, 4%) in which 6
(3%) articles were in the later period.
There were 22 (12%), 96 (51%) and 71 (38%) articles reporting
use of 2 to 3, 4 to 5 and more than 5 statistical methods
respectively. There were no significant differences in the number
of methods used between the two eras. Similarly there were no
significant differences between the two eras in the number of
Table 2. Types of study designs and sample sizes.
2002–2006 2007–2011
Research Design No. (%) No. (%) p-value
Prospective 67 74 62 63 0.66
Retrospective 23 25 33 34 0.14
Case control 1 1 3 3 -
Prospective 1 - 0 - -
Retrospective 0 - 3 - -
Total 91 98
Sample sizes
up to 200 22 24 15 15 0.5
201 to 500 21 23 25 26
501 to 1,000 16 18 20 20
.1,000 32 35 38 39
doi:10.1371/journal.pone.0087356.t002
Table 3. Summary of statistical methods.
2002–2006 2007–2011
Statistical methods
No. of publications
(N=91) (%)
No. of publications
(N=98) (%) p-value
Descriptive statistics 88 97 94 96 0.78
Inferential methods
t-test 13 14 19 19 0.35
Contingency table analysis
Basic (chi-square/Fisher exact) 25 27 37 38 0.13
Correlation 9 10 1 1 -
Epidemiologic statistics 39 43 45 46 0.67
Analysis of variance 3 3 1 1 -
Regression
#Multiple regression 13 14 31 32 0.005
Survival analysis
Kaplan-Meier 69 76 53 54 0.002
Cox-Regression 68 75 63 64 0.12
Time dependent Cox regression 21 23 11 11 0.03
Cox-Regression with frailty 1 1 6 6 -
Non-parametric methods 86 95 91 93 0.64
No. of different inferential methods
2 or 3 methods 10 11 11 11 0.96
4 or 5 methods 44 48 43 44 0.54
More than 5 methods 37 41 44 45 0.56
"Basic analysis 36 40 45 46 0.38
*Advanced analysis 90 99 97 99 0.96
#Refers to logistic, conditional logistic, generalized estimating equations and Poisson regression methods.
"Refers to Student t-test, Chi-Square and Fishers Exact test, Mann-Whitney, Kruskall-Wallis, Wilcoxon, simple ANOVA and correlation.
*Refers to Logistic Regression, Conditional Logistic Regression, Poisson Regression and Survival Analysis and Epidemiologic statistics.
doi:10.1371/journal.pone.0087356.t003
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articles reporting use of basic or advanced statistical analysis
methods.
A total of 149 (79%) of the articles used appropriate methods
while 40 (21%) used sub-optimal methods to determine the
predictors of mortality in HIV-infected participants. Of the articles
using appropriate methods, 116 (78%) were prospective and 33
(22%) retrospective. There were significantly more articles from
the first period using appropriate methods compared to the second
(n = 80, 88% vs. n= 69, 70%, p-value = 0.003). Table 4 presents
findings on the appropriateness of the statistical methods used. A
significantly higher number of articles in the first period could
have used Cox regression analysis with frailty as the appropriate
method, since they had clustered data (n = 82, 92% vs. n= 65,
68%; p,0.0001) while overall they were 147 (78%).
Discussion
This paper aimed at reviewing articles on predictors of all-cause
mortality in HIV-infected people to investigate the appropriate-
ness of statistical methods used and nature of study designs. We
reviewed a total of 189 articles. Like in any other study, there were
several limitations. The literature review of the articles included in
this study was searched in Pubmed/Medline ostensibly because
this was not a systematic review requiring a measure of effect. Any
relevant articles indexed elsewhere or in a language other than
English were not considered.
Our findings concur with others reporting on study designs,
statistical methods used and their appropriateness. Prospective
study designs remain the most common type of design used in
studies of predictors of HIV mortality in the last decade.
Retrospective study designs formed about one third of all articles
included in this study. It may be that retrospective study designs
are used as a cost-effective way of saving on huge expenses
required for running prospective studies as a way for stimulating
academic research. However there was no significant difference in
the type of study designs used between the two periods.
Basic statistical analysis procedures like t-tests, Chi-Square and
Fishers Exact tests, Mann-Whitney, Kruskall-Wallis and Wilcoxon
are commonly used. There was no difference in the number of
articles reporting use of t-tests between the two periods. This is
similar to previously reported studies that have shown the
popularity of t-tests [4,19].
All the studies used at least two statistical tests. We contend that
our inclusion criteria and the nature of studies included in this
review all required using a type of statistical analysis to address the
research question. Our findings concur with those reported earlier
showing majority of articles apply more than one statistical test
[5,7,20]. But this is contrary to the findings of a review on study
designs and statistical methods in Chinese journals that found a
low proportion of studies reporting use of multiple statistical tests
[21].
Survival analysis approaches remain popular in the studies
looking at predictors of mortality in HIV-infected people,
especially the Cox proportional hazards regression modeling.
Though fewer studies used extensions of the Cox proportional
hazards regression, our findings show that there is an interest in
using advanced approaches like the time-dependent Cox propor-
tional hazards or Cox proportional hazards regression with frailty
in modeling survival data in HIV-infected cohorts. We found a
higher proportion of the studies could have used Cox regression
analysis with frailty, an appropriate technique. While the methods
used were not wrong, they could have gained more information by
using Cox regression analysis with frailty. Previously reported
work on statistical methods in medical research show that while
use of sophisticated methods is increasing, inappropriate tech-
niques still remain a challenge [1,6,7,22]. It may be that recent
techniques are advanced and require rigour to implement.
Furthermore the techniques may not necessarily be easily
implemented in standard statistical software [23]. As a result,
researchers use techniques that are fairly straight-forward and
implementable in standard statistical software.
Our findings show that not all the studies in our sample used
optimal statistical tests in the determination of the predictors of
mortality. Survival analysis techniques produce better estimates
that are more informative when analysed using optimal methods.
Furthermore, in clinical research where objectives require a
multivariable analysis approach, it is prudent to adjust for
confounding appropriately by using optimal statistical methods
[24]. Cox regression analysis and its extensions provide a better
picture compared to logistic regression when using survival data.
Unlike previously reported research [21,25], the proportion of
studies using sub-optimal statistical tests was lower in our sample.
These findings are contrary to those reported in other clinical
fields where there was a high proportion of articles using sub-
optimal methods [3,11,19,26,27].
Descriptive statistics and survival analysis techniques remain the
most common methods of analysis in publications on predictors of
Table 4. Appropriateness of statistical methods for predictors of mortality.
2002–2006 2007–2011
Prospective (N=68) Retrospective (N=23) Prospective (N=62) Retrospective (N=36)
Statistical methods No. (%) No. (%) No. (%) No. (%)
Appropriate statistical analysis
Cox regression 53 (78) 15 (65) 48 (77) 15 (42)
Time dependent Cox regression 16 (24) 5 (22) 10 (16) 1 (3)
Cox regression analysis with frailty 1 (1) 0 (0) 3 (5) 3 (8)
Poisson regression 3 (4) 0 (0) 4 (6) 0 (0)
Sub-Optimal statistical analysis
Logistic regression 4 (6) 4 (17) 7 (11) 17 (47)
Unclear 1 (1) 2 (9) 2 (3) 3 (8)
Note: Totals in this table do not add up to the number of articles because some articles used more than one method in their analysis.
doi:10.1371/journal.pone.0087356.t004
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all-cause mortality in HIV-infected cohorts while prospective
research designs are favoured. These results suggest the impor-
tance of understanding advanced survival analysis methods in
interpreting research findings in this set-up. However complex and
appropriate methods like Cox regression analysis with frailty
remain scarcely utilised. Our findings are in agreement with others
who also reported a high use of descriptive statistics [4,6]. The
more sophisticated techniques of time dependent Cox regression
and Cox regression with frailty are scarcely used. This motivates
for more training in the use of advanced time-to-event methods.
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Abstract 
Background 
Shared survival frailty models are commonly used to assess clustered time-to-event 
data where individuals enrolled into a study are followed until an event occurs or they 
are censored. While parametric frailty models are commonly used, semiparametric 
frailty models are increasingly being adopted. We compare four selected 
semiparametric frailty methods using different packages. 
Methods  
Using simulated clustered data, we compared the integrated nested Laplace 
approximation (INLA), h-likelihood (frailtyHL), penalized likelihood estimation 
(frailtyPack)  and penalised partial likelihood (coxph). Performance of the methods is 
estimated using the mean squared error (MSE). 
Results 
In the simulations, INLA had a slightly better fit with consistently lower MSE values 
compared to the other methods in both gamma and log-normal frailty models. The 
random effects estimate for INLA, whose method is slightly different, was lower than 
other methods. 
Conclusions 
Although the MSE for INLA was slightly lower, the fixed-effects estimates were very 
similar with slight differences. All the methods handled the semiparametric frailty 
modelling well while others used slightly more computer resources with regards to 
time. 
Keywords: Time-to-event; Heterogeneity; Semi-parametric Frailty; 
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Introduction 
Time-to-event statistical methods are commonly used where time is an important 
consideration in relation to a primary outcome of interest. Here, Cox proportional 
hazards model is the preferred method in testing the effect of covariates on the 
hazard rates. It is defined as ℎሺ𝑡ሻ = ℎ଴ሺ𝑡ሻexp⁡ሺߚ𝑋ሻ where ℎ଴ሺ𝑡ሻ is the baseline 
hazard, ߚ is a vector of coefficients and 𝑋 comprises the covariates [1]. It assumes 
independence between observations and linearity of covariates and the hazard ratio. 
It has the advantage of not assuming a distribution for ℎ଴ሺ𝑡ሻ and being available in  
standard statistical software whereas its disadvantage includes not accounting for 
unobserved heterogeneity due to clustering. 
Shared frailty models, the main focus of this study, are an extension of the Cox 
proportional hazards regression that account for unobserved heterogeneity in the 
presence of clustering [2, 3]. Examples include people living in one household, 
repeatedly collected data on an individual, a clinic or a school. These models are 
also suitable in situations where subjects in a study are more prone to failure than 
others. Initially introduced in lifetime models, extensions exist in several different 
fields. In time-to-event analysis, failure to account for unobserved heterogeneity may 
lead to biased estimates and incorrect interpretation of results. In frailty modelling, a 
random parameter is introduced in the hazard rate model to account for unobserved 
heterogeneity.   
Frailty modelling assumes some form of distribution for the frailties. Several 
distributions for the frailties have been proposed in the literature with the most 
common being the gamma and log-normal. The gamma distribution is commonly 
used due to its mathematical tractability while the log-normal fits in well with the 
generalised linear mixed models [4]. Frailty models may be implemented in 
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parametric or semi-parametric forms. In the parametric form, a distribution is 
assumed for the survival time while in the non-parametric form, no distribution is 
assumed allowing for flexibility in the modelling process. While methods for 
modelling the parametric form are well developed, the semi-parametric form requires 
use of more complicated approaches [4, 5].  
The comparison of various parametric shared frailty models using simulations has 
previously been done. The gamma and lognormal frailty distributions have been 
used to assess the correlation between variance estimates and the correlation of 
frailties [6]. Parametric frailty models fitted by maximum marginal likelihood with 
several possible baseline hazards have been illustrated to show how well they 
perform [4, 7]. A time-dependent frailty model within a Bayesian framework has 
previously been examined and compared with a constant frailty model using a 
recurrent events data [8]. Others have demonstrated the use of penalized likelihood 
to fit efficient shared frailty models [9]. Several frailty distributions, their statistical 
properties and various maximisation techniques are summarised elsewhere in 
excellent reviews on frailty models [10-13]. 
Semi-parametric frailty models have been used to compare various frailty 
distributions with the most common frailty distributions being the gamma and log-
normal. Using a comparison of four models involving correlated data, it was shown 
that the semi-parametric frailty models perform better than the naïve Cox model [14]. 
The use of the Dirichlet process prior in the Bayesian modelling of frailties has been 
shown to perform better in the semi-parametric frailty modelling compared with the 
parametric [15]. Using simulations, several softwares capable of fitting shared semi-
parametric frailty models were compared and found to fit well but with varying levels 
of complexity [16]. Other examples on the performance of various semiparametric 
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methods have been presented in literature using both gamma and lognormal frailties 
[10, 12, 13]. 
While several excellent examples on the use of semiparametric frailty models exist, 
research in the field continuous with more approaches being proposed. Additionally, 
several articles comparing how well semiparametric frailty methods perform exist. 
However, articles presenting an overview of maximisation methods in 
semiparametric frailty models that include the integrated nested Laplace 
approximation are limited. This study provides such an overview using the gamma 
and lognormal frailties through simulations.  
Methods 
Notation 
Let ݆ = ͳ,… , ݊௜ ⁡ be subjects that belong to cluster ݅⁡, where ݅ = ͳ,… ,݉ and the 
endpoint of interest is a time-to-event outcome, for example death. Further let the 
observation time be ௜ܶ௝ where an event may or may not occur. In this case, the 
observation time may be defined as ௜ܶ௝ = minሺܶ, 𝐶ሻ where 𝐶 = ͳ if no censoring 
occurs and 𝐶 = Ͳ when censored. The shared frailty model is defined as ℎ௜௝ሺ𝑡ሻ =ℎ଴ሺ𝑡ሻ⁡݁ݔ݌(𝑋௜௝௧ ߚ + ݓ௜) where ℎ௜௝ሺ𝑡ሻ is conditional hazard for subject ݆ in cluster ݅, ݓ௜ is 
random effect defined as the frailty term, ߚ is a vector of fixed effects or parameter 
estimates and 𝑋௜௝௧  is a vector of covariates from the observed data [10, 13]. This 
model is referred to as the shared frailty model because subjects in the same cluster 
are considered to share the same frailty. In the parametric form, a distribution is 
assumed for the time of events hence the baseline hazard ℎ଴ሺ𝑡ሻ while in the 
semiparametric form, no distribution is specified.  
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In the semiparametric frailty model with gamma frailty, the frailty term is assumed to 
follow the gamma distribution. Here, we confine our study to the one-parameter 
gamma distribution ?݂?ሺݓሻ = {ݓଵ 𝜃⁄ −ଵ݁ݔ݌ሺ−ݓ/ߠሻ} ߠଵ 𝜃⁄ 𝛤ሺͳ/ߠሻ⁄  where the 
heterogeneity between clusters is assessed by ߠ [10]. Frailty values > 1 signify 
higher risk while < 1 suggests low risk. The gamma distribution is commonly used 
due to its ease in mathematical manipulations [10, 13].  
The lognormal distribution is used due to its flexibility in modelling both random and 
fixed effects. It is defined as ?݂?ሺݓሻ = ሺͳ ݓ√ʹ𝜋ߛሻexp⁡ሺ− ሺlogݓሻଶ ʹߛ⁄ ሻ⁄  where ߛ⁡is the 
variance and is always positive. While not as commonly used as the gamma 
distribution, the lognormal distribution is less tractable [10, 13]. The lognormal frailty 
model is restrictive in the quantification of the frailty variance due to its form [13]. 
Both gamma and lognormal frailty models analyse data using varying maximisation 
procedures. Below we briefly describe the maximisation procedures used in the 
methods adopted in this study. 
Penalized partial likelihood  (CoxPH) 
In this approach, smoothing splines that help in parameter estimation through 
transformations, are used in conjunction with the penalized partial likelihood to 
determine parameter estimates. The penalized partial likelihood is given by  ݈𝑃𝑃௅௦ ሺߚሻ = ݈݋݃ [∏ ∏ [exp(݃ሺ. ሻ) /∑ exp⁡ሺ݃ሺ. . ሻሻ𝑅ሺ௧೔ೕሻ ]𝜎೔ೕ𝑛೔௝=ଵ𝑛௜=ଵ ] − 𝜆 ∫{݃′′ሺݖሻ}ଶ݀ݖ  where  
the parameter estimate ߚ defines functions ݃ሺ. ሻ, ݃ሺ. . ሻ and ݃′′ሺݖሻ and 𝜆 ∫{݃′′ሺݖሻ}ଶ݀ݖ 
is the penalty term subtracted from each iteration during the parametrization process 
[17, 18]. 
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H-Likelihood (frailtyHL) 
The h-likelihood functions fit both the gamma and lognormal frailty distributions. The 
approach utilises the Laplace approximation procedures leading to efficient 
parametrisation of frailty estimates. The approach is defined as ℎ = ℎሺߚ, ℎ଴, ߙሻ = ݈଴ +݈ଵ where ݈଴ and ݈ଵ are conditional log densities and sum of log densities respectively 
[19]. An indepth analysis of the h-likelihood theory and its potential applications are 
presented elsewhere [19-21]. 
Piecewise log-constant baseline hazard (INLA)  
In this Bayesian approach, the time of observation is partitioned and the baseline 
hazard in each partition is assumed to remain constant. Additionally, the effect of the 
covariates is assumed to remain constant. Here, parameter estimation is carried out 
using data augmentation through latent Gaussian models and through a first-order 
random walk (RW1) [22, 23]. The likelihood of the ݆௧ℎ observation in the ݅௧ℎ cluster is 
given by 𝜋(ݕ௜௝|ߟ௜௝ , ߠ) where ߟ௜௝ is a linear predictor and ߠ is a vector of hyper-
parameters [23]. 
Penalized full Likelihood (frailtyPack) 
This method uses a full likelihood in conjunction with splines in parameter estimation. 
Splines are useful where precise estimations in semiparametric frailty modelling are 
unachievable [24]. A penalty is imposed on the likelihood by this method through 
introduction of large values on functions classified as rough. It is defined as ݌݈ሺℎ଴ሺ. ሻ, ߚ, ߠሻ = ݈ሺℎ଴ሺ. ሻ, ߚ, ߠሻ − ∑ 𝐾𝑑 ∫ ℎ଴𝑑′′⁡ଶሺ𝑡ሻ⁡݀𝑡∞଴௄𝑑=ଵ  and ݈ሺℎ଴ሺ. ሻ, ߚ, ߠሻ is the full 
likelihood and 𝐾𝑑 ൒ Ͳ are smoothing parameters per stratum [24, 25]. 
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Simulation 
We simulated the semiparametric frailty model with gamma and lognormal frailties 
following the frailtysurv R package approach [26] under the assumption that the 
gamma distribution has an 𝐸ሺ𝑋ሻ = ͳ and ܸܽ𝑟ሺ𝑋ሻ = ߠ whereas the lognormal has an 𝐸ሺߠ ʹ⁄ ሻ = ͳ and ܸܽ𝑟ሺ𝑋ሻ = 𝐸ሺʹߠሻ − 𝐸ሺߠሻ. For each of the frailty models, 10 clusters 
of size 50 and 100 were generated 1,000 times. For each ݆௧ℎ observation that 
belongs to the ݅௧ℎ cluster, the conditional survival function was derived by 
௜ܵ௝(𝑡|ܼ௜௝ , ݓ௜) = ݁ݔ݌(−ܪ଴ሺ𝑡ሻݓ௜݁ݔ݌⁡ሺߚ𝑋௜௝ሻ) where the unspecified cumulative hazard 
function is represented by ܪ଴ሺ𝑡ሻ and ݓ௜ and ߚ𝑋௜௝ are as previously defined [26]. To 
simulate the failure time ௜ܶ௝ in the region ሺͲ,∞ሻ, ܪ଴ሺ𝑡ሻ is inverted and the failure 
times are determined by ௜ܶ௝ = ܪ଴−ଵ(−݈݊( ௜ܷ௝)exp⁡ሺ−ߚ𝑋௜௝ሻ/ݓ௜) where ௜ܷ௝ is uniformly 
distributed. The generated frailties are dependent on the selected frailty distributions, 
in our case the gamma and lognormal. Using a normal distribution for right 
censoring, an indicator for failure time was defined as 𝜎௜௝ = ܫ( ௜ܶ௝ ൑ 𝐶௜௝) where 𝐶௜௝ is 
the censoring variable for the ݆௧ℎ subject in the ݅௧ℎ cluster. For purposes of 
illustration, we only present simulated data generated using 10 clusters that have a 
fixed censoring rate of 20%. 
Statistical analysis 
Simulated data were analysed by fitting semiparametric gamma and lognormal frailty 
models where parameter estimates and their standard errors were outputted. 
Additionally, frailty variances were generated for each model. The mean squared 
error (MSE) defined as 𝑀ܵ𝐸(̂ߠ) = 𝐸 [(̂ߠ − ߠ)ଶ] was used to compare parameter 
estimates across all simulated models. For comparison, box plots were generated for 
parameter estimates and standard errors for the models. 
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The semiparametric frailty models were fitted using the following R packages: 
Integrated Nested Laplace Approximation (INLA) for Piecewise log-constant baseline 
hazard, frailtyHL for H-likelihood, coxPH for penalized partial likelihood and  
frailtyPack for penalized full likelihood. The SAS SGPLOT procedure in SAS 
Enterprise Guide 7.1 (SAS Institute, Cary, NC) was used to generate plots. 
Results 
In the semiparametric gamma frailty models of cluster size 50 and 100 (figure 1a and 
1b), the four methods with differing maximisation procedures produced similar 
results. Even though the parameter estimates were similar, INLA parameter 
estimates were slightly lower relative to those produced by other methods. 
The lognormal frailty parameter estimates were also similar across all the methods 
for both clusters. In general, there was less variability in the clusters with more 
members (cluster size n=100) in comparison to that of cluster size n=50 (figures 1c 
and 1d). 
The standard errors and INLA standard deviations are presented graphically in figure 
2. In figure 2a, while the gamma plots appear similar, there seems to be greater 
variability with cluster size 50 compared to cluster size 100. In the lognormal plots, 
the standard errors/INLA standard deviation is similar across the methods. However 
the penalized full likelihood appears to have more variability under the lognormal 
frailty model with cluster size 100. 
When comparing the MSE for each of the parameter estimates across all the four 
methods, they were all similar to 2 decimal points (table 1). Though a small 
difference, the MSE of INLA was consistently lower than other methods. Additionally, 
the MSE was lower with larger cluster sizes. 
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In the gamma frailty model considering both cluster sizes, the frailty variances were 
similar for penalized partial likelihood, H-likelihood and penalized full likelihood and 
ranged between 1.8 and 1.9 (table 2). The piecewise log-constant baseline hazard 
frailty variance was less. In the lognormal frailty, the frailty variances for the 
piecewise log-constant baseline hazard and penalized partial likelihood were similar 
and ranged between 1.1 and 1.2. Frailty variances estimated using the H-likelihood 
and penalized full likelihood methods were larger and ranged between 1.7 and 1.9. 
Discussion 
Our study has compared the performance of different maximisation procedures using 
simulations where parameter estimates and their standard errors/standard deviation 
were generated. Estimates from the four semiparametric frailty models including the 
Bayesian INLA were assessed by the MSE. While the estimates were generally 
similar, the MSE values showed that INLA had consistently lower values in 
comparison to the other methods. All the approaches were implemented with ease 
though some may take longer to iterate depending on the cluster size. This 
observation is similar to a previous study where several semiparametric frailty 
models were compared and found to be easily implementable but with varying 
computational complexities [16]. 
The semiparametric gamma frailty models are generally the most preferred due to 
their ease in implementation and appealing mathematical properties. In our study, 
the parameter estimates and standard errors/INLA standard deviation were similar. 
Additionally, less variability was observed with large clusters. Our findings are in 
harmony with other studies involving simulated gamma frailty models where the 
semiparametric gamma frailty model performed well [10, 13, 24]. Their standard 
errors were also similar across the methods. In the semiparametric lognormal frailty 
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modeling, parameter estimates were also similar. While the standard errors/INLA 
standard deviations were similar, some variability was observed in the penalized full 
likelihood approach. 
The four methods compared in this study were all capable of analysing clustered 
semiparametric frailty models. Among them, the penalized partial likelihood was the 
fastest in iterating. This finding is in harmony with a previous study that compared 
several semiparametric frailty models [16]. Additionally, the four methods were 
compared using the MSE. Though the MSE findings were similar, the piecewise log-
constant baseline hazard approach used by INLA produced lower values 
consistently. 
The frailty variances were similar in a third of the methods assessed under the 
gamma frailty model and a half in the lognormal frailty. These differences are not 
unusual because the frailty variances in these approaches are estimated using 
different methods. Unfortunately only one approach using the H-Likelihood provides 
frailty variances that are accompanied with standard errors. 
Limitations of this study include the complexity of accounting for unobserved 
heterogeneity which is conditional on latent variables. It is also important to correctly 
specify the frailty model. In addition, this study only focussed on four semiparametric 
methods that are available in the R packages. While other semiparametric frailty 
models exist such as those found in the R packages coxme and phmm amongst 
others, a detailed overview of their performance has been previously presented [10, 
16, 19, 24, 26]. Using several different cluster sizes and censoring rates would have 
provided more diversity in the performance of these methods. However, and unlike 
previous research, this study adds INLA whose parameter estimation follows the 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Bayesian theory (INLA) and is compared with the frequentist approaches using the 
MSE.  
In conclusion, semiparametric frailty models can be implemented using any of these 
methods. However, one has to decide on an approach that utilises less computer 
time resources while at the same time providing optimal results. Our MSE findings 
suggest that INLA may be a worthy consideration if one is considering fitting a 
Bayesian model. Alternatively, the penalized partial likelihood approach would suffice 
for semiparametric frailty modelling using a frequentist approach.  
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Table 1: Mean-squared error of the parameter estimates 
Parameter Estimates INLA frailtyHL frailtyPack coxph 
     Semiparametric Gamma Frailty 
    
     Cluster size (n=50) 
    Z1 0.0033 0.0036 0.0035 0.0035 
Z2 0.0041 0.0046 0.0044 0.0044 
Z3 0.0051 0.0054 0.0056 0.0058 
     Cluster size (n=100) 
    Z1 0.0015 0.0017 0.0017 0.0017 
Z2 0.0020 0.0022 0.0022 0.0022 
Z3 0.0025 0.0026 0.0027 0.0027 
     Semiparametric Log-Normal Frailty 
    
     Cluster size (n=50) 
    Z1 0.0030 0.0033 0.0032 0.0032 
Z2 0.0043 0.0047 0.0049 0.0046 
Z3 0.0053 0.0058 0.0058 0.0058 
     Cluster size (n=100) 
    Z1 0.0015 0.0016 0.0018 0.0016 
Z2 0.0020 0.0022 0.0025 0.0022 
Z3 0.0024 0.0026 0.0031 0.0026 
     NB: INLA- Piecewise log-constant baseline hazard; frailtyHL-H-Likelihood; frailtyPack-Penalized full 
likelihood; CoxPH-Penalized partial likelihood; 
 
 
 
 
 
 
 
 
 
 
Table Click here to download Table Tables.docx 
Table 2: Median and interquartile ranges of the frailty variances 
Variable INLA FrailtyHL FrailtyPack CoxPh 
    
 
Gamma frailty 
   
 
    
 
Gamma (cluster size n=50) frailty 
variance 1.1 (1.0-1.1) 1.9 (1.4-2.4) 1.8 (1.3-2.3) 1.8 (1.3-2.3) 
    
 
Gamma (cluster size  n=100) 
frailty variance 1.1 (1.0-1.1) 1.9 (1.4-2.5) 1.8 (1.3-2.3) 1.8 (1.3-2.3) 
    
 
    
 
Log-Normal frailty 
   
 
    
 
Log-Normal (cluster size n=50) 
frailty variance 1.1 (1.1-1.2) 1.9 (1.3-2.5) 1.8 (1.2-2.5) 1.2 (0.9-1.6) 
    
 
Log-Normal (cluster size n=100) 
frailty variance 1.1 (1.1-1.2) 1.8 (1.3-2.5) 1.7 (1.2-2.3) 1.2 (1.0-1.6) 
    
 
NB: INLA- Piecewise log-constant baseline hazard; frailtyHL-H-Likelihood; frailtyPack-Penalized full 
likelihood; CoxPH-Penalized partial likelihood; 
 
 Figure 1a: Gamma frailty parameter estimates 
(Cluster size n=50) 
 
Figure 1b: Gamma frailty parameter estimates 
(Cluster size  n=100) 
 
Figure 1c: Log-Normal frailty parameter estimates 
(Cluster size  n=50) 
 
Figure 1d: Log-Normal frailty parameter 
estimates (Cluster size  n=100) 
Figure 1: Semiparametric gamma frailty parameter estimates from four methods 
 
 
 
 
 
Figure Click here to download Figure Figures.docx 
 Figure 2a: Gamma standard error/INLA SD 
(cluster size n=50) 
 
Figure 2b: Gamma standard error/INLA SD 
(Cluster size n=100) 
 
Figure 2c: Lognormal standard error/INLA SD 
(Cluster size n=50) 
 
Figure 2d: Lognormal standard error/INLA SD 
(Cluster size n=100) 
Figure 2: Semiparametric gamma frailty standard errors and INLA standard deviation from four 
methods 
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Factors associated with mortality in HIV-infected people
in rural and urban South Africa
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Background: Factors associated with mortality in HIV-infected people in sub-Saharan Africa are widely
reported. However ruralurban disparities and their association with all-cause mortality remain unclear.
Furthermore, commonly used classical Cox regression ignores unmeasured variables and frailty.
Objective: To incorporate frailty in assessing factors associated with mortality in HIV-infected people in rural
and urban South Africa.
Design: Using data from a prospective cohort following 6,690 HIV-infected participants from Soweto (urban)
and Mpumalanga (rural) enrolled from 2003 to 2010; covariates of mortality were assessed by the integrated
nested Laplace approximation method.
Results: We enrolled 2,221 (33%) rural and 4,469 (67%) urban participants of whom 1,555 (70%) and 3,480
(78%) were females respectively. Median age (IQR) was 36.4 (31.044.1) in rural and 32.7 (28.238.1) in
the urban participants. The mortality rate per 100 person-years was 11 (9.712.5) and 4 (3.64.5) in the rural
and urban participants, respectively. Compared to those not on HAART, rural participants had a reduced
risk of mortality if on HAART for 612 (HR: 0.20, 95% CI: 0.100.39) and 12 months (HR: 0.10, 95%
CI: 0.050.18). Relative to those not on HAART, urban participants had a lower risk if on HAART 12
months (HR: 0.35, 95% CI: 0.270.46).
The frailty variance was significant and 1 in rural participants indicating more heterogeneity. Similarly it
was significant but B1 in the urban participants indicating less heterogeneity.
Conclusion: The frailty model findings suggest an elevated risk of mortality in rural participants relative to
the urban participants potentially due to unmeasured variables that could be biological, socioeconomic,
or healthcare related. Use of robust methods that optimise data and account for unmeasured variables could
be helpful in assessing the effect of unknown risk factors thus improving patient management and care in
South Africa and elsewhere.
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S
outh Africa has the highest number of people living
with HIV and the largest antiretroviral treatment
(ART) programme globally (1). Driven by the need
to achieve the millennium development goal of increasing
the number of HIV-infected people accessing treatment
(2), over 2 million people have been started on ARTwith
another half million planned to be started each year.
Mortality in HIV-infected individuals is high (3, 4),
especially prior to ART treatment and while awaiting
ART (5). This is associatedwith highly immunosuppressed
patients with low CD4 counts and high viral loads. While
survival on ART is markedly improved, mortality rates in
the early stages of treatment remain relatively high (4, 6)
signifying the importance of immunosuppression at
the time of ART initiation. Knowledge of risk factors for
mortality is important to improve ART programmes and
to prolong life. Factors associated with mortality in HIV-
infected people in sub-Saharan Africa are widely reported
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with variations. They include CD4 and total lymphocyte
counts, HIV RNA level, WHO and CDC staging, anae-
mia, malnutrition, and gender amongst others (611).
However, prior studies do not specifically report and
compare mortality in rural and urban settings. Further-
more time-to-event methods remain the most commonly
used for the investigation of mortality risk factors parti-
cularly in HIV-infected cohorts (12). Cox proportional
hazards regression analysis, the most popular approach
assumes that the risk of mortality is homogeneous (13),
an assumption that does not often hold (14). In epidemio-
logical studies where some participants are related either
genetically or are from the same family, share some un-
measured covariates, or have multiple recurrence events,
their survival times are not independent due to within -
subject dependency (15). Analysis of such data requires use
of a method that accounts for dependence leading to
heterogeneity such as frailty modelling (1416), an exten-
sion of the Cox regression. Frailty modelling incorporates
within-subject dependency by considering that the indivi-
dual risk of events differs between subjects through
accounting for unmeasured variables (1517). Adjusting
for within-subject correlation and accounting for unmea-
sured variables are some of the advantages of frailty
modelling. Disadvantages include handling of compet-
ing risks and assuming the same risk within a cluster of
unobserved variables.
Understanding the dynamics of mortality in HIV-
infected people in sub-Saharan Africa is important as it
influences patient management and care. As such, assess-
ment of mortality surveillance patterns requires the use
of robust statistical analysis methods that will optimise
findings leading to appropriate policy decisions from
evidence-based research. While current methods are well
established, recent approaches, though more complex,
provide further insight through their ability to model
dependency. Detailed research from sub-Saharan Africa
comparing factors associated with mortality in HIV-
infected people between rural and urban areas using
recently developed advanced methods are limited. Further-
more, those employing methods that account for unmea-
sured variables in this setting are not properly described.
And, more importantly, we hypothesise that they inade-
quately capture uncertainty and are less precise. We there-
fore sought to assess and compare factors associated
with mortality in HIV-infected adults in a large cohort of
participants in a wellness programme in rural and urban
South Africa while accounting for unmeasured variables
in both sites.
Methods
Setting and study population
Data from two South African study sites were used:
Perinatal HIV Research Unit (PHRU) in Soweto and
Tintswalo hospital in Mpumalanga. In this study, parti-
cipants enrolled in PHRU were classified as urban while
those enrolled in Tintswalo were classified as rural. While
both sites provided treatment using the same guideline
from the department of health and similar resources such
as nurses with similar qualifications, Tintswalo hospital
is a primary health centre while the PHRU clinic is a
research centre.
Soweto is an urban area in the city of Johannesburg
in Gauteng, South Africa, with a population greater than
a million people (18). It is in the southwestern part of
Johannesburg where approximately 40% of the popula-
tion resides. While many households are poor with high
unemployment rates, there is a mix of poor and wealthy
residents (18).
Tintswalo hospital is situated in the Bushbuckridge
district of rural South Africa’s northeast with a population
of 541,247 people. Bushbuckridge is among the poorest
areas of South Africa with up to 75% of the population
living in poverty (19).
A nurse-based wellness programme was established in
PHRU and Tinstwalo to provide pre- and post-treatment
care for HIV-infected adults between the years 2003
and 2010. Participants in the study were referred from
voluntary counselling and testing centres, surrounding
clinics, hospital wards, or research programmes. Referrals
for ART were made for those eligible, based on the
South African ART treatment guidelines at the time
(CD4 cell count B200 cells/mm3) (20). Inclusion criteria
were diagnosis of HIV, 18 years of age or older, receiving
primary clinical care at PHRU or Tintswalo clinics and
providing written informed consent. Further study proce-
dures are presented elsewhere (21, 22).
Study questionnaires were administered at baseline
and follow-up visits that occurred every 6 months. Losses
to follow-up were minimised through actively following
up participants by way of telephone calls, letters, and
then home visits. Weight, CD4 counts, creatinine, and
haemoglobin estimations were measured at scheduled
six monthly visits while other investigations were done
according to clinical presentation. To be considered pos-
itive for tuberculosis (TB), subjects had to meet at least
one of the following criteria (21): initiation of multidrug
TB therapy, presence of acid fast bacilli on microscopy or
a biopsy suggestive of TB, mycobacterium culture positive
for acid fast bacilli or Mycobacterium tuberculosis, hospi-
talisation due to TB or cause of death ascribed to TB.
Measures
For this study, the outcome measure was all-cause
mortality, primarily through making contact with the
next of kin. Socio-demographic measures included age,
household income, number of people and rooms in a
household, ever smoked and ever employed. Others were
height and weight for calculating body mass index (BMI),
Kennedy N. Otwombe et al.
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HAART status, ever had TB and CD4 counts. BMI was
categorised into three groups using the CDC classifica-
tion: underweight (B18.5), normal (18.524.9), or over-
weight/obese (]25) while CD4 count was categorised
into 0200, 201350, 351500, and 500 cells/mm3.
Ethics
Ethical approval was provided by the Human Research
Ethics Committee of the University of the Witwatersrand.
Statistical analysis
Data were stratified by site. Continuous measures at
enrolment such as age, BMI, and CD4 count were assessed
descriptively by median and interquartile ranges and com-
pared between the two groups using the KruskalWallis
non-parametric test. Frequencies and associated pro-
portions were determined for categorical measures and
compared using the Fishers Exact and Chi–square analy-
sis as appropriate.
Mortality rates (95% confidence interval) per 100
person-years were determined using Poisson regression
modelling by site for different lengths of time pre- and
post-HAART and presented graphically. The Kaplan
Meier test was used to determine differences in surveil-
lance patterns by site.
Factors associated with mortality by site were assessed
using the integrated nested Laplace approximation
(INLA) (23, 24), where univariate and multivariate shared
gamma frailty models were fitted. INLA is a Bayesian
inference technique, computationally efficient due to its
speed relative to existing methods and more accurate
parameter estimates. For the purpose of interpretation,
posterior Bayesian estimates generated from INLA were
exponentiated to determine their approximate hazard
ratios and 95% confidence intervals (25).
INLA accounted for unmeasured variables and allowed
for the comparison of frailty variances between sites.
A significant frailty variance with a value 1 suggests
a higher rate for the event (or shorter survival times)
than would be predicted under the basic Cox model while
B1 suggests a lower rate (longer survival times). Hence,
failure to account for frailty may overestimate or under-
estimate the hazard rate.
Backward selection together with inclusion of plausible
socio-demographic and clinical factors was used to deter-
mine the final multivariate model. Socio-demographic
variables included gender, ever employed, and ever smoked.
Clinical variables included HAARTstatus, BMI, CD4 cell
count, and ever had TB. The most recent information was
used for HAART status while BMI and CD4 cell count
values were considered over time.
A 95% confidence interval excluding one was deter-
mined as significant. Model fit was assessed using the
deviance information criterion.
Multiple imputation (MI) under the missing-at-random
mechanism was used to impute 18% (n1,195) and 11%
(n704) of missing CD4 count and BMI data, respec-
tively (2628). Five imputed datasets reflecting different
scenarios were generated and analysed following the MI
procedure.
Several sensitivity analyses were performed using
INLA. This included assessing factors associated with
mortality overall, pre- and post-HAART. KaplanMeier
plots of time to death by gender, HAART use, CD4
count, WHO staging, and BMI were also fitted. For
participants that were lost to follow-up, their time in the
study up to their last visit was included in the analysis.
All statistical analyses were performed using R and
SAS Enterprise Guide 5.1 under the assumption of a two-
sided test at 5% significance level.
Results
Overall, 6,690 participants were enrolled and followed
up for a cumulative total of 2225.8 and 8185.9 person-
years in the rural (33%) and urban (67%) sites, respectively.
The median (IQR) pre- and post-HAART time in years
was 0.6 (01.9) and 1.1 (0.52.6), respectively. Overall,
75% were women: rural (70%) and urban (78%). The
median age at enrolment was 36.4 (IQR: 31.044.1) and
32.7 (IQR: 28.238.1) years for rural and urban sites,
respectively.
Rural participants were more likely to report a house-
hold income of 5R1,000 per month compared to those
in the urban areas (72.8% vs. 48.5%; pB0.0001). The
proportion not on HAART at the end of the study was
significantly higher in the urban area compared to the
rural area (63.2% vs. 30.0%; pB0.0001) while unemploy-
ment was significantly higher in the rural area (86.7% vs.
70.7%; pB0.0001) relative to the urban areas.
At enrolment, 54% of the rural and 27% of the urban
participants had either started HAART or were already
on HAART. On follow-up, 17 and 10% of rural and
urban participants, respectively, initiated HAART.
The median BMI of urban participants was higher than
that of the rural participants (24.9 vs. 21.0; pB0.0001).
Similarly, the median CD4 count at entry of rural
participants was lower than that in the urban participants
(178 cells/mm3 vs. 303 cells/mm3; pB0.0001, Table 1).
The proportion on HAART for B6 months and with a
most recent CD4 count B200 cells/mm3 was significantly
higher in the urban compared to the rural participants
(76% vs. 59%; pB0.0001). Similarly, urban participants
on HAART for 612 months and with a most recent
CD4 count B200 cells/mm3 were significantly more
than in the rural participants (69% vs. 53%; p0.0004).
The proportion unemployed andwith a CD4 count B200
cells/mm3 was significantly higher in the rural partici-
pants compared to the urban participants (40% vs. 24%;
pB0.0001). The proportion ever with TB in the rural
participants was significantly higher than in the urban
participants (44.8% vs. 25.4%; pB0.0001, Table 2).
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Table 1. Participant characteristics at enrolment by site
Rural Urban
Variable Overall (n2,221) Male (n666, 30%) Female (n1,555, 70%) Overall (n4,469) Male (n989, 22%) Female (n3,480, 78%)
Median age (IQR) in years 36.4 (31.044.1) 39.2 (33.348.1) 35.2 (30.042.5) 32.7 (28.238.1) 35.7 (31.541.5) 31.7 (27.437.0)
Age group in years
1825 (%) 216 (9.7) 30 (4.5) 186 (12.0) 672 (15.0) 65 (6.6) 607 (17.4)
2630 (%) 342 (15.4) 72 (10.8) 270 (17.4) 1,117 (25.0) 158 (16.0) 959 (27.6)
3134 (%) 420 (18.9) 111 (16.7) 309 (19.9) 984 (22.0) 222 (22.4) 762 (21.9)
3539 (%) 424 (19.1) 136 (20.4) 288 (18.5) 864 (19.3) 250 (25.3) 614 (17.6)
40 (%) 819 (36.9) 317 (47.6) 502 (32.3) 832 (18.6) 294 (29.7) 538 (15.5)
Median CD4 count (IQR) 178.0 (81.0333.6) 162.0 (69.0289.9) 184.0 (86.0350.6) 303.0 (156.0470.7) 281.0 (142.0443.7) 309.0 (163.0478.2)
CD4 categories
0200 (%) 1,235 (55.6) 398 (59.8) 837 (53.8) 1,474 (33.0) 367 (37.1) 1,107 (31.8)
201350 (%) 472 (21.3) 144 (21.6) 328 (21.1) 1,102 (24.7) 241 (24.4) 861 (24.7)
351500 (%) 284 (12.8) 75 (11.3) 209 (13.4) 915 (20.5) 190 (19.2) 725 (20.8)
500 (%) 230 (10.4) 49 (7.4) 181 (11.6) 978 (21.9) 191 (19.3) 787 (22.6)
Median BMI (IQR) 21.0 (17.925.0) 19.9 (17.223.4) 21.4 (18.425.8) 24.9 (20.729.2) 22.5 (18.226.4) 25.6 (21.430.0)
BMI
Underweight (%) 638 (29.0) 241 (36.9) 397 (25.7) 594 (13.4) 240 (24.8) 354 (10.2)
Normal (%) 987 (44.9) 299 (45.7) 688 (44.6) 1,612 (36.4) 393 (40.6) 1,219 (35.2)
Obese/overweight (%) 572 (26.0) 114 (17.4) 458 (29.7) 2,226 (50.2) 336 (34.7) 1,890 (54.6)
Median crowding index (IQR) 1.5 (1.02.3) 1.3 (0.82.0) 1.6 (1.02.5) 1.5 (1.02.3) 1.0 (1.02.0) 1.5 (1.02.5)
Median household income (IQR)
in Rands
600.0 (189.81010.0) 780.0 (50.01500.0) 500.0 (190.0974.7) 1080.0 (500.02130.0) 1200.0 (600.02400.0) 1020.0 (500.02020.0)
Household income
5R1,000 (%) 1,516 (72.8) 423 (67.4) 1,093 (75.2) 2,161 (48.5) 453 (45.9) 1,708 (49.2)
R1,001R5,000 (%) 528 (25.4) 193 (30.7) 335 (23.1) 2,092 (46.9) 487 (49.3) 1,605 (46.3)
R5,000 (%) 37 (1.8) 12 (1.9) 25 (1.7) 203 (4.6) 47 (4.8) 156 (4.5)
BMI, body mass index; HAART, highly active antiretroviral therapy; TB, tuberculosis.
Crowding index is the number of people divided by the number of rooms in a household; household income refers to household monthly income; for household income, 1USD was
equivalent to R7 at the time of the study.
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Overall, 566 (8%) of the participants died during
follow-up: 11 and 7% in rural and urban sites, respec-
tively (pB0.0001). Of these, majority were females (63%
rural vs. 69% urban; p0.1952). Overall, the mortality
rate per 100 person-years in rural sites was higher at 11
(95% CI: 9.712.5) compared to urban sites at 4 (95%
CI: 3.64.5). In the first 6 months, 48% of rural partici-
pants had died while 51% of the deaths in the urban site
occurred after 12 months. Mortality rates per 100 person-
years while on HAART were 11 (95% CI: 8.714.0) and
7 (95% CI: 5.98.3) for rural and urban participants,
respectively. When taking HAART, majority of the
deaths in the rural site occurred within the first 3 months
of treatment initiation (49%) whereas they occurred after
12 months in the urban site (44%). Further description
of those who died pre- and post-treatment in the two
sites by CD4 category and BMI is presented in Table 3.
Relative to the urban participants, mortality rates in the
rural participants was higher (Fig. 1).
In the rural participants, being on HAART for 612
months (HR: 0.20, 95% CI: 0.100.39) and 12 months
(HR: 0.10, 95% CI: 0.050.18) relative to no HAART
was protective after adjusting for CD4 count (Table 4).
However, underweight BMI compared to normal BMI
was associated with a higher risk of mortality (HR: 1.74,
95% CI: 1.062.85).
Being on HAART for B6 months (HR: 4.48, 95% C:
3.06.56) and 612 months (HR: 2.39, 95% CI: 1.60
3.47) compared to no HAART was associated with an
elevated risk of mortality in the urban participants after
adjusting for CD4 count, employment, smoking, and TB
history. However, those with overweight/obese BMI (HR:
0.73, 95% CI: 0.560.90) had a significantly lower risk of
mortality compared to those with normal BMI.
The estimated frailty variances were statistically sig-
nificant for rural and urban sites; 5.65 (95% CI: 4.50
7.19) and 5.4105 (95% CI: 1.5105  8.0104)
respectively.
Discussion
In sub-Saharan Africa where the burden of HIV is the
greatest, research on factors associated with all-cause
mortality in HIV-infected cohorts has widely been done.
However, research on risk factors using advancedBayesian
methods such as INLA that incorporate unmeasured
variables is limited (23, 24). Common protective factors
against mortality included HAART use for 12 months
and CD4 count above 200 cells/mm3 while underweight
BMI was positively associated with mortality. Even with
differences between the rural and urban participants, the
hazard rates were often in the same direction.
While both frailty variances were significant, our
findings show that the frailty variance for participants
in the rural site was higher than that of the urban. This
suggests important unmeasured variables relevant to par-
ticipants in the rural site may not have been considered
(as the variance was 1) signifying more heterogeneity
(variability). In contrast, the variance for participants in
the urban site was B1 signifying less heterogeneity and
probably that the model accounted for most of the
important variables. Available literature on covariates of
mortality relies on classical statistical methods that do
Table 2. Distribution of HAART status, employment, smoking, and TB by site
Rural Urban
Variable
Overall
(n2,221)
Male
(n666, 30%)
Female
(n1,555, 70%)
Overall
(n4,469)
Male
(n989, 22%)
Female
(n3,480, 78%)
Time on HAART
No HAART (%) 666 (30.0) 174 (26.1) 492 (31.6) 2,826 (63.2) 555 (56.1) 2,271 (65.3)
B6 months (%) 468 (21.0) 153 (23.0) 315 (20.3) 356 (8.0) 108 (10.9) 248 (7.1)
612 months (%) 434 (20.0) 133 (20.0) 301 (19.4) 178 (4.0) 35 (3.5) 143 (4.1)
12 months (%) 653 (29.0) 206 (30.9) 447 (28.7) 1,109 (24.8) 291 (29.5) 818 (23.5)
Ever employed
Yes (%) 296 (13.3) 143 (21.5) 153 (9.8) 1,309 (29.3) 400 (40.4) 909 (26.1)
No (%) 1,925 (86.7) 523 (78.5) 1,402 (90.2) 3,160 (70.7) 589 (59.6) 2,571 (73.9)
Ever smoked
Yes (%) 358 (16.1) 295 (44.3) 63 (4.1) 1,284 (28.7) 706 (71.4) 578 (16.6)
No (%) 1,863 (83.9) 371 (55.7) 1,492 (95.9) 3,185 (71.3) 283 (28.6) 2,902 (83.4)
Ever had TB
Yes (%) 995 (44.8) 350 (52.6) 645 (41.5) 1,134 (25.4) 313 (31.6) 821 (23.6)
No (%) 1,226 (55.2) 316 (47.4) 910 (58.5) 3,335 (74.6) 676 (68.4) 2,659 (76.4)
The most recent value is provided for time on HAART.
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not account for unmeasured variables (12). Potential
unmeasured variables include 1) biological factors such
as undiagnosed TB and/or other opportunistic infec-
tions such as cryptococcosis, 2) socio-economic factors
that were not included in the data collection process,
3) healthcare-related factors, 4) adherence to HAART
medication, and 5) cultural and religious beliefs. A study
from Portugal assessed predictors of mortality in HIV-
associated hospitalisations, and through frailty modelling,
it was shown how unmeasured variables in the form of
quality in healthcare in different hospitals affected mor-
tality (17). Hence, an assessment that allows for the use of
a mixed methods approach may provide an opportunity
for further insight of the unmeasured variables that may
qualify as risk factors.
Underweight BMI was associated with mortality in
both rural and urban areas with a slightly higher hazard
in the urban group. Our findings concur with others
from previous studies (5, 21, 29). While overweight or
obese BMI was not associated with mortality in rural
participants, it was associated with decreased mortality in
the urban participants. Previous studies have shown that
overweight or obese BMI reduces the risk of mortality
(21). The proportion of participants with underweight
BMIwas higher in the rural groupwhile that of overweight
or obese participants was higher in the urban group
Table 3. Characteristics of those who died
Rural Urban
Variable Overall Male Female Overall Male Female
Total deaths 242 88 154 324 101 223
Mortality rate per 100 person-years (95% CI) 11 (9.712.5) 14 (11.417.3) 10 (8.511.7) 4 (3.64.5) 6 (4.97.3) 3 (2.63.4)
Time to death in months
03 (%) 76 (31.5) 30 (34.1) 46 (30.1) 38 (12.1) 17 (17.7) 21 (9.6)
36 (%) 40 (16.6) 16 (18.2) 24 (15.7) 47 (15.0) 16 (16.7) 31 (14.2)
69 (%) 32 (13.3) 10 (11.4) 22 (14.4) 36 (11.5) 9 (9.4) 27 (12.4)
912 (%) 26 (10.8) 10 (11.4) 16 (10.5) 27 (8.6) 5 (5.2) 22 (10.1)
12 (%) 67 (27.8) 22 (25) 45 (29.4) 166 (52.9) 49 (51) 117 (53.7)
CD4 categories
0200 (%) 167 (69.0) 59 (67.0) 108 (70.1) 195 (60.2) 66 (65.3) 129 (57.8)
201350 (%) 35 (14.5) 11 (12.5) 24 (15.6) 69 (21.3) 18 (17.8) 51 (22.9)
351500 (%) 24 (9.9) 11 (12.5) 13 (8.4) 36 (11.1) 11 (10.9) 25 (11.2)
500 (%) 16 (6.6) 7 (8.0) 9 (5.8) 24 (7.4) 6 (5.9) 18 (8.1)
BMI
Underweight (%) 109 (45.2) 41 (46.6) 68 (44.7) 75 (23.6) 34 (35.1) 41 (18.6)
Normal (%) 95 (39.6) 37 (42.0) 58 (38.2) 126 (39.6) 40 (41.2) 86 (38.9)
Overweight/obese (%) 36 (15.0) 10 (11.4) 26 (17.1) 117 (36.8) 23 (23.7) 94 (42.5)
Deaths on HAART 68 31 37 133 52 81
Mortality rate per 100 person-years (95% CI) 11 (8.714.0) 15 (10.521.3) 9 (6.512.4) 7 (5.98.3) 9 (6.911.8) 6 (4.87.5)
Time to death in months
03 (%) 33 (48.5) 15 (48.4) 18 (48.6) 21 (16.4) 10 (20.4) 11 (13.9)
36 (%) 12 (7.6) 5 (16.1) 7 (18.9) 17 (13.3) 8 (16.3) 9 (11.4)
69 (%) 9 (13.2) 3 (9.7) 6 (16.2) 18 (14.1) 6 (12.2) 12 (15.2)
912 (%) 4 (5.9) 2 (6.5) 2 (5.4) 13 (10.2) 2 (4.1) 11 (13.9)
12 (%) 10 (14.7) 6 (19.4) 4 (10.8) 59 (46.1) 23 (46.9) 36 (45.6)
CD4 categories
0200 (%) 43 (63.2) 19 (16.3) 24 (64.9) 86 (64.7) 39 (75.0) 47 (58.0)
201350 (%) 11 (6.2) 3 (9.7) 8 (21.6) 23 (17.3) 6 (11.5) 17 (21.0)
351500 (%) 9 (13.2) 6 (19.4) 3 (8.1) 13 (9.8) 3 (5.8) 10 (12.3)
500 (%) 5 (7.4) 3 (9.7) 2 (5.4) 11 (8.3) 4 (7.7) 7 (8.6)
BMI
Underweight (%) 25 (37.3) 13 (41.9) 12 (33.3) 30 (22.9) 19 (38.0) 11 (13.6)
Normal (%) 24 (35.8) 9 (29.0) 15 (41.7) 48 (36.6) 21 (42.0) 27 (33.3)
Overweight/Obese (%) 18 (26.9) 9 (29.0) 9 (25.0) 53 (40.5) 10 (20.0) 43 (53.1)
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suggesting differences in nutrition between the two groups.
It may also be that the use of HAART mediated in the
lack of association between mortality and overweight or
obese BMI in the rural participants.
Higher, most recent CD4 count was protective in both
groups as similarly reported in previous studies (30, 31).
However at enrolment, rural participants had a lower
median CD4 count that qualified them to initiate therapy
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Fig. 1. Survival and mortality rate plots by site. a) displays the cumulative probability of death by site in the cohort of HIV-
infected people in South Africa. b) is a plot of mortality rates during follow-up by site showing the period prior to initiating
HAART to post-HAART.
Table 4. Factors associated with mortality in rural and urban South Africa
Rural Urban
Univariate Multivariate Univariate Multivariate
Variable HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Gender
Female vs. male 0.69 (0.451.1) 0.78 (0.481.27) 0.53 (0.420.67) 1.09 (0.801.44)
Time on HAART
B6 months vs. No HAART 1.12 (0.562.22) 1.16 (0.622.16) 17.25 (11.7424.78) 4.48 (3.06.56)
612 months vs. No HAART 0.17 (0.080.37) 0.20 (0.100.39) 7.20 (4.8910.35) 2.39 (1.603.47)
12 months vs. No HAART 0.10 (0.050.20) 0.10 (0.050.18) 1.03 (0.801.32) 0.35 (0.270.46)
BMI
Underweight vs. normal 2.20 (1.403.24) 1.74 (1.062.85) 4.29 (3.265.62) 2.49 (1.873.11)
Overweight/obese vs. normal 0.55 (0.300.98) 0.61 (0.311.16) 0.55 (0.420.71) 0.73 (0.560.90)
CD4 Count (cells/mm3)
201350 vs. 0200 0.26 (0.110.56) 0.25 (0.130.47) 0.19 (0.140.24) 0.22 (0.160.29)
351500 vs. 0200 0.49 (0.201.08) 0.44 (0.210.89) 0.09 (0.060.13) 0.11 (0.070.17)
500 vs. 0200 0.25 (0.080.66) 0.22 (0.090.53) 0.04 (0.020.08) 0.05 (0.030.09)
Ever employed
No vs. Yes 0.95 (0.531.83) 1.13 (0.582.24) 2.03 (1.552.70) 1.87 (1.422.48)
Ever smoked
Yes vs. No 0.99 (0.561.56) 2.07 (1.662.59) 1.37 (1.041.79)
Ever had TB
Yes vs. No 1.66 (1.102.47) 1.55 (0.982.46) 2.84 (2.293.54) 2.76 (2.193.48)
Bold entries represent significant values.
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as per the treatment guidelines at the time. As in many
treatment programmes across sub-Saharan Africa, first
time testers often present for care with low CD4 count.
Previous studies have underscored the relationship be-
tween treatment initiation, low CD4 count, and early
mortality (3235).
Those on treatment for 6 months had a lower risk
of mortality in the rural participants compared to 12
months in the urban participants. Among those on
treatment for 612 months in the urban participants,
a greater proportion had a most recent CD4 count B200
cells/mm3. Findings from prior research show an elevated
risk of early mortality especially in immunocompromised
patients in the early period of treatment (4, 9, 34, 36, 37).
The high mortality rate in urban participants may be due
to late initiation of treatment leading to advanced
HIV disease. Furthermore, the association between late
initiation of treatment and low CD4 count is well esta-
blished. It may also be that mortality was accelerated
in this group by opportunistic infections that were not
identified in time including undiagnosed and untreated
TB. TB remains the most common opportunistic infec-
tion diagnosed in HIV-infected people.
Unemployed urban participants had a higher risk of
mortality, a finding that concurs with previous research
(3841). HIV care was provided at no cost in both sites
irrespective of their employment status. It maybe that
mortality is affected by differential access to care in
urban participants. Other studies have shown that mor-
tality could be affected by poor social situations such
as unemployment, poor housing, and social isolation.
Furthermore, these factors may influence one’s health
negatively (38, 39).
There was an association between ever suffering from
TB and mortality in participants from the urban site.
Contrary to our findings, a previous study fromDurban in
South Africa found no association (36). TB is a common
opportunistic infection in HIV-infected individuals and
its association with mortality is indisputable (21, 37, 42).
Since urban participants were significantly more likely
to have CD4 counts B200 cells/mm3 up to 12 months on
HAART, it may be that they are immune-compromised
and more susceptible to opportunistic infections, such as
TB, and early mortality.
Some variables such as employment were self-reported
and may have been influenced by social desirability bias.
Using cumulative variables such as ‘ever smoking’ or
‘ever employed’ may lead to misclassification given the
fact that it is the cumulative, rather than the instanta-
neous. While all attempts were made to collect and report
all measures, there were some missing values that were
estimated by MIs which may have introduced some bias.
Some deaths may have been misclassified since some
participants were lost to follow-up and reasons for loss
to follow-up were not systematically recorded. However,
an advantage of our study was the large sample size and
the use of a Bayesian frailty survival model that accounts
for unmeasured factors.
Conclusion
Our findings suggest that using robust advanced statis-
tical analysis methods may provide further insight to risk
factors for mortality. Furthermore, and where appropri-
ate, a mixture of methods involving both quantitative and
qualitative approaches could be employed allowing for
further understanding of the unmeasured variables. Such
an approach is likely to inform HIV care managers and
policy makers of important factors for which interven-
tions could be developed or existing ones enhanced to
improve patient management and care. Any such inter-
ventions should alleviate ruralurban healthcare dispa-
rities not only in South Africa but also in other countries
with similar experiences. Interventions should specifically
help in alleviating the challenges faced by rural commu-
nities in accessing care.
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Abstract 
Background: The burden of HIV remains high in South Africa where up to 7 million 
people are living with HIV. Of these, just over half are on treatment yet the benefits 
of treatment in relation to HIV associated mortality are well known. Although HIV 
associated mortality has lowered, the number still dying is significant. Hence this 
qualitative study explores perceived risk factors associated with HIV mortality in 
which persons that are living, talk about their demised friends or relatives. 
Method: Twenty participants undertook in-depth interviews between May and 
August 2014 at a clinic in the Perinatal HIV Research Unit. 
Results: The 20 enrolled participants ages ranged from 18 to 63 years; 17 were 
females. Participants reported knowing the deceased persons for between 5 and 40 
years. Perceived risk factors for mortality included risky sexual behaviour, negative 
attitude by healthcare workers, religious prayers and traditional medicine, food 
security and social support structure. 
Conclusion: Our findings showed the importance of providing social support to HIV-
infected individuals. Social support such as helping in domestic chores, food security 
and support to move around was perceived importantly as a factor that may have 
reduced the burden of disease and potentially alleviate the risk of mortality. More 
research is required to show the association of social support and mortality in HIV 
infected people. 
Keywords: HIV; Perceived risk factors; Mortality; 
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Introduction 
HIV remains the greatest burden of disease in South Africa where 
approximately 7 million people live with HIV (PLWH) and more than half are currently 
on treatment.(1) Access to treatment with good adherence counselling services has 
been critical in reducing HIV associated mortality. While the number of PLWH 
increased between 2005 and 2010, mortality decreased by more than half within the 
same period.(1) The decrease in mortality is associated with provision of free 
antiretroviral therapy (ART) in public health care facilities amongst other reasons. 
Risk factors associated with mortality in HIV infected individuals have been 
widely researched and include socio-economic as well as clinical factors. Under 
socio-economic factors, gender, employment and age have been reported; clinical 
factors have included low CD4 count, high viral load, tuberculosis and other 
opportunistic infections have previously been associated with HIV mortality.(2-7) 
Additionally, substance use and non-adherence to treatment have also been 
reported. Treatment guidelines have been updated to recommend immediate 
initiation of HIV treatment following a positive test but it is not unusual to find several 
HIV infected individuals initiating therapy with poor immunological and virological 
outcomes.(5, 6) 
Understanding of perceived risk factors associated with HIV mortality amongst 
friends and relatives of demised HIV infected people has not been well explored. 
Often, research on HIV related perceptions is conducted on a sample of people to 
understand their perception of various aspects associated with HIV such as stigma, 
social norms, HIV testing and health care workers amongst others.(8-10) Research 
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is limited on key informant interviews of relatives and friends of HIV infected people 
that demised seeking their perceptions on potential risk factors for mortality.  
There is a paucity of qualitative research focussing on perceptions of risk 
factors for HIV mortality in which persons that are living, talk about their demised 
friends or relatives. Our research is unique because the reported perceptions focus 
on areas that may have elevated the risk of death in the demised HIV infected 
individuals. Additionally, perception was assessed in relation to level of illness, home 
based care, financial support, food security, treatment and treatment adherence and 
health care workers.  
Qualitative Methods 
Study Setting and Population 
The present study was conducted at the Perinatal HIV Research Unit (PHRU), 
a division of the University of the Witwatersrand and based at the Chris Hani 
Baragwanath Hospital in Soweto.  Soweto is an urban area in the city of 
Johannesburg in Gauteng, South Africa with a population above one million 
people.(11) Soweto is in the South western part of Johannesburg and approximately 
40% of Johannesburg’s population reside there.(12) While many households are 
poor with high unemployment rates, there is a mix of poor and wealthy residents.(12) 
The overall HIV prevalence of the province where Soweto is located is 12.4% and 
females are disproportionately affected.(13) While mortality in HIV infected people 
has declined as a result of free antiretroviral treatment, deaths due to late initiation of 
treatment and tuberculosis still remain a concern.(2, 3, 14)  
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Sampling 
Participants were recruited through the PHRU ZAZI voluntary counselling and 
testing (VCT) centre.  ZAZI is a successful HIV testing service that is offered for free 
to clients in Soweto and surrounding areas. In the present study, participants were 
purposively recruited from the ZAZI VCT. Of the 26 participants invited to participate, 
20 were enrolled.  During the VCT counselling process, clients were routinely asked 
about the loss of a person in their life and probed further to determine if it was due to 
HIV. Those responding to the affirmative were probed further by counsellors to 
determine who it was, when it happened and how they dealt with the loss. They were 
also asked if the deceased person was HIV infected and if they were, are invited to 
participate in this study. Those willing to participate provided their telephone contact 
and thereafter interviews were scheduled within a period of seven days. A day prior 
to the scheduled interview date, a telephone call was made to confirm the 
appointment. At the start of the interview, we asked how close participants were to 
the deceased persons and how often they saw each other. Most of them were 
related with relations such as aunt, uncle, brother, sister or cousins. We also asked 
whether the deceased persons were in a relationship such as marriage prior to 
death. 
Eligibility 
To be eligible, participants had to be 18 years or older, have known a close 
person who had died due to HIV and were willing to participate in a face-to face in-
depth interview.  
Ethical considerations  
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Study procedures were approved by the Human Research and Ethics 
Committee of the University of the Witwatersrand. We obtained written informed 
consent to participate in the study from all eligible participants. Consenting occurred 
at two levels: for participation in the study and audio-recording. The consent forms 
and interview guides were written in English but the consenting process and the in-
depth interviews were carried out in either English or Zulu as appropriate. 
Participants were re-imbursed approximately $15 (~ 150 ZAR) for their transport 
costs. Participants were informed that counselling will be provided by counsellors 
based at the ZAZI VCT should they be distressed during the interview. 
In-depth interviews 
Data were collected between May and August 2014 using in-depth interviews 
to understand the characteristics of the participant and their deceased loved one. A 
demographic questionnaire assessed age, gender, primary home language and 
educational level and was administered prior to the in-depth interview.  
Interviews were conducted in English and/or isiZulu by a trained interviewer 
who had experience in conducting qualitative interviews. The in-depth interviews 
explored participants perceptions about: the deceased persons’ relationships with 
significant others or in general, health seeking behaviours, attitude of healthcare 
workers towards HIV-infected patients seeking care, initiation and adherence to 
antiretroviral therapy (ART), home-based care support, nutrition and/or food security 
and financial stability. Interviews occurred in private rooms at the ZAZI VCT centre 
and lasted between 45 and 60 minutes.  
All interviews were audio-recorded and transcribed verbatim one day after the 
interview. Transcriptions were performed by an external team with experience in 
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transcribing audio recordings that was approved by the study team. Where audio-
recordings had a mixture of the local language and English, translations into English 
occurred during the transcription process. Every second transcript was selected by 
the interviewer for comparison with the audio recording to check for consistency. 
Where discrepancies were identified, audio-recordings were transcribed again. A 
total of 10 transcripts were selected for comparison with the audio-recordings for 
quality checks (that were done by a bilingual research assistant). 
All the study procedures were recorded in a study work book that was used to 
monitor study progress. It contained information such as how many people had been 
interviewed, how many more were likely to be interviewed, scheduled interview 
appointments and administrative information such as participant re-imbursements for 
transport. 
Data analyses 
Data were analysed through a framework analysis approach where similar and 
interrelated codes were grouped together to form sub-themes and themes in a data 
matrix.(15, 16) Core codes were independently developed by two research 
assistants and agreed upon in collaboration with an experienced qualitative 
researcher. The first four transcripts were reviewed by two research assistants line 
by line and the findings used to develop a code book. A meeting was organised 
between the research assistants and a qualitative analysis expert to verify the 
consistency of the codes. Divergent codes were discussed and a resolution reached 
on the most appropriate coding term. Subsequent transcripts were assessed based 
on the code-book. Updated codes were only included if subsequent codes could not 
fit within the initial ones.  
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The data matrix was instrumental in assessing the coding progress allowing for the 
development of sub-themes and themes.(15, 16) The process of developing sub-
themes and themes was regularly refined during the analytic process as new codes 
emerged. Any discrepancies in coding were resolved through consensus. 
Development of codes, sub-themes and themes followed a combined approach of 
deductive and inductive data reduction procedures.  
Trustworthiness of the data 
Trustworthiness of the data was assessed using various methodologies.(17-
20) An audit trail was kept to monitor the study progress such as evaluating the first 
two interviews and amending the interview guides as appropriate. Codes were 
independently prepared by the research assistants and harmonised in a meeting 
together with an experienced qualitative researcher. Thereafter, a codebook was 
developed for all subsequent interviews. Code development stopped when no further 
changes occurred. Audio-recordings were compared with the transcripts to verify 
consistency, ensure translations matched the recordings and make any appropriate 
amendments. Clarity during the interview process was achieved through probing of 
responses by the research assistant. Final results were shared with the study team 
for verification of the themes and interpretation. Differences in the coding, themes 
and interpretations were resolved as a team. 
Results 
Demographics 
Of the 20 participants that were enrolled, their minimum and maximum ages were 18 
and 63 years respectively and 17 were females. Their highest school grade was 
between 2nd and 12th Grades and 9 reported Isizulu as their main language. They 
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reported living in households with between 1 and 9 people and the total rooms in the 
house ranging from 1 to 17. There were 10 and 7 participants from female headed 
households where the head of household was aged 18-60 and > 60 years 
respectively. Participants reported knowing the deceased persons for between 5 and 
40 years. Eight participants were employed, 8 were unemployed and 4 were 
students in tertiary institutions. Deceased persons were either an aunt (n=5), cousin 
(n=7), son (n=2) or other relation (n=6).  
Participants reported that the deceased persons were aged between 18 and 54 
years, 8 reported IsiZulu as their main language and their highest school grade was 
between 2 and 12. Of the 20 deceased persons, 15 were females. Among the 
deceased persons, 12 were employed, 6 were unemployed and 2 were students in 
tertiary institutions. 
Emerging themes on perceptions of mortality risk factors 
Following the interviews, several themes emerged that were perceived as 
having an association with mortality among the deceased persons. Participants 
perceived that engagement in risky sexual behaviour such as multiple sexual 
partnerships may have a role in worsening the situation for a HIV-infected person. A 
a negative attitude by healthcare workers towards HIV-infected people was 
perceived to be associated with avoidance in seeking care. Believing in the healing 
power of religion while ignoring antiretroviral treatment and traditional medicine were 
perceived to have worsened the conditions of the deceased persons. Food security 
such as availability of regular meals as well as a good social support structure such 
as receiving help in domestic chores was perceived as important in keeping the HIV-
infected persons healthy. 
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Perceived engagement in risky sexual behaviour 
Participants reported about the deceased’s risky behaviour such as multiple 
partnerships, unprotected sex without condoms and alcohol use. Some of the 
deceased were perceived to be involved in multiple relationships whilst being 
married.  For instance, a participant stated the following of her father:  
 
“I stayed with him for that 6 years and he was alright but you could see that 
even when he was here in Joburg, he still had a gift of liking women…he used 
to take me with him when he went to see his women (girlfriends). He was 
aware that he is with me. He had 4 (wives).” (Female Participant 1 in relation 
to her deceased father) 
 
Another provided the following summary of her friend’s husband: 
 “She told me about (her husband) from what he does and so on. She said 
(her husband) would come back home in the morning and he knew very well 
that we (husband and deceased) are sick but he still did the things he did. 
That was reason why I moved out of the house cause he made me sick. He 
should have done the right thing. I joked about it and told her that she 
shouldn’t have had just one boyfriend in life till they got married. She 
(deceased) said that is one thing that hurt her and made her sad. On the other 
hand, her partner (husband of the deceased) went on and slept with multiple 
partners” (Female participant 6 in relation to her deceased friend’s husband) 
 
Participants commonly reported that once the deceased persons had improved while 
on treatment, they defaulted on their treatment. Thereafter they went back to their 
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previous habit of drinking alcohol and engaging in multiple partnerships. A participant 
stated the following of her aunt: 
 
“Yes she (deceased person) recovered then she stopped taking the treatment 
and went back to drinking again, continued with her boyfriends and that’s 
where she fell ill and got worse.” (Female participant 12 in relation to her 
deceased aunt) 
 
Participants reported that engagement in unprotected sex occurred and it was 
unclear if disclosure of their HIV status happened. A female participant quoted the 
following of her aunt: 
 
“Now she (deceased person) is in a relationship with a pastor who has a wife 
and they don’t use a condom and who knows if (my aunt) told him that she is 
sick” (Female participant 6 in relation to her deceased aunt) 
 
It was perceived that the deceased persons engaged in multiple partnerships and 
unprotected sex while knowing their HIV status. Furthermore, it was unclear if they 
disclosed their HIV status to their partners. 
 
Negative attitude by healthcare workers 
A negative attitude by the healthcare workers was perceived to be a barrier in 
seeking care in public health facilities. The quote below summarises an advise given 
by a clinician to the deceased aunt of a participant: 
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“He (the doctor) told her to terminate (her pregnancy) but she didnt want to 
and she never went back to the doctor and that is why she never went to the 
clinic to get medication to protect the baby from getting infected.” (Female 
participant 6 in relation to her aunt) 
 
Another participant reported on the perceived negative attitude shown to her 
deceased relative by the nurses in the local clinic. The perceived negative attitude to 
a sister-in-law is summarised below:  
 
“She (deceased person) said that nurses were not treating her well. I asked 
her why she didn’t tell us because we could ask our aunt to take her to the 
(local) clinic and you (the deceased) would take the treatment there. She said 
that she was afraid. I asked her, how long would she be afraid when she had 
kids who were already complaining that their mother is always sleeping and 
they didn’t understand what was going on.” (Female participant 16 in relation 
to her sister-inlaw) 
 
Sometimes when participants reported on the perceived negative attitude by 
clinicians, they failed to be specific. A female participant provided the following 
summary of her deceased aunt’s experience: 
  
“The only thing she (deceased person) told me was that the doctors are rude. 
That is the only thing I knew. People usually used to say that. But she 
(deceased person) would never explain to you why she’s saying they are 
rude. I would ask why you (deceased person) say they are rude and she 
13 
 
would say they are rude. And the nurses when you call them, they take their 
time (to respond)” (Female participant 9 in relation to her deceased aunt” 
It was perceived that the negative attitude by healthcare workers discouraged the 
deceased persons from seeking care in the public health care facilities and that may 
have led to deteriorating health. 
 
 
 
Preference for religion and traditional medicine 
The use of religious prayers as well as traditional medicine for purposes of healing 
was espoused during the interviews. Others perceived withcraft as the cause of their 
HIV infection. They believed someone bewitched them into their status. 
The perceived use of religious prayers as a measure of healing by an aunt is 
summarised in the following quote by a female participant: 
 
“She (deceased) believed in the church. She never went to sangomas 
(traditional healer). She went (to the church) because she loved it. She 
believed in it. She knew even if she was HIV (infected), God is there. She 
believed that miracles do happen” (Female Participant 6 in relation to her 
deceased aunt) 
 
Others attended churches where the clergy provided holy water or tea. Holy water 
refers to water that has been blessed by the clergy and apparently contains healing 
powers. Similarly holy tea is blessed tea. This is summarised in the following quotes 
by relatives of deceased persons:  
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 “She (deceased person) believed in church. They asked the pastor and the 
congregation to come to our house. Then they prayed for her (deceased 
person). And they prayed for the (holy) water and told her how she must drink 
it and she must wash with it.” (Female Participant 10 in relation to her 
deceased cousin) 
 
 “He had a belief that since he is a member of (name of church) that he will 
get healed (by drinking tea).  It was tea that they got from the church. How 
can you get healed by drinking tea? I even asked him (deceased person). Has 
he ever seen anyone get healed by drinking tea” (Male Participant 11 in 
relation to his deceased brother) 
 
The use of traditional medicine in managing HIV emerged during the interview. It 
was perceived that traditional medicine, provided by sangomas (traditional healers), 
was favoured by either the deceased person or their families. This is encapsulated 
by relatives of deceased persons in the following quotes: 
 
“You know they even tried to consult a Sangoma to help her to get better. 
You know the traditional healers said we need to slaughter a chicken and 
make a ceremony for her. Oh and the Sangoma said she must drink the 
chicken’s blood.” (Female Participant 9 in relation to her deceased aunt) 
 
“They (family) did take him to a traditional healer and he was given traditional 
tonic and medication and things like that. I am not sure, but they took him to a 
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traditional healer because of the chest pains suspecting that he was 
bewitched in his beer. You know how people are? So they suspected 
witchcraft because he was complaining of pain at the side of his chest.” 
(Female Participant 20 in relation to her deceased aunt) 
 
Other participants reported that some family members perceived withcraft as the 
cause of the illnesses suffered by the deceased. One participant summarised the 
following of her aunt: 
“No I don’t think she (deceased person) told them because they did not visit 
her while she was sick. My aunt suspected witchcraft and because I knew the 
situation, I told her not to point fingers because I was here when mother was 
very sick. I saw her. Some people are like that. They blame witches for 
everything. When things go wrong, when their children fail at school, they say 
it is witchcraft.” (Female Participant 8 in relation to her deceased mother) 
 
The significance attached to religious prayers, traditional medicine and witchcraft 
emerged during the interview. These were perceived as avenues that offered 
alternative forms of care for HIV infected individuals.   
Food security 
During the interviews, it emerged that food security was perceived as a matter of 
concern for HIV infected individuals that had to stop working due to HIV associated 
opportunistic infections. A female participant summarised her mother’s experience 
as follows: 
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 “When she started coughing seriously, she had to quit (working). It was her 
decision. Her body became weak and she was not coping. She was very sick 
and feeling pain she could not go to work.” (Female Participant 8 in relation to 
her deceased mother) 
 
Unfortunately not working led to loss of income followed by reduced availability of 
food especially for those who were self-employed and running their own businesses. 
A participant stated the following of her deceased aunt:  
 
“She used to sell food in a shop (in Soweto). So when she got sick, she 
couldn’t go sell. So there was no one running her business. She was used to 
doing things on her own. That actually stressed her because on the other 
hand she didnt have money. So my uncle that lives in Pimville (township in 
Soweto) and other aunt that lives with us helped her. They told her if she 
needs anything, they will help. They told her not to worry but to focus on her 
health. That is when she relaxed a bit.” (Female Participant 7 in relation to her 
deceased aunt) 
 
Participants reported that some of the deceased persons were unemployed and 
relied on others such as parents, friends or partners for food. A female participant 
summarises the experience of her deceased cousin as follows: 
 
“Her mother would bring her food but then she said there were times when 
she had nothing to eat. So she would have to go eat with her friends or her 
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boyfriends, something like that.” (Female Participant 2 in relation to her 
deceased cousin) 
 
Not only did the deceased persons stop working and impacting on household food 
security but also those who cared for them. As one participant noted, of the mother 
of one of the deceased persons: 
“Yes, then she (mother of deceased) stopped (working) when her daughter 
got sick.Yes, she (mother of deceased) stopped working so that she can take 
care of…(her daughter) and her child (grandchild)” (Female Participant 5 in 
relation to her deceased cousin) 
 
The perceived importance of food security and its association with income emerged 
during the interview. Those who stopped working due to illness lost their income. 
Participants said that the support provided by the family and friends enabled the 
deceased persons an opportunity to live without worrying about food. 
Social support structure 
The perceived importance of the social support structure such as the family, relatives 
and friends emerged during the interviews. Discussions revealed that deceased 
persons were able to receive home-based care in the form of support in attending to 
domestic chores or attending clinics. While other deceased persons received family 
support, others did not. A female participant noted the following of her aunt who 
never got support from the boyfriend: 
“The only thing that I heard was about her (aunty’s) boyfriend. She (aunty) 
complained that since she started being sick, he (boyfriend) didn’t come and 
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see her. He wasn’t there for her”. (Female Participant 7 in relation to her 
deceased aunt) 
 
 There were those who became weak, frail and bedridden and required support with 
domestic cores such as washing their dirty linen. As one female participant noted of 
her aunt, the frail required help. 
 
“They did everything for her. Her father would wake up early in the morning to 
make porridge for her and her mother would give her a bath. She would 
change her linen for her. She was very clean. Every Sunday, they would get 
someone to drive her to church because she liked church. They would drive 
her everywhere she would want to go “ (Female Participant 6 in relation to her 
deceased aunt) 
 
Participants reported that support to move around and take treatment on time was 
possible due to the availability of a social support structure.  
 “She made food for her. Made sure that she takes her pills on time. If she 
needed her to help her stand, she would do that for her. The pills that she was 
taking was grandpas (analgesics) that she bought herself at the spaza shop 
(informal store). She would boil water for her and also rub her feet if they 
needed to get rubbed until she went to the hospital” (Female Participant 7 in 
relation to her deceased aunt) 
The perceived importance of a social support structure to provide support to frail 
HIV-infected persons was emphasised during the interviews. The social support 
structure enabled the deceased HIV-infected persons lead a comfortable life. 
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Additionally taking treatment timely was assured due to the presence of a person to 
ensure that medication is taken. 
Discussion 
Our study was conducted to determine the perceived factors associated with 
mortality in deceased HIV-infected people with a close relationship to the participants 
enrolled in the study. Emerging themes included risky sexual behaviour, negative 
attitude by healthcare workers, religious prayers and traditional medicine, food 
security and social support structure. 
It was perceived that the risk of mortality in the deceased persons may have been 
elevated by engagement in risky sexual behaviour such as multiple sexual 
partnerships and unprotected sex. The role of multiple sexual partnerships as well as 
unprotected sex in relation to HIV and new HIV cases has widely been 
researched.(21-26) Additionally, evidence is now available to show that HIV infection 
is likely to occur in stable relationships.(22, 25) Unfortunately partners only become 
aware of their HIV status when their health condition deteriorates. Often this leads to 
late diagnosis and initiation of therapy when the immune system is severely 
immunosuppressed leading to early mortality.(5, 6) While antiretroviral therapy is 
provided for free in public health facilities, mortality rates associated with HIV still 
remain high. 
Negative attitude by healthcare workers was perceived to have discouraged the 
deceased persons from seeking care in the public healthcare facilities. This finding is 
consistent with existing literature about discrimination of HIV-infected people by 
healthcare workers.(8, 27-29) While there has been more awareness about 
management of HIV among healthcare workers,(9) some still display a negative 
attitude towards HIV-infected individuals. Unfortunately discriminatory practice 
against HIV-infected individuals dissuades them from seeking care in public 
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healthcare facilities. This in turn worsens their health condition and may lead to 
death as a result of improper care and management. Additionally, discrimination of 
HIV-infected individuals leads to poor quality of life due to low levels of treatment 
adherence and low utilisation of healthcare services.(8, 9, 30)  
In our findings, participants perceived that some deceased person had more faith in 
healing through religious prayers. They believed that going to church, asking for 
forgiveness and praying might lead to a miracle that would reverse their HIV 
condition. Indeed, this was reinforced by religious leaders willing to offer prayers and 
support towards healing. Furthermore, some clergy even presented a form of 
blessed water suggesting that consuming it would lead to healing from HIV. The use 
of religion as a coping mechanism for HIV has previously been documented.(31, 32) 
While religion frames the way of life for many people including HIV-infected 
individuals, the choice of ignoring care and initiation of therapy for those eligible to 
start treatment for the sake of religious prayers may be detrimental to their health. It 
may worsen the health of immunosuppressed individuals leading to negative 
consequences such as death.(5, 6) It may be that healthcare providers need to 
consider an integrated approach that provides care to HIV-infected individuals while 
at the same time accommodating their religious way of life such as allowing them to 
continue seeking healing through prayers. The interplay between religion and the 
belief that it leads to healing of HIV requires further research. 
We found preference for traditional medicine over antiretroviral therapy by some of 
the deceased persons. The perceived benefits associated with the use of traditional 
medicine in treating HIV remains unclear. However it may be that its use is 
associated with the need to identify with one’s indigenous identity, family 
expectations, privacy and confidentiality.(33, 34)  Furthermore use of traditional 
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medicine in combination with antiretroviral therapy may lead to drug interactions(35) 
and poor health outcomes such as death. Healthcare providers should consider use 
of both traditional and contemporary medicine under their supervision in order to 
mitigate any adverse events and manage them accordingly.(33) This should be 
feasible within systems where regulations governing use of traditional medicine are 
in place such as in South Africa.  
The combined effect of a HIV-related death and food insecurity has previously been 
studied where it has been shown that social and development implications cannot be 
ignored.(36, 37) Participants perceived a threat to food security in the livelihood of 
deceased persons due to loss of income when they ceased employment. This was 
often due to HIV-associated illnesses. Mortality is disproportionately high in the HIV-
infected people who are often economically active.(36, 38, 39) As a result, the 
livelihood of their dependents is put at risk. Our findings concur with previously 
reported research showing the association between food insecurity and mortality in 
HIV-infected individuals.(37, 40-42)   
Limitations in this study may include social desirability bias where participants were 
more likely to say things that portray them positively to the interviewer. All of the 
participants were VCT clients and thus likely to follow a line of thought introduced to 
them by the VCT counsellors. For some of the participants, it is likely that recall bias 
may have affected their responses since the demised HIV infected person may have 
died a few years earlier.  
Our findings showed the importance of providing social support to HIV-infected 
individuals. Participants perceived that provision of social support such as helping in 
domestic chores, food security and support to move around may have reduced the 
burden of disease and potentially reduced the risk of mortality. While literature on 
22 
 
social support such as home-based care for HIV-infected people is widely 
available,(4, 10, 43-45) there is limited information if any to show how provision of 
social support is associated with mortality in HIV-infected individuals.(46) More 
research is required to determine the effect of social support structure on morbidity 
and mortality of HIV-infected people especially in sub-Saharan Africa where the 
burden of disease is high. 
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